Western University

Scholarship@Western
Electronic Thesis and Dissertation Repository
8-12-2013 12:00 AM

Neurodevelopmental Consequences of Prenatal Alcohol
Exposure: Behavioural and Transcriptomic Alterations in a Mouse
Model
Katarzyna Mantha, The University of Western Ontario
Supervisor: Dr. Shiva Singh, The University of Western Ontario
A thesis submitted in partial fulfillment of the requirements for the Doctor of Philosophy degree
in Biology
© Katarzyna Mantha 2013

Follow this and additional works at: https://ir.lib.uwo.ca/etd
Part of the Molecular Genetics Commons

Recommended Citation
Mantha, Katarzyna, "Neurodevelopmental Consequences of Prenatal Alcohol Exposure: Behavioural and
Transcriptomic Alterations in a Mouse Model" (2013). Electronic Thesis and Dissertation Repository.
1462.
https://ir.lib.uwo.ca/etd/1462

This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

NEURODEVELOPMENTAL CONSEQUENCES OF PRENATAL ALCOHOL EXPOSURE:
BEHAVIOURAL AND TRANSCRIPTOMIC ALTERATIONS IN A MOUSE MODEL

(Thesis format: Monograph)

By

Katarzyna Mantha

Graduate Program in Biology

A thesis submitted in partial fulfillment
of the requirements for the degree of
Doctor of Philosophy

The School of Graduate and Postdoctoral Studies
The University of Western Ontario
London, Ontario, Canada

© Katarzyna Mantha 2013
i

ABSTRACT

Fetal Alcohol Spectrum Disorder (FASD) is an umbrella term referring to a range of physical,
behavioural, and cognitive deficits resulting from prenatal alcohol exposure. The resulting
abnormalities are heterogeneous and often attributed to timing and dosage of alcohol exposure.
However, the specific effects of developmental timing are not well-known.

This research used C57BL/6J (B6) as an animal model for early (human trimester one) and midgestation (human trimester two) alcohol exposure. Pregnant B6 mice were injected with 2.5 g/kg
ethanol on gestational day (GD) 8 and 11 (trimester one equivalent), or on GD 14 and 16
(trimester two equivalent). Resulting pups were followed from birth to adulthood using FASDrelevant behavioural tests. At postnatal day (PD) 70, whole brain tissues were extracted. A third
group of dams were injected on GD 16 (short-term). Two hours post injection, fetal brains were
removed. Brains were used for genome-wide expression analysis, including microRNAs.
Downstream analyses were completed using software packages and online databases.

All ethanol-treated pups showed motor skill delays, increased activity, and spatial learning
deficits. Gene expression analysis resulted in altered expression of 48 short-term genes between
ethanol and control mice treated during the second trimester. Fifty-five and 68 genes were
differentially-expressed in the long-term analyses of mice treated during trimester one and two,
respectively. Genes involved in immune system response were disrupted across all treatments.
Disrupted short-term processes included cytoskeleton development and immunological
functions. Processes altered in long-term exposures included stress signaling, DNA stability, and
cellular proliferation. MicroRNA analyses returned eight and 20 differentially-expressed
miRNAs in trimesters one and two, respectively. Target filtering of trimester one microRNAs
ii

and mRNAs resulted in inverse relationships between miR-532-5p and Atf1, Itpripl2, and Stxbp6.
Trimester two target filtering resulted in miR-302c targeting Ccdc6.

Gene expression and microRNA results demonstrate the stage-specific genes and processes
altered during neurodevelopment upon ethanol exposure. Certain cellular processes are disrupted
no matter the timing of ethanol exposure. Given that microRNAs are fine-tuners of gene
expression, they may play an important role in the maintenance of FASD. Furthermore,
transcriptomic changes in the brain may explain the observed behavioural effects of prenatal
ethanol exposure.

Keywords
Fetal Alcohol Spectrum Disorder (FASD), Ethanol, C57BL/6J, Neurodevelopment, Behaviour,
Brain, Gene Expression, Microarray, MicroRNA, Transcriptome.
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Introduction
1.1 Fetal alcohol spectrum disorders (FASD)
1.1.1 Clinical background on FASD
The maternal consumption of alcohol during pregnancy may lead to neurodevelopmental
abnormalities in exposed children1,2. Children exposed to ethanol prenatally may acquire a
continuum of permanent birth defects known as Fetal Alcohol Spectrum Disorders (FASD)3,4.
FASD affects approximately one in 100 live births5. FASD-related abnormalities may include
physical, behavioural, and cognitive dysfunctions of varying degrees2,6–9. Growth deficiency, low
birth weight, spatial learning delays, neuromuscular coordination deficits, central nervous system
damage, and craniofacial malformations are key features of FASD9–15. Children and adults who
have been exposed to alcohol in utero may experience problems in attention span, judgment,
communication, executive functioning, memory, and social adaptation16–18. Once affected by
alcohol, a child is affected for life, and there is no cure. Even with behavioural interventions,
individuals with FASD may live with lifelong learning disabilities and poor social skills9.
The spectrum of disabilities resulting from prenatal alcohol exposure ranges from mild
defects, defined as Fetal Alcohol Effects (FAE), to more severe and diagnosable cases of Fetal
Alcohol Syndrome (FAS). FAE are characterized by the occurrence of minimal abnormalities;
meanwhile, FAS is the most severe form on the FASD spectrum19,20. FAS is characterized by all,
or a combination of the following: severe mental illness, craniofacial abnormalities, intrauterine
growth retardation, depression or psychosis, and antisocial behaviour6,19,21. Unlike any other
forms of FASD, FAS is an official International Classification of Diseases (ICD) diagnosis22.
Other conditions resulting from in utero alcohol exposure include Alcohol-Related
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Neurodevelopmental Disorder (ARND) and Alcohol-Related Birth Defects (ARBD)7.
Hyperactivity, anxiety, emotional problems, and learning disabilities are common across the
FASD spectrum7,14,19. Due to the behavioural heterogeneity in individuals with FASD, it is
difficult to diagnose children with different types of FASD. To overcome this limitation, a
quantitative behaviour checklist is used to categorize abnormalities observed in children who
have been exposed to alcohol prenatally19. In this way, cases can be distinguished based on
child-specific behavioural manifestations of FASD disabilities. Specific classifications across the
FASD spectrum allow for more thorough insight into how an individual was developmentally
influenced by alcohol, both physically and mentally.
1.1.2 FASD is a wide-spread and costly disorder
The prevalence of FASD in Canada and the United States is approximately 9.1 in 1000
live births, as reported by the Public Health Agency of Canada5. In the late 1980’s, this number
was 1.9 per 1000 live births3. The number of individuals affected with FASD has been steadily
increasing. One possibility for the increasing rate of FASD is an increasing rate of disregard for
proper lifestyle habits during pregnancy. Also, pregnant women may be unaware of their
pregnancies and may continue to consume alcohol throughout early pregnancy. Other
possibilities for the increasing numbers of FASD could be due to increased awareness and selfreporting, resulting in more diagnoses. FASD is the most common, preventable cause of mental
retardation in Canada and the United States23. In Canada, the annual cost of FASD amounts to
5.3 billion dollars5.
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1.1.3 Current treatments for FASD exclude biological mechanisms
There is no treatment or cure for physical defects and central nervous system (CNS)
damage resulting from fetal alcohol exposure. However, the severity of learning disabilities can
be diminished. Parents and teachers can help children who have been characterized with FASD.
A multi-disciplinary approach is needed to characterize deficits in children with FASD7,18,24. In
the same way, a multi-disciplinary approach is also needed to help a child with FASD reach his
or her full potential. Other than parents and teachers, individuals who may be involved include
psychologists, social workers, and health counsellors. Techniques used by clinicians to evaluate
children with FASD may involve measuring a child’s growth rate and examining his or her facial
features25. Psychologists, speech-language pathologists, and occupational therapists may assess
CNS damage to help characterize the severity of defects resulting from prenatal alcohol
exposure26. Across a population, children with FASD have highly variable IQ scores27–29.
Individual learning profiles of each child must be developed and implemented. However, many
children with FASD are ineligible for special services because their intellectual abilities often
fall within the average range of intelligence30. These children ― who were exposed to alcohol
prenatally, but still have average intelligences ― benefit from IQ and achievement
measurements30. Functional classroom assessments, family information, and school assessment
processes allow educators and counsellors to work together to assess the impact of
environmental conditions on a child’s abilities. This helps to evaluate which conditions may
disrupt effective functioning and learning. The efficacy of Child Friendship Training has been
reported upon; this type of training improves knowledge of appropriate social behaviour in
children with FASD31. Another method, Cognitive Control Therapy, is often used to teach
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progressive skill-building that focusses on the child’s ability to understand his or her own
learning style and challenges30.
1.1.4 Difficulty in diagnosing FASD based on phenotypes
Prenatal alcohol exposure is the most common preventable cause of cognitive disabilities
in the western world23. However, FASD is difficult to properly diagnose, particularly because it
shares traits with other complex disorders such as Attention Deficit Hyperactive Disorder
(ADHD)32. ADHD is diagnosed in up to 94% of individuals who have experienced heavy in
utero alcohol exposure32. Often, children with FASD have co-morbid ADHD, and can be
diagnosed improperly. FASD-affected children may receive incorrect or insufficient treatment.
Rasmussen and colleagues analyzed 52 children with FASD, and found that 63% received a comorbid diagnosis of ADHD33. The authors also found that children with FASD and ADHD
performed worse than children with FASD but without ADHD on sensory/motor, cognitive,
communication, memory, executive functioning, attention, and adaptive behaviour tasks33.
Another study found that out of 2,231 FASD-affected youth, 41% were diagnosed with ADHD,
17% were diagnosed with learning disorders, and 16% were diagnosed with oppositionaldefiant/conduct disorder11. Although researchers make efforts to identify behavioural
characteristics differentiating children with FASD and ADHD, the psychological services are not
always available11,34. Maternal self-reported drinking as a means of predicting behavioural
dysfunctions in “at-risk” children can be misconstrued35. Other difficulties in the characterization
of FASD include absence of craniofacial malformations in children who have undergone in utero
alcohol exposure, coupled with the unavailability of maternal drinking data34. Also, an increase
in binge drinking among women of child-bearing age, coupled with the unawareness of
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pregnancy early in the first trimester, could contribute to the pervasiveness and eventual
mischaracterization of FASD36–38.
A further complication resulting in difficulty in characterization of FASD includes the
inconsistency of symptoms due to dosage-specific effects of alcohol. Since the 1960’s,
researchers have reported on the relevance of a multitude of factors in determining the severity
of FASD abnormalities; factors include: quantity, frequency, and timing of alcohol39. For
instance, facial dysmophology is caused by alcohol exposure during early gestation
(gastrulation)40. Heavy drinking increases the likelihood of FASD in offspring; children
prenatally exposed to high amounts of alcohol perform worse on measures important for reading
and arithmetic skills than children exposed to low amounts of alcohol41. Dosage- and timingspecificity may be attributable to disruption of specific neurodevelopmental patterns that occur
during fetal development. Though the timing- and dosage-specificity underlying FASD is not
well-established, women have been advised that no amount of alcohol is safe to consume during
pregnancy38. Researchers suggest that, in addition to genetic background, the timing and dosage
of prenatal alcohol exposure is an important factor in determining the variation in behavioural
manifestations related to FASD3,5,42.
1.2 Ethanol exposure can lead to adverse effects in the fetus
1.2.1 Ethanol’s mechanism of action
Prenatal alcohol exposure leads to alterations in fetal brain structures that give rise to
developmental and behavioural abnormalities in children19. The metabolism of alcohol in the
maternal liver involves the oxidation of ethanol into acetaldehyde by an enzyme called alcohol
dehydrogenase (ADH); ADH is further oxidized into acetate by another enzyme, acetaldehyde
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dehydrogenase (ALDH)43. The intermediary compound, acetaldehyde, is harmful to the fetus43.
Acetaldehyde leads to increased accumulation of oxygen radicals, which have harsh implications
on the developing brain. For instance, DNA replication and DNA repair enzymes can be
impaired44,45. Tissue damage may be a direct result of the accumulation of reactive oxygen
species (ROS) through the process of ethanol oxidation. Accumulation of acetaldehyde can result
from ADH conversion; the ADH complex is used to convert ethanol to acetaldehyde 90% of the
time43. Acetaldehyde can result in protein adducts, which lead to cellular damage, and
subsequent oxidative stress.
1.2.2 Ethanol toxicity in the developing fetus
In a developing fetus, morphological changes occur in multiple areas of the brain due to
ethanol toxicity. It is well-established that prenatal alcohol exposure can alter brain development,
leading to neurodegeneration in humans46–49, and in mice21,50–55. Ethanol can lead to reductions
in cerebellar volume and surface area, reductions in basal ganglia, decreases in dendritic
complexity, abnormalities in grey and white matter distribution and density, and apoptosis in
sensitive brain regions2,52,55. The affected brain areas are necessary for hormone regulation,
sensory information processing, learning, and memory. Ethanol (or its metabolites) can pass
through the blood-brain barrier and disturb the developing fetal brain. The basis for the observed
behavioural heterogeneity in FASD is unknown. Certain time points during pregnancy are
critical stages of neurodevelopment, and are particularly sensitive to environmental toxins (eg.
alcohol)2. Alcohol exposure at critical stages during pregnancy may lead to the spectrum of
abnormalities observed in children with FASD.
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1.3 Binge drinking and its adverse effects on offspring
Binge drinking is defined as a pattern of alcohol consumption that raises blood alcohol
concentration (BAC) to 0.08 gram percent or above, which is equivalent to the consumption of
five or more drinks within a couple of hours of each drink56. This definition has been revised to
three or more drinks per occasion; this level of drinking highly correlates with child
dysmorphology and behavioural alterations57. Binge drinking has been identified as the most
damaging form of alcohol consumption because it produces a high BAC in the mother, which
can have adverse effects on the developing fetus58,59. Peak BACs are higher in binge models of
alcohol exposure than more moderate, continuous-drinking paradigms; these data correlate with
increased atherosclerotic plaque development in binge versus continuous models of FASD in
mice60. Alcohol-induced neuronal loss in developing rats leads to increased brain damage
following maternal binge drinking61. Binge drinking is particularly harmful to the developing
fetus because alcohol takes longer to metabolize at higher BACs, particularly in women62. Also,
the specific gestational time of binge drinking may correlate with key stages of brain
development, which may lead to more severe deficits in offspring. On another note, there is a
strong association between binge drinking and unplanned pregnancy63. In cases of unplanned
pregnancy, women may consume alcohol without knowledge of pregnancy. These women may
continue to drink heavily into their pregnancies, having exposed their fetuses to the teratogenic
effects of alcohol.
1.4 Timing and dose-dependent effects of alcohol on neurodevelopment
The neurodevelopmental effects of alcohol are specific to the timing of exposure and the
developmental processes that occur during specific times. One of the critical points during
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neurodevelopment occurs during the embryonic stage of gestation (first trimester)2. Exposure to
alcohol during gastrulation negatively impacts formation of germ layers and reduces neural
progenitors64. These reductions lead to long-term effects on the forebrain and brainstem65,66.
Maternal binge drinking during the early stage of embryogenesis is also associated with a high
incidence of craniofacial malformations and mental disabilities67,68. Another critical stage during
fetal development occurs in humans from 7-20 weeks of gestation (second trimester). At this
stage, the fetal brain undergoes neuroepithelial cell proliferation and migration69. Most of the
areas of the nervous system (except cerebellum) begin to differentiate2,64,70. Prenatal ethanol
exposure can alter neuronal migration and lead to reductions in the numbers of neurons and glial
cells in the neocortex, hippocampus, and sensory nucleus in the fetal brain64,70. Such disturbances
to brain development can lead to long-term abnormalities in brain size and likely contribute to
cognitive deficits in individuals with FASD48.
Dosage is also an important factor that influences the severity of neurodevelopmental
deficits associated with prenatal alcohol exposure. Alcohol may affect the developing fetus in a
dose-dependent manner. Binge alcohol consumption produces more severe deficits in offspring
development and behaviour than daily moderate consumption59,60. Exposure to heavy drinking (>
48-60 grams ethanol/day) may cause FAS, whereas moderate drinking (between 24-48 grams
ethanol/day) can result in “alcohol effects”71. Binge drinking, with intakes of 4-5 drinks of
ethanol per sitting (> 90 grams ethanol/day), can result in greater peak BACs than other forms of
alcohol consumption72. It is difficult to define and characterize developmental risks associated
with binge drinking in human subjects due to inconsistencies in dosage and timing.
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1.5 Using mouse models to study FASD
1.5.1 The impact of the C57BL/6J mouse in FASD research
FASD, specifically when studied in the C57BL/6J (B6) mouse, has been examined by
various methods. The B6 mouse is the most widely used inbred strain and was the first to have
its genome sequenced73. The B6 mouse is commonly used in alcohol-related research. Years ago,
alcohol’s causative role in FAS was examined through administration of ethanol injections in
pregnant mice74. B6 mice were often used in ethanol preference tests to study defects in
locomotor activity and passive avoidance behaviour1. Using B6 mice in ethanol preference
models was beneficial since B6 mice prefer to drink ethanol to water ~70% of the time75.
Therefore, these mice are useful for studies on FASD. Once the genetics of alcohol metabolism
were elucidated, more researchers used mice for molecular studies of ethanol exposure. The
results of this research led to identification of polymorphisms in the ADH genes, which are
associated with the conversion of ethanol to acetate; ADH genes were detected in human
subjects, and could be subsequently used for knockout studies in mice76. Throughout the years,
studies have continued using B6 mouse models to identify FASD-related phenotypes through
various means. Some of the studies included proteomics screenings of amniotic fluid77,
behavioural testing78, placental biomarker identification79, dendrite sectioning55, candidate gene
selection80,81, and more recently, genome-wide studies82–84.
1.5.2 Advantages of a mouse model for complex disorders
Although studies use a variety of model organisms, there are many advantages to using a
mouse model:
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1. Mouse genomes and human genomes both contain the same approximate number of
genes (~30,000), of which 95-99% are homologous85.
2. Genetic determinants of diseases in humans are highly conserved in mice86–88.
3. The B6 strain has been used successfully in replicating a variety of FASD-related
phenotypes with well-defined experimental tools1,78,89–91.
4. The effects of prenatal ethanol exposure on neurodevelopment are well-studied in B6
mice21,51,92–95.
5. The B6 mouse has been used to examine transcriptomic alterations in the brain using
high-density, mouse-specific arrays80,81,96–98.
6. Using the B6 mouse allows for precise control of ethanol timing and dosage21.
7. Many behavioural tests used for mice are well-established and representative of
human behaviours89,91,99–101.
1.5.3 Differences in dosage of ethanol in producing FASD-relevant phenotypes
Various ethanol dosages, resulting in varying BACs, have been examined in mice. BACs
must remain above a toxic threshold of neurodegeneration, in the range of 180-200 mg/dl, to
produce FASD-relevant behavioural deficits in mice21. This toxic threshold was proposed by
Ikonomidou and colleagues, who found that ~200 mg/dl was the minimum condition for
triggering neurodegeneration21. With a dose of 2.5 g/kg of ethanol, given once, BAC barely
crosses the toxic threshold for neurodegeneration. When 2.5 g/kg ethanol is given twice, spaced
two hours apart, BAC rises to ~500 mg/dl and remains above 200 mg/dl for ~14 hours. This
double injection paradigm allows for enough ethanol to raise the BAC above 200 mg/dl. Also,
this paradigm gives a second boost of alcohol, allowing the BAC to remain > 200 mg/dl for
several hours. The maintenance of increased BAC occurs because the degenerative response
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becomes progressively more severe. This effect results in long-lasting behavioural deficits,
neurodevelopmental abnormalities, and gene expression changes in the offspring91,102. In
addition to dose, the method of ethanol delivery is important. Researchers have consistently used
injections to administer ethanol to pregnant females21,103,104. The most widely used routes of
injection in mice include subcutaneous (sc) and intraperitoneal (ip) injections105. However,
because ip injections can result in direct ethanol injection into the womb and severe discomfort
for the female, sc injections provide a safer route of administration105.
1.5.4 A variety of mouse-specific behaviour tests to model FASD
It is well-known that individuals with FASD have a range of behavioural deficits,
depending on the timing and dosage of prenatal alcohol exposure. In order to characterize these
disabilities, a variety of mouse-specific behaviour tests can be used. Behavioural traits that can
be measured include: developmental milestones, activity, anxiety-related behaviours, and
learning and memory. Activity and anxiety-related behaviours can be measured using an
Actitrack apparatus (PanLab Harvard Apparatus, Holliston, MA). An Elevated Plus Maze (EPM)
and a Light/Dark Box (LDB) and can also be used to measure anxiety-related behaviours99,100.
Spatial learning and memory can be assessed in mice using a Barnes Maze89.
Developmental milestone assessment on neonatal and postnatal mice will be completed
following a protocol outlined by Hill and colleagues101. The milestones outlined in this protocol
are: surface righting, negative geotaxis, cliff aversion, forelimb grasp, air righting, open field
traversal, eye opening, and ear twitching. The milestones are assessed from postnatal day (PD) 221. Each of the tasks represents an examination of FASD-relevant milestones that are delayed in
children exposed to alcohol prenatally. Some of the delays represent deficits in strength, reflex,
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motor coordination, and balance44,106–108. The usefulness of these tasks has been demonstrated in
previous studies of complex disorders, including FASD91,109,110.
As juveniles, mice can be assessed at PD 25-30 for exploratory behaviour to examine
general activity and anxiety-related traits in a novel, open-field, environment using the locomotor
apparatus91. PD 25-30 corresponds to the prepubescent period in mice111. The prepubescent stage
is a common time for diagnosing ADHD in children112,113. At PD 25-30, anxiety can assessed
concurrently using the locomotor apparatus. Anxiety disorders manifest in childhood, but rise
into adolescence114. Examining anxiety-related traits in mice between PD 30-35 will allow for
assessment at adolescence. In this case, the EPM and LDB, which are popular tools to assess
anxiety-related traits in rodents, are used beginning PD 3099,100. The locomotor apparatus, EPM,
and LDB rely on the rodent’s innate aversion to brightly illuminated or open areas; these tests
also rely on the spontaneous exploratory behaviour of the animals100. Anxiety-relevant results
from each of these tests should be complementary. Due to the complexity and
multidimensionality associated with anxiety-related traits, it is beneficial to use more than one
tool to generate data regarding anxiety-related behaviours in mice115.
Spatial learning and memory are assessed using a Barnes Maze, beginning PD 45-5089.
The timing corresponds to early adulthood in mice, and allows for the comparison of these
behaviours to adult humans36. Although learning disabilities are observable in children with
FASD, the reasoning behind testing at young adulthood is to examine whether disabilities
persists from birth to adulthood. In the Barnes Maze, mice rely on spatial orientation to learn the
location of a target hole89. Given that mice have dichromatic vision, four spatial reference points
― coloured black, orange, or blue ― are used to visually create shade/shape-differences across
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walls. An overhead light and white noise are generated to motivate mice to learn the spatial
orientation of a target hole in order to escape the open field area.
1.6 Evidence for ethanol’s effect on gene expression
Along with behavioural abnormalities, molecular pathways are differentially affected by
prenatal alcohol exposure43,82. Cellular death, resulting from prenatal ethanol exposure, is
dependent on the ability to transcribe and translate genes116. Strongly-supported ethanol targets
include enzymes that bind alcohol (i.e. ADH)43, and postsynaptic receptors such as N-methyl-Dasparate (NMDA)-type glutamate receptors and γ-aminobutyric acid type A (GABAA)
receptors117,118. Treatment of animals with ethanol alters the expression and function of genes
and proteins87,119,120. Even with the accumulation of knowledge surrounding ethanol’s effects on
genes, it is not well-understood which genes are affected by ethanol. Also, specific gene
knockouts do not necessarily implicate any of the resulting proteins as direct targets of ethanol
action120,121. A protein’s particular role may be downstream from the initial binding sites for
alcohol. Candidate gene studies are not sufficient to explain complex mechanisms of ethanol’s
neurotoxic effects. Complex disorders, such as FASD, are multifactorial, with multiple gene
interactions underlying its phenotypes122. A polymorphism or misregulation of a single gene is
not enough to explain the wide spectrum of FASD phenotypes. Also, a candidate gene approach
to conducting genetic studies focuses on associations between genetic variation within predefined genes-of-interest and phenotypes or disease states. This approach fails to elucidate the
molecular underpinnings of complex disorders for various reasons. Spectrum disorders, like
FASD, typically vary in severity of symptoms, which results in difficulty in defining an
appropriate phenotype. Also, these disorders vary in their aetiological mechanisms, which may
involve various biological pathways. Finally, complex diseases are likely caused by
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dysregulation of several, and even numerous, genes, each with a small overall contribution and
relative risk123. To combat these issues, genome-wide approaches have been undertaken.
However, previous genome-wide studies lack consistent and comprehensive dosage regimens. In
particular, reports are not consistent when comparing behaviours and transcriptomes in ethanol
and control subjects between different time points. With the increase in knowledge from gene
chip analysis (microarray) studies, the gene expression changes resulting from prenatal ethanol
exposure can be better understood. Once ethanol-responsive genes and pathways are identified,
insight into causes, therapies, and treatments may be possible.
1.7 Microarrays to study global gene expression patterns
1.7.1 Microarrays as a means of studying complex disorders
Microarrays, commonly known as DNA chips, are defined as a collection of microscopic
DNA spots attached to a solid surface. They are used to measure the expression levels of large
numbers of genes simultaneously. Each of the DNA spots contains picomoles of a specific DNA
sequence known as a probe. A probe is a short section of a gene, or other DNA element, that is
used to hybridize a complementary DNA (cDNA) or complementary RNA (cRNA) sample under
high stringency conditions. Detection of hybridization is usually through a fluorophore-labeled
target, which is used to determine relative abundance of nucleic acid sequences in the target.
Microarrays have been used extensively for humans and mice, in the search for gene expression
changes associated with complex disorders such as: aging, cancer, obesity, schizophrenia,
Alzheimer’s Disease, autism, alcoholism and, more recently, FASD124–131. As a disclaimer in this
thesis, when referring to gene expression, I specifically mean mRNA levels (i.e. the
transcriptome). The application of microarrays to mice, particularly the B6 mouse, is well-
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documented; mouse microarrays are useful for examining the underlying biological mechanisms
governing complex phenotypes, which include abnormalities resulting from prenatal alcohol
exposure91,132–134. Complementary DNA microarrays allow for the quantification of large
numbers of messenger RNA transcripts for the purpose of large-scale insight into cellular
processes involved in the regulation of gene expression135.
1.7.2 Overview on functional, pathway, and network analysis of microarray data
Following the identification of differentially-expressed genes (DEGs) using microarrays,
various software programs can be used to determine the importance of specific pathways and
networks in relation to behavioural phenotypes. For functional characterization of DEGs, the
following databases are applicable: The Database for Annotation, Visualization and Integrated
Discovery (DAVID)136, Gene Ontology Enrichment (GE) (Partek Inc., St. Louis, MO, USA), and
Ingenuity Pathway Analysis (IPA) (Ingenuity® Systems, Redwood, CA). The freely available
DAVID program relies on functional annotation clustering, which uses a p-value to examine the
significance of gene-term enrichment using a modified Fisher’s exact test136,137. A p < 0.05
suggests that an input gene is significantly more enriched than by random chance. The Partek
Genomics Suite software version 6.6 (Partek Inc., St. Louis, MO) tool, GE, returns a list of
functions based on the DEGs. The higher the enrichment score, the more overrepresented a
functional group is in the gene list. This score is calculated using a chi-squared test, which
compares the proportion of the gene list in a group to the proportion of the background in the
group138. An enrichment score > 1 indicates that the functional category is over expressed, while
a score of 3 corresponds to significant over expression (p < 0.05). IPA, a commercially available
tool, is regarded as a high-quality functional analysis and knowledge discovery program. In IPA,
a p-value is associated with a function, and is calculated using a right-tailed Fisher’s exact test139.
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The p-value is calculated by considering the number of focus genes that participate in a process,
versus the total number of genes that are known to be associated with that process. The p-value
identifies significant over-representation of focus genes in a given process. Over-represented
functional processes are those that have more focus genes than expected by chance (righttailed)139.
To identify genes in already-established pathways, Pathway Express (Intelligent Systems
and Bioinformatics Laboratory, Michigan, USA), Pathway Enrichment (PE), and IPA will be
used. The freely available Pathway Express database is considered as a high-throughput pathway
visualization tool that focuses on pathways alone (no functional characterization). By default,
Pathway Express uses hypergeometric distribution for p-value calculation140. The impact factor
associated with a pathway is a probabilistic term that takes into consideration the proportion of
DEGs in the pathway. Essentially, Pathway Express quantifies the influence of DEGs on a given
pathway. The quantification of DEGs, in addition to the p-value, is used to distinguish between
pathways that have the same proportion of DEGs141. Pathway Enrichment is a new feature
incorporated in Partek software. PE generates an enrichment score, in addition to a p-value, for
each pathway. This score is the negative natural log of the enriched p-value (Fisher’s exact
test)142. Both PE and Pathway Express rely on information from the Kyoto Encyclopedia of
Genes and Genomes (KEGG) database (Kanehisa Laboratories, Tokyo, Japan); therefore, the
results should be similar between the programs. Canonical pathway assessment using IPA results
in a list of significant pathways that are altered based on the input genes. Canonical pathways are
determined based on two parameters: a ratio of the number of genes from the data set that map to
the pathway, divided by the total number of genes that map to the canonical pathway, and a p-
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value calculated using Fisher’s exact test that determines the probability that the association
between the genes in the data set and canonical pathway is due to chance alone143.
Two tools, GeneMANIA (Donnelly Centre for Cellular and Biomolecular Research,
Toronto, Ontario) and IPA, can be used for network analysis of inputted genes that have shown
to interact with other molecules. GeneMANIA incorporates a linear-regression algorithm. This
algorithm is used to calculate a functional association network of inputted genes with other genes
that are known to interact with the input genes; GeneMANIA uses this algorithm to predict gene
function144. To complement GeneMANIA results, IPA can be used to further identify interacting
networks. IPA has been successfully used by various researchers to examine networks of
interacting genes that may play a role in a variety of diseases and disorders including FASD94,145–
148

. IPA links genes and molecules by interactions, which are based on current knowledge from

records maintained in the Ingenuity Pathways Knowledge Base. Highly-interconnected networks
are likely to represent significant biological function149,150. In IPA, each network is limited to
~35 genes, by the algorithm. A p-score, which is derived from a p-value, is calculated using
Fisher’s exact test. This score is assigned to each network, and is simply a measure of the
number of focus genes in a network (user-specified genes)151. Another way to define the score is,
the likelihood that the focus gene within the network was found by random chance152. A high
number of focus genes leads to a higher network score. The network score is equal to the
negative exponent of the respective p-value such that a score of 3 corresponds to a p-value of
10E-3153. Therefore, a network is considered significant with a p-score > 2. The combination of
results from the DEG list, along with the functional, pathway, and network analyses, will give
insight into FASD-relevant genes.
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For a gene to be determined relevant to FASD-related phenotypes, it must be
differentially-expressed on the microarray. Also, the gene must be implicated in
neurodevelopment or behaviour, implicated in a top pathway or network, or involved in an
inverse relationship with a differentially-expressed microRNA (miRNA). If the gene is classified
as a central “hub” molecule in one of the top three networks, it may also be worthy of
investigation. For the purpose of this study, a “hub” is defined as a molecule that appears in a top
IPA network with strong intramodule connectivity to all other genes in the same module
(analogous to the definition of a “hub” node in protein-protein interaction networks); a hub does
not necessarily need to be altered, itself154. Previous studies have defined “hubs” as nodes with
connectivity greater than five molecules155–157. In my thesis, a hub is restricted to a minimum of
10 interactions in order to provide a stringent analysis. A hub molecule is linked to dysregulated
gene(s), which suggests that there are common mechanisms associated with neurodevelopmental
ethanol exposure. The hub genes identified in this thesis are based on the number of interactions
in the network158.
1.8 Examining microRNAs (miRNAs) in the maintenance of FASD
1.8.1 MiRNAs and their role in the brain
In an attempt to explain the maintenance of gene expression changes in the adult brain
following prenatal ethanol exposure, I will assess the importance of miRNAs in this role.
MiRNAs are short (~17-25 nucleotides) endogenous noncoding RNAs that post-transcriptionally
repress expression of protein-coding genes by base-pairing with the 3’ untranslated region (UTR)
of the target messenger RNA (mRNA)159,160. The ability of one miRNA to target multiple
mRNAs suggests that miRNA are exceptionally important regulators of various cell processes.
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MiRNAs can suppress gene expression through multiple mechanisms such as translational
inhibition and mRNA degradation161. This degree of coverage implicates miRNAs in a vast
regulator RNA network that enables flexible control of mRNA expression, especially in the
brain. The brain is composed of 100-200 billion neurons, and each is connected to 5000-200,000
neurons162–164. Local control of gene expression upon synaptic activation and/or inhibition,
coupled with gene expression, may be influenced by miRNAs. MiRNA genes are encoded within
the genome, suggesting that their transcription may be tightly coordinated with their transcription
of other genes (i.e. targets).
MiRNAs have been referred to as “master regulators of gene expression”, thus it may be
useful to examine their roles in complex disorders. MiRNAs appear to be responsible for fine
regulation of gene expression, thereby “tuning” the cellular phenotype during delicate cellular
processes such as development and differentiation165. Given that many miRNAs are conserved in
sequence between distantly-related organisms, they may participate in essential processes166,167.
During neurodevelopment, miRNAs are expressed in neurons and show distinct expression
patterns within the developing CNS168,169. MiRNA expression in the CNS demonstrates their
relevance to brain development and function. Researchers have implicated various miRNAs and
their target genes ― particularly GABA and NMDA-related genes ― in psychopathology
including: Tourette’s syndrome170, schizophrenia171, bipolar disorder171, autism172 and Rett
Syndrome173 .
1.8.2 MiRNAs are ethanol-responsive
One of the first pieces of evidence that miRNAs mediate ethanol’s teratogenic effects
came from Sathyan and colleagues, who screened ~200 mouse miRNAs for ethanol sensitivity in
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fetal neural stem cells174. Following this discovery, it was demonstrated that, between the latter
half of the first trimester to the middle half of the second trimester period in mice, ethanol altered
approximately 3% of the assessed mature miRNAs in whole brain RNA samples175. More
recently, reseachers showed that differentiated neurons exposed to “chronic intermittent ethanol”
resulted in significant alterations in ~11% of detected miRNAs176. Although only a small subset
of miRNAs is known to be regulated by ethanol, these studies provide evidence for the
dysregulation of miRNAs in FASD. The number of ethanol-sensitive miRNAs increases with
developmental stage, which may reflect increasing complexity and diversity of miRNAs during
neuronal maturation176. MiRNAs exhibit development stage-specific sensitivity to ethanol175,176.
Some miRNAs are ethanol-sensitive over multiple developmental stages174,176. There is evidence
for regional specificity of dysregulated miRNAs in the brains of ethanol individuals177. However,
a global analysis of miRNA regulation in the whole brain will strive to complement and compare
the results to global gene expression results.
MiRNAs may play an important role in the maintenance of FASD. Some miRNAs play
important roles in early neural tube patterning, telencephalic neurogenesis, and early
differentiation, which occur during fetal development178,179. MiRNA knockouts in mice result in
FAS-like phenotypes such as fetal growth retardation and microcephaly180. Studies suggest that
GABAA receptors (GABAAR) and nicotinic acetylcholine receptors (nAChRs) mediate ethanol
effects on miRNA expression174,181. Several ethanol-sensitive miRNAs are localized within
chromosomal regions that are susceptible to epigenetic modification. Therefore, ligand-gated ion
channel receptors, such as GABAARs and nAChRs, and epigenetic modifications, are potential
mediators of ethanol’s effects on fetal miRNA182.
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1.8.3 Detecting globally disrupted miRNAs in the brain using arrays
There are several miRNA:mRNA target strategies that could be employed to examine the
relationship between genes and miRNAs. There are various bioinformatic miRNA target
prediction programs that produce lists of predicted targets for a given miRNA. For instance,
TargetScan uses the Ensembl database to define 3’ UTRs in order to identify genuine miRNA
targets183. Prediction program rates of false positives range between 24-70%184. Experimental
data are necessary to identify genuine miRNA targets. One experimental strategy to identify
miRNA targets includes gene-specific experimental confirmation with well-established
techniques such as quantitative reverse transcription PCR (qRT-PCR) to assess individual
miRNA:mRNA interactions185. However, this strategy would not give a global picture of all
possible miRNA:mRNA interactions in a specific state. Additionally, demonstrating individual
miRNA:mRNA interactions misses the capacity to regulate complex genetic networks.
Uncovering such networks requires large-scale and unbiased methods of miRNA target
identification, followed by downstream gene expression analysis (microarray and qRT-PCR).
Quantitative RT-PCR may be useful in the downstream confirmation of specific miRNAs.
Only in the past decade have miRNA chips been used to study global changes in response
to ethanol exposure174,185. When coupled, miRNA and gene expression arrays are useful for
detecting inverse relationships between genes and miRNAs188. Launched in 2011, the Affymetrix
GeneChip miRNA 2.0 Array (Affymetrix, Santa Clara, CA) offers the broadest coverage of
known miRNA, encompassing 131 organisms on one array, and allowing for downstream,
independent interrogation of mouse-specific miRNA expression189. An overall analysis of
mouse-specific miRNA alterations in response to prenatal ethanol exposure will be useful in
determining molecular changes associated with FASD. MiRNAs that are found to be

22

differentially-expressed ― using the same fold change and p-value criteria as those used in gene
expression analysis ― can be submitted to IPA Target Filtering. Target Filtering is used to
predict miRNA:mRNA inverse relationships.
1.9 Background on FASD summarized
FASD represents a major health concern in the developing world. FASD is the leading
cause of preventable birth defects in North America, affecting approximately one in 100
individuals, and costing Canada 5.3 billion dollars annually5. Given the rise in binge-drinking
among women of child-bearing age190,191, FASD remains a major health concern. The correlation
between binge-drinking and risky behaviour, including unplanned pregnancy, further increases
the chances of birthing a child with FASD192. Difficulties arise in the study of FASD in human
populations. The biological mechanisms governing this disorder are not well-elucidated, and
require the use of a model organism. Given these issues, researchers should focus on the
developmental understanding of prenatal ethanol exposure, including its effects on behaviour and
the brain transcriptome. A more-comprehensive understanding of FASD needs to be generated,
with a focus on timing, mechanism, and potential molecular targets for corrective measures.
1.10 Hypothesis and objectives
1.10.1 Hypothesis
Prenatal alcohol exposure (binge) during the first and second term of gestation causes
FASD-related behavioural abnormalities, and involves immediate and lifelong changes in brain
gene expression affecting specific molecular pathways and networks.
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1.10.2 Specific objectives
1. To establish if
a) binge-like prenatal ethanol exposure alters developmental milestones, and
b) leads to behavioural abnormalities associated with FASD in C57BL/6J mice.
1. To establish if binge-like prenatal ethanol exposure leads to immediate (fetal) and longterm (adult) alterations in genome-wide gene expression in the brain, including miRNAs.
2. To establish if the changes observed in 2. are specific to molecular pathways and
networks related to behaviour and/or neurodevelopment.
3. To establish if changes in 3. may account for changes in behaviours observed in 1.a and
1.b.
4. To establish any role for miRNAs in altered gene expression in response to binge-like
prenatal ethanol exposure.
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2. Materials and Methods
2.1 Animals
2.1.1 Animal care and use
This research uses C57BL/6J mice. All animal protocols were approved by the Animal
Use Subcommittee at the University of Western Ontario (Appendix A) and complied with the
ethical standards outlined by the Canadian Council on Animal Care. Mice were originally
obtained from Jackson Laboratories (The Jackson Laboratory, Bar Harbor, ME) and
subsequently bred at the Health Sciences Animal Care Facility at the University of Western
Ontario (SOP #2007-059-10). Males and females were housed in separate (same-sex) cages.
Food and water were provided ad libitum. Eight-week-old B6 females were time-mated
overnight with 8-12-week-old B6 males. The following morning, gestational day (GD) 0, males
were removed from cages and females remained alone for the duration of their pregnancies.
Cages were standardized between animals and included only nestlets and bedding. Mice were
kept on a 14/10 hour light/dark cycle at a temperature of 21-24°C with 40-60% humidity.
2.1.2 Experimental design
Pregnant dams were randomly divided into three groups. These included: 1) trimester two
treatment, short-term exposure (T2-S), 2) trimester one treatment, long-term exposure (T1-L),
and 3) trimester two treatment, long-term exposure (T2-L). Each experimental group consisted of
two randomly assigned subgroups of dams: ethanol-exposed (ethanol) and saline-exposed
(control). The experimental design is shown in Figure 1 and includes subjects, treatments,
groups, experimental tests, and criteria for FASD-relevant candidate genes and miRNAs.
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To assess the immediate effects of ethanol exposure on the developing brain, a group of
pregnant dams (T2-S) was randomly assigned to two subgroups: ethanol and control. Dams were
subcutaneously injected at GD 16 with 2.5 g/kg of ethanol in 0.15 M saline at 0 h and 2 h.
Matched control dams were injected with 2.5 g/kg saline at 0 h and 2 h on GD 16. Two hours
following the second injection, dams from both subgroups were euthanized by CO2 asphyxiation
and cervical dislocation. Fetal brains from the two groups of dams were extracted and used for
gene expression arrays (Figure 1).
To model acute, binge-like ethanol exposure during the first trimester equivalent (T1-L)
dams were subcutaneously injected at GD 8 and 11 with 2.5 g/kg of ethanol in 0.15 M saline at 0
h and 2 h21,193–195. Matched control dams were injected with 2.5 g/kg saline on GD 8 and 11 at 0
h and 2 h. Mothers were allowed to give birth, and T1-L offspring were followed from birth (PD
2) until early adulthood (PD 70) using a battery of behavioural tests. At PD 70, animals were
euthanized by CO2 asphyxiation, followed by cervical dislocation. Whole brains were used for
transcriptome analysis, which included gene expression arrays and miRNA arrays (Figure 1).
To model binge-like ethanol exposure during the second trimester equivalent (T2-L),
dams were injected with 2.5 g/kg of ethanol in 0.15 M saline at 0 h and 2 h on GD 14 and
1621,158. Matched controls were injected with 2.5 g/kg saline at 0 h and 2 h on GD 14 and 16.
Once again, mothers were allowed to give birth, and T2-L offspring were followed from PD 2-70
using a battery of behavioural tests. At PD 70, mice were euthanized by CO2 asphyxiation and
cervical dislocation. Whole brains were dissected for gene expression and miRNA analysis
(Figure 1).
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Figure 1. Experimental layout showing short-term (T2-S) and long-term (T1-L and T2-L)
groups, behavioural and transcriptomic experiments, and criteria for relavant
transcriptomic changes following prenatal ethanol exposure. The number of mice (n) used
for behavioural experiments are shown. The number (n) of individual mice (biological replicates)
is shown for each molecular experiment. For array experiments, six individuals were segregated
onto two arrays with three pooled mice on each array. T2-S = trimester two, short-term effect
(pink). T1-L = trimester one, long-term effect (blue). T2-L = trimester two, long-term effect
(green). miRNA = microRNA. mRNA = messenger RNA. qRT-PCR = quantitative reverse
transcription PCR. Gene expression and qRT-PCR were completed on T2-S samples. Behaviour,
gene expression, miRNA analysis, and qRT-PCR (genes and miRNAs) were completeted on T1L and T2-L. Genes and miRNAs were considered candidates for Fetal Alcohol Spectrum
Disorder (FASD) if they were: implicated in neurodevelopment or behaviour and/or if they were
found in a top pathway/network or had an inverse miRNA:mRNA relationship.
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2.2 Behaviour testing
2.2.1 Developmental milestone assessment
T1-L and T2-L ethanol and control mice were followed from PD 2-21 for the
achievement of developmental milestones101. Achievement was based on the ability of a pup to
display a positive response for two consecutive days. For each milestone, the number of days to
reach the milestone was recorded. The second consecutive day was recorded as the day of
acquisition of the milestone. Testing commenced at 10:00 am each day, with the dam placed in a
separate cage throughout the testing procedure.
a) Surface righting
Beginning on PD 2, the pup’s ability to right itself on a plastic surface was evaluated.
Pups were placed on their backs with all four limbs held to the top and, once released, the time
(seconds) taken to roll over and place all four paws on the surface was measured. This test
measures the development of the vestibular reflex and motor coordination. Positive responses
were noted when pups were able to complete the task for two consecutive days in < 1 second.
b) Negative geotaxis
On PD 2, the pup’s ability to rotate its body 180° while on a sloped platform was
measured. Pups were placed on a mesh wire platform, angled at 45° from the horizontal, with
their nose pointed towards the ground. The latency to rotate the body until the nose pointed
upward was recorded. Latency to rotate the body is considered a measurement of vestibular and
postural reflexes. Positive responses were noted once pups were able to complete the task for two
consecutive days in < 30 seconds.
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c) Cliff aversion
Beginning on PD 2, the pup’s ability to avert a cliff was assessed. Pups were placed on
the end of a 2-inch-high platform with their noses and fore-digits suspended over the edge of the
simulated cliff. The latency to back away from the edge of the cliff, turn, and crawl away was
measured. This test is considered an evaluation of sensory and motor coordination development.
Positive responses were noted when pups completed the task < 30 seconds for two consecutive
days.
d) Forelimb grasp
On PD 4, the pup’s ability to grasp a wire rod and suspend its own bodyweight was
evaluated. Pups were placed with their forepaws on a rod held 10 cm above a 5-cm-deep pile of
woodchip bedding. Once released, the time the pup remained grasping onto the rod was
recorded. A minimum of 1 second indicated a positive response. This task assesses balance,
coordination, and motoric strength.
e) Auditory startle
Beginning on PD 7, pups were tested for an auditory reflex in response to a loud noise.
An auditory reflex was assessed in the form of a rapid involuntary jump or “startle” in response
to a clapping noise. One clap was performed 10 cm from the pup, and a positive response
(startle) was recorded for two consecutive days.
f) Ear twitch
On PD 7, pups were tested for the presence of a tactile reflex of the ear. The edge of a
fine filament was gently rubbed against the pup’s ear three times. A positive response was
recorded when the ear twitched rapidly in response to the brushing motion, for two consecutive
days.
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g) Open field taversal
On PD 8, the pup’s locomotion and ability to extinguish pivoting behaviour was assessed.
Pups were placed in the center of a 13-cm circle, and the latency to exit the circle was measured.
All four paws must be outside the perimeter of the circle to consider the milestone reached. A
positive response was noted once the pup exits the circle in < 30 seconds for two consecutive
days.
h) Air righting
Beginning PD 8, pups were tested for the achievement of vestibular reflex function and
motor coordination using the air righting task. Pups were held upside down, 10 cm above a 5cm-deep pile of woodchip bedding, and released. A positive response was noted when a pup
could right its body in the air such that it landed on the bedding on all four paws.
i) Eye opening
Beginning PD 10, pups were examined daily for eye opening. The first day in which both
eyes were opened was considered achievement of this milestone.
2.2.2 Open-field activity
The daytime and overnight activity of each mouse was assessed using a Panlab Infrared
(IR) Actimeter (Harvard Panlab, Holliston, MA) from PD 28-35. The open-field apparatus
consisted of a 450 (W) mm x 450 (D) mm square arena with 450 (H) mm x 350 (W) mm acrylic
walls mounted to the base. Thirty-two IR beam sensors were located around the perimeter of the
apparatus to provide sensitive movement detection. Movement was recorded using Actitrack
Tracking Software (PanLab, Holliston, MA, USA).
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a) Daytime novel activity
Daytime activity levels were assessed from PD 28-30. The Actimeter was used to
measure a mouse’s locomotor response to a novel environment. Locomotor response was
represented by recording breaks in the IR beams (beam breaks) within the recording frame of the
apparatus (Figure 2). Total locomotor activity, as measured by the total number of beam breaks,
was recorded using Actitrack software. Testing commenced at 10:00 am, and lasted for 15
minutes for each individual. The arena and Plexiglas walls of the apparatus were wiped with
30% isopropanol following each test in order to remove olfactory cues and excrement. Solutions
of 10-30% isopropanol are sufficient for removal of olfactory cues91,196.
b) Overnight home cage activity
At PD 30-35, mice were introduced into a simulated home cage 24 hours prior to
overnight activity testing. The simulated home cage included standard woodchip bedding, food
pellets, and water. Following acclimation, the home cage was placed in the Actimeter for 12
hours overnight. The period of recording consisted of a 2-hr light period (6:00 pm -8:00 pm) and
a 10-hr dark period (8:00 pm – 6:00 am), spanning the overnight phase. The IR beams detected
locomotor patterns of a mouse’s nocturnal activity while encaged. A measurement of total
locomotor activity (total number of beam breaks) was recorded using the Actitrack software.
Data from the analysis software were analyzed as a whole (one 12-hr period) and in blocks
(twelver 1-hr periods).
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Figure 2. A photograph of the Panlab Infrared (IR) Actimeter apparatus used to measure
novel, open-field activity in mice. The total number of IR beam breaks was recorded for each
15-minute period. A C57BL/6J mouse is depicted at the top corner of the arena. The Panlab
Actimeter was acquired from Harvard Panlab, Holliston, MA.
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2.2.3 Anxiety-related traits
a) Panlab infrared actimeter
The IR Actimeter was used to assess thigmotaxis in mice at PD 28-30. The amount of
time spent in the center versus the periphery of the locomotor apparatus in the 15 minute period
was recorded (Figure 2). This measurement relied on the rodent’s natural tendency to stay in the
periphery of an open field arena and not venture into the middle of the open field.
b) Elevated plus maze
An EPM was used as a measure of anxiety-related behaviour in mice at PD 35-40
(Figure 3). The maze comprised of 4 adjoining, cardboard arms (2 open, 2 enclosed) that stood
50 cm above the ground. Closed arms were 50 cm (L) x 10 cm (W) x 40 cm (H). Open arms were
50 cm (L) x 10 am (W). The arms were connected in a plus-formation such that the mice were
able to cross between arms. The EPM relies on the rodent’s natural tendency to seek dark,
sheltered areas, and avoid bright (200 lx), exposed, and high-altitude areas197. At the beginning
of the trial, a mouse was placed facing an open arm at the intersection of the apparatus. The
mouse’s movement was recorded by AnyMAZE Video Tracking software (San Diego
Instruments, San Diego, CA). Testing was conducted for a single, 5-minute period for each
mouse. A 5-minute interval is considered capable of revealing differences in anxiety-related
traits across mice197. In between trials, the Plexiglas cover on the maze was wiped with 30%
isopropanol.
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Figure 3. A photograph of the Elevated Plus Maze (EPM) apparatus used to assess anxietyrelated traits in mice. The time spent in the closed arms versus the open arms in a 5-minute
period was recorded. A C57BL/6J mouse is depicted in the top closed arm of the EPM.
Plexiglas, in a plus-formation, covers the white arms of the maze.
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c) Light/dark box
At PD 35-40, the LDB was used as a measure of exploratory behaviour and anxietyrelated behaviour in a novel, illuminated environment (Figure 4). The apparatus was constructed
following a design by Bourin and Hascoet, which included two compartments consisting of a 27
cm (L) x 27 cm (W) x 27 cm (H) light arena (plastic), and a 18 cm (L) x 27 cm (W) x 27 cm (H)
dark arena (cardboard)100. A 7.5 cm x 7.5 cm opening was created between the light and dark
regions. At the beginning of each trial, the mouse was placed in the light area facing the opening.
The mouse was allowed to freely explore both areas for 5 minutes, with an overhead light at 200
lx. Movement was recorded by AnyMAZE Video Tracking software. In between trials, the
plastic arena was wiped with 30% isopropanol
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Dark

Light

Figure 4. A photograph of the Light/Dark Box (LDB) used to assess anxiety-related traits
in mice. The time spent in the closed area (black cardboard box) versus the open area (white
plastic box) in a 5-minute period was recorded. A C57BL/6J mouse is depicted in bottom right
corner of the LDB. Arrows point to the dark and light areas of the LDB.
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2.2.4 Spatial learning and memory
From PD 45-70, the Barnes Maze was used as a test of spatial learning, short-term recall,
and long-term recall. The maze was constructed by Ph.D. candidate, Morgan Kleiber, according
to Sunyer and colleagues89 (Figure 5). The apparatus was comprised of a circular wood platform
with a 92-cm-diameter, punctuated with 20 equally-spaced holes (each 5 cm in diameter) along
the periphery of the platform (7.5 cm between holes). The platform stood 105 cm above the
ground. One of the holes along the perimeter was a target hole, through which mice were able to
enter an escape box. Black cardboard sheets were placed underneath the other 19 holes. The
escape box was painted black to remain visually indistinguishable from other holes.
Experimenter-prepared visual cues were constructed and placed around the testing room to
provide spatial details regarding the location of the target hole. Aversive stimuli were added to
the test, in the form of a 150 W bright light. An 85 dB white noise was generated using
AnyMAZE software. AnyMAZE was also used to track the mouse’s movements during each
trial. Upon the mouse’s entry into the escape box, the light and white noise were turned off for a
period of 1 minute to allow the mouse to acclimatize to the box. The platform and escape box
were wiped with 30% isopropanol between trials.
a) Learning
Mice were given four trials over four acquisition days (learning days) to learn the
location of the target hole. At the beginning of each trial, a mouse was placed in the center of the
maze inside a cylindrical start-chamber for 10 seconds. Once the start-chamber was removed, the
mouse was allotted 3 minutes to explore the maze and locate the target hole. If the mouse entered
the target hole within the 3 minute period, the overhead light and white noise were terminated.
The mouse was allotted 1 minute in the escape box following its entry. If the mouse did not
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locate the target hole within the 3 minute period, the mouse was guided to the escape box
following the trial and allowed to remain inside the box for 1 minute. Each mouse was trained on
the Barnes Maze for four consecutive days, with each training day consisting of four 3-minute
trials. There was a 15 minute interval between trials. After each trial, the mouse was returned to
its home cage. The latency (seconds) to enter the escape box was measured using AnyMAZE
software.
b) Memory
The fifth (short-term recall) and twelfth (long-term recall) days of Barnes Maze testing
are referred to as “probe” trials. Good memory on probe trials in the Barnes Maze is defined as
selective search for the former location of the target, compared with equivalent locations in other
zones198. On probe days 5 and 12, the escape box was removed, and the target hole was covered
with black cardboard. Each mouse was given one 1-minute trial on each day to explore the maze
(Figure 5). The number of explorations to each hole was recorded.
2.2.5 Statistical analysis of behavioural data
For each behavioural test, data were analyzed using appropriate analysis of variance
(ANOVA) methods depending on the number of independent variables (sex, treatment, repeated
day of testing). Where data were analyzed across days, repeated measures ANOVA (RMANOVA) with “treatment” as the between-subjects factor. “Day” (Barnes maze) or “hour”
(Overnight home-cage activity) was used as the within-subjects factor was used. All data were
reported as mean ± standard error of the mean (SEM). For the Barnes Maze probe trials, a
Bonferroni correction was applied to correct for multiple testing. Effects of litter were analyzed
using “litter” as a covariate in the ANOVA; however, no litter effects were observed for any of
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the behavioural measures. Data were stratified by sex only if sexually dimorphic effects were
observed. All statistical analyses were performed using Statistical Package for the Social
Sciences (SPSS) version 16 (SPSS Inc., Chicago, IL).
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Target
hole

Figure 5. A photograph of the Barnes Maze used to assess spatial and learning memory in
mice. Spatial cues, consisting of various shapes and colours, are displayed around the testing
room. All holes, except the target hole, are covered with black cardboard cut-outs. The target
hole leads to a black escape box, positioned underneath the platform. Arrow points to the
location of the target hole.
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2.3 Gene expression analysis
2.3.1 Tissue extraction and RNA isolation
Whole brains (T2-S, T1-L, and T2-L) were harvested, snap-frozen in liquid nitrogen, and
stored at -80°C. Total RNA was extracted using Trizol® according to the manufacturer’s
instructions (Invitrogen, Carlsbad, CA). To check the quality of RNA, 2 μl of each sample was
quantified using the ND-1000 Spectrophotometer (Thermo Fisher Scientific Inc., Wilmington,
DE) and Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., Palo Alto, CA) at the London
Regional Genomics Center (LRGC) (University of Western Ontario, London, Ontario). An
automated gel image was generated based on the results of the electropherogram, in order to
visualize the quality of the RNA sample as if it were electrophoresed through on a standard 1%
agarose gel. RNA was shown to be of good quality by A260/A280 ratio in the range of 1.8-2.1,
which is indicative of pure RNA199. Also, only those samples with concentrations > 100 ng/µl,
ratios of A260/A230 between 2.0-2.2, and RNA Integrity Numbers within the range of 8-9.5
were used for analysis. If a sample with A260/A280 < 1.8 was identified following microarray
analysis, it was discarded in qRT-PCR confirmation experiments.
2.3.2 Microarray preparation
Whole brain RNA from B6 mice was sent to LRGC for hybridization to Affymetrix
Mouse Gene 1.0 ST arrays, which are high-density oligonucleotide arrays. Each chip contained
three pooled samples (three different mice) of RNA. Pooling samples allowed for reduction of
litter effects between mice. For each experiment, one control and one experimental array were
analysed, along with a biological replicate of each. For T2-S mice, 4 gene chips were used (2
control, 2 ethanol), with a total of 12 RNA samples (different mice). For T1-L and T2-L, 8 arrays
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were used (2 control, 2 ethanol per group), with a total of 24 RNA samples (different mice). A
biological replicate was preferred to a technical replicate because biological diversity is
controlled by using different samples (ie. mice) of the same treatment. For the entire experiment,
a total of 12 microarrays and 36 RNA samples were used. In order to pool samples for each
array, 2 µl of RNA was diluted to 100 ng/µl. The concentrations of the diluted samples were
double checked. If inaccurate, the original RNA was diluted again using the correct
concentration. Samples were then pooled (~100 ng/µl).
Microarray cDNA synthesis, in vitro transcription, cRNA fragmentation, and
hybridization reactions were carried out at LRGC. Using 200 ng of total RNA, the RNA was first
reverse transcribed to single-stranded complementary DNA (sscDNA) using the Ambion WT
Expression Kit for Affymetrix GeneChip Whole Transcript WT Expression Arrays (Applied
Biosystems, Carlsbad, CA) and the Affymetrix GeneChip WT Terminal Labeling kit and
hybridization manual (Affymetrix, Santa Clara, CA). First-cycle cDNA was transcribed in vitro
to cRNA, and used to synthesize 5.5 μg of sscDNA that was subsequently end-labeled (biotin)
and hybridized for 16 hours at 45°C to Affymetrix Mouse Gene 1.0 ST arrays. Liquid-handling
steps were performed by a GeneChip Station 450. The arrays were stained using StreptavidinPhycoerythrin, which binds to the biotin molecules and emits a fluorescence when run through
the GeneChip Scanner 3000 7G using Command Console version 1.1 (Affymetrix In., Santa
Clara, CA, USA). The scanner output the raw intensity values and images for each probe into a
probe level (.CEL) file, which allowed visualization of the fluorescence.
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2.3.3 Microarray data analysis
Probe-level (.CEL) data were generated using Affymetrix Command Console version 1.1
and probes were summarized to gene-level data using Partek Genomics Suite software version
6.6 (Partek Inc., St. Louis, MO). Array analysis for each of the experiments (T2-S, T1-L, and T2L) was completed. Data were background corrected, quantile-normalized, summarized, and log2transformed. Subsequent statistical analyses were performed using Partek software to determine
gene-level ANOVA p-values and fold changes. Because prenatal ethanol exposure has been
shown to produce subtle changes in gene expression94,158, a ± 1.2 fold change and p < 0.05 were
used as criteria for building gene lists for functional, pathway, and network analyses. Unannotated genes and standards were removed from the gene lists. All data files from the array
experiments have been deposited in the National Center for Biotechnology Information Gene
Expression Omnibus, under the accessions: GSE34469 (T1-L and T2-L) and GSE43324 (T2-S).
Complete lists of DEGs identified for T2-S, T1-L, and T2-L are given in Appendices B, C, and
D, respectively.
2.3.4 Statistical analysis of microarray data
Statistical analysis of microarray data is necessary to make inferences about a
phenomenon based on empirically measured data. Microarrays measure the mRNA levels of
thousands of genes, and are then analyzed to identify genes that are correlated to a phenotype of
interest. Here, gene-level summarization was performed using an ANOVA to compare ethanol
and control data. The ANOVA condensed the dataset into a manageable set of DEGs based on
certain criteria: a fold-change and an alpha level of significance (based on the ANOVA). The
inputted data from the arrays (.CEL file extension) were normalized using an internal algorithm.
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The using the GeneChip-Robust Multiarray Averaging algorithm, with GC-content background
correction (GC-RMA) ― which accounts for probe GC-content200 ― was used since it has been
shown to perform well by other researchers201,202. GC-RMA incorporates probe sequence
composition into background adjustment based on the assumption that probe affinity is
dependent on its base composition and the position of each base along the probe; herein, this
suggests that the probe sequence can significantly affect the intensity of the signal generated
from that probe, independent of the level of quantity of its target203. Researchers have reported
on the use of GC-RMA and its outstanding performance in detecting low-intensity, DEGs, and
its consistency with qRT-PCR202,204.
Partek is an exploratory data tool used for the identification of DEGs using ANOVA205.
The ANOVA is a powerful method of data analysis that is motivated by consideration of the
experimental design206. The challenge with an ANOVA is to detect as many real differences as
possible while maintaining control over the rate of false detection. The most popular approach to
rectify this is to apply a false discovery rate (FDR) correction; an FDR correction generates a list
of DEGs such that the expected proportion of false detections on the list is bounded at a userdefined level207. In Partek analysis, the ANOVA was performed on all genes. A table was created
that allowed the investigator to browse and create gene lists from the results based on p-value
and fold change.
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2.3.5 Functional, pathway, and network analysis of differentially-expressed genes
(DEGs)
Once identified by Partek, DEGs were analyzed using three functional characterization
tools. The functional annotation and clustering tool, DAVID137,208, was used. DAVID uses a
modified version of Fisher’s exact test to identify statistically significant Gene Ontology (GO)
terms including biological process (BP), cellular component (CC), and molecular function
(MF)209. Other annotations used to group genes in DAVID include: BioCarta pathways
(BioCarta LLC, San Diego, California, USA), KEGG pathways, Protein Sequence Analysis and
Classification (InterPro) (Wellcome Trust Genome Campus, Cambridgeshire, United Kingdom),
Simple Modular Architecture Research Tool (SMART)210,211, and Swiss-Prot and Protein
Information Resource (SP PIR) (Georgetown University Medical Center, Washington, DC,
USA). Using the Gene Enrichment tool, Partek was used to identify over-represented GO terms
associated with genes showing altered expression. Finally, IPA was used to cluster genes based
on biological functions. Upregulated and downregulated gene lists (± 1.2 fold change, p < 0.05)
were assessed concurrently for each analysis.
To characterize sets of functionally related DEGs, three sets of pathway analysis
programs were used. Pathway Express was used. Gene sets (± 1.2 fold change and p < 0.05)
were inputted into the Pathway Express tool to translate these lists into functional profiles (using
GO terms) in order to characterize the impact of prenatal ethanol exposure. For each GO
category, statistical significance values were calculated using a Fisher’s exact test140. The results
from Pathway Express were complemented using the Pathway Enrichment tool in Partek. PE
also relies on the KEGG database to assign enriched pathways for each of the DEG lists. Lastly,
canonical pathways were assessed using IPA. The goal of using three pathway tools was to
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compare the results, and to generate biologically meaningful and comprehensive data from each
of the gene lists.
Network analysis of the DEGs was completed using two programs. The publically
available pathway tool, GeneMANIA, was used to find genes (using a linear regression-based
algorithm) that were related to the input genes; such an analysis gives input on specific genetic
interactions, pathways, co-expression, co-localization, and protein domain similarity in mice212.
The gene lists were further inputted into IPA to identify networks in which genes and proteins
have been reported to interact with each other, whether directly or indirectly. By employing
various functional, pathway, and network analyses on the lists of DEGs, this method gave
comprehensive insight into the biological mechanisms underlying FASD.
2.3.6 Confirmation of gene expression by quantitative RT-PCR (qRT-PCR)
Excess RNA extracts that were used for array hybridization were also used to confirm the
expression of selected genes by qRT-PCR. Complementary DNA was synthesized using 2 µg of
total whole brain RNA using a High-Capacity cDNA Reverse Transcription kit (Applied
Biosystems, Foster City, CA) according to the manufacturer’s protocol. Gene-specific TaqMan®
Assay Reagents and TaqMan Gene Expression Assay products were used on a StepOneTM Real
Time PCR System (Applied Biosystems, Foster City, CA). Primers and 6-carboxyfluorescein
(FAM)-labeled probes for specific genes (Table 1) were obtained from Applied Biosystems
Inventoried Assays and used as per the manufacturer’s instructions. Reactions were multiplexed
with Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) or Actin, beta (Actb) using genespecific primers and VIC-labeled probes. Reactions were performed using a standard ramp speed
protocol using 10 μl volumes. PCR cycling consisted of a 10 minute initiation at 95°C, followed
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by 40 cycles consisting of a 15 second denaturation at 95°C and an anneal and extension at 60°C
for 60 seconds. Experiments included six biological replicates per treatment (only five biological
replicates were available for T2-L ethanol samples) and three technical replicates per sample.
Relative expression was calculated according to the comparative CT method213 using StepOneTM
version 2.0 software from Applied Biosystems. All PCR data are reported as mean ± SEM
relative expression values. Significant differences were assessed using a student’s t-test in SPSS.
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Table 1. Candidate genes for FASD selected for confirmation by quantitative RT-PCR.
Groupa Gene
Symbolb
Ccl3
T2-S
Ccnt1
Gpr50
Lair1
Pip5k1b
Rybp
Slitrk2
Trdn
Atf1
T1-L
Ceacam1

T2-L

a

Gene Name

Reference
Genec
Chemokine (C-C motif) ligand 3
Actb
Cyclin T1
Gapdh
G protein-coupled receptor 50
Gapdh
Leukocyte-associated immunoglobulin-like receptor 1
Gapdh
Phosphatidylinositol-4-phosphate 5-kinase, type I, beta
Actb
RING1 and YY1 binding protein
Gapdh
SLIT and NTRK-like family, member 2
Gapdh
Triadin
Actb
Activating transcription factor 1
Actb
Carcinoembryonic antigen-related cell adhesion molecular 1 Actb
(biliary glycoprotein)
Eomes
Eomesodermin (Xenopus laevis) homolog
Gapdh
Htr5a
5-hydroxytryptamine (serotonin) receptor 5A, G-protein Gapdh
coupled
Map3k1
Mitogen-activated protein kinase kinase kinase, E3 ubiquitin Actb
protein ligase
Stxbp6
Syntaxin binding protein 6 (amisyn)
Actb
Synpr
Synaptoporin
Gapdh
Tnfrsf19
Tumor necrosis factor receptor superfamily, member 19
Gapdh
Camk1g
Calcium/calmodulin-dependent protein kinase 1G
Gapdh
Ccdc6
Coiled-coil domain containing 6
Actb
Cdkn1a
Cyclin-dependent kinase inhibitor 1a
Gapdh
Egr3
Early growth response 3
Gapdh
Homer1
Homer homolog 1 (Drosophila)
Gapdh
Hsp90aa1 Heat shock protein 90kDa alpha (cytosolic), class A member Actb
1
Hspa5
Heat shock 70kDa protein 5 (glucose-regulated protein, Actb
78kDa)
Manf
Mesencephalic astrocyte-derived neurotrophic factor
Gapdh
Tbxa2r
Thromboxane A2 receptor
Actb
Xbp1
X-box binding protein 1
Actb

Groups: T2-S = trimester two, short-term effect. T1-L = trimester one, long-term effect. T2-L = trimester two, longterm effect.
b
Genes are listed in alphabetical order for each group.
c
Reference gene was either Actin, beta (Actb) or Glyceraldehyde-3-phosphate dehydrogenase (Gapdh).
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2.4 MicroRNA analysis
2.4.1 Experimental design and miRNA arrays
The RNA samples used for long-term gene expression analyses (T1-L and T2-L) were
also used for global miRNA analysis using miRNA arrays. For each long-term group, each array
contained three pooled samples of RNA, corresponding to the animals used in gene expression
experiments. For each group, two biological replicates of a control and ethanol array were
performed (n = 4 arrays per group; total n = 8 arrays). All sample labeling, hybridization, and
processing were performed at LRGC. One microgram of total RNA was labeled using the Flash
Tag Biotin HSR kit (Genisphere, Hatfield, PA, USA) and hybridized to Affymetrix MiRNA 2.0
arrays for 16 hours at 45°C. Probe level (.CEL file) data were generated using Affymetrix
Command Console version 1.1 (Affymetrix In., Santa Clara, CA). Probes were summarized to
gene-level data in Partek using the Robust Multiarray Averaging (RMA) algorithm200. Partek
software was used to determine differences between ethanol and control samples using one-way
ANOVA and corresponding p-values and fold changes. For each group, the miRNAs on the
array were filtered using stringency criteria including a p < 0.05 and ± 1.2 fold change. The
miRNA expression array results for both groups (T1-L and T2-L) were deposited within the
NCBI GEO database under accession number GSE34413.
2.4.2 MiRNA target filtering and selection criteria
Data generated using T1-L and T2-L miRNA arrays were analyzed using IPA.
Concurrently, T1-L and T2-L gene lists from gene expression analyses (± 1.2 fold change, p <
0.05) were combined with their corresponding miRNA list in IPA’s Target Filter analysis. Target
filtering was performed to generate a list of interactions between genes and miRNAs in each
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group. Results were filtered based on a moderate or high confidence of interaction and an inverse
miRNA to target mRNA expression relationship214.
2.4.3 Confirmation of miRNAs using quantitative RT-PCR
Excess RNA extracts that were used for miRNA array hybridization were also used to
confirm the expression of selected miRNAs by qRT-PCR. Complementary DNA was
synthesized using 2 µg of total whole brain RNA using the Applied Biosystems TaqMan Reverse
Transcription Kit (Applied Biosystems, Foster City, CA, USA) and sequence-specific step-loop
reverse transcription primers from TaqMan MicroRNA Assays (Applied Biosystems, Foster
City, CA, USA) according to the manufacturer’s protocol. All qRT-PCR primers and miRNAspecific TaqMan probes were selected using the Applied Biosystems (Carlsbad, CA, USA)
search engine to identify previously characterized TaqMan MicroRNA Assays. FAM-labeled
probes for miRNA 1192 (miR-1192, T1-L), miRNA 532-5p (miR-532-5p, T1-L), and miRNA
302c (miR-302c, T2-L) were obtained from Applied Biosystems Inventory Assays and used as
per the manufacturer’s instructions. Small nucleolar RNA 202 (snoRNA 202) was chosen as an
endogenous control95,215. The target and control reactions were performed in separate tubes on
the same plate for each sample as per the manufacturer’s protocol. Three technical replicates
were used for both the endogenous control and gene of interest for each sample. As with qRTPCR for genes, six biological samples were used for each treatment (except for T2-L ethanol
samples, where only five experimental samples were used). Quantitative PCR reactions were
performed on the StepOne Real-Time PCR System according to the manufacturer’s protocol.
Reactions were run following a standard ramp speed protocol using 20 μl volumes. Fold change
was calculated using the ∆∆CT method216. Data were analysed using Applied Biosystems
DataAssistTM Software version 3.0. Statistical significance was assessed using a two-tailed t-test.
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3. Results
3.1 Overview on presentation of results
This chapter includes results on behaviours and brain gene expression, including
miRNAs, using B6 mice, following in vivo binge-like ethanol treatment at two stages of
neurodevelopment. The timings include, GD 8 and 11 (representing human trimester one), and
GD 14 and 16 (representing human trimester two). All behavioural testing was performed on
resulting trimester one and two progeny. Behavioural testing began at early development (PD 2)
until maturity (PD 70), at which time mice were euthanized for brain transcriptome analysis. A
separate experiment assessed gene expression patterns 2 hrs following ethanol treatment on GD
16 to represent short-term effects of ethanol exposure. The results are now published in the
Journal of Neurodevelopmental Disorders158, Journal of Behavioural and Brain Science217, and
Disease Models and Mechanisms95. I have obtained permission for using copyright images from
the editor of the Journal of Behavioural and Brain Science for inclusion in this thesis (Appendix
E). This copyright includes the adaptation of any images from the article. A copyright approval
was not required from other journal editors since I have not included images from these articles.
For specifics on authorship, please refer to co-authorship statement (p. ix).
3.2 FASD-relevant behaviours are altered in mice following gestational ethanol exposure
3.2.1 Developmental milestone achievement is delayed following prenatal ethanol
exposure
All pups from trimesters one and two were evaluated from PD 2-21 for the ability to
reach critical developmental milestones. The day each specific milestone was achieved (second
consecutive day), for each group, is shown in Table 2217. Ethanol exposure during the first
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trimester equivalent significantly delays the abilities of pups to right themselves when placed on
their backs (F1,46 = 29.90, p < 0.001), grasp a rod with their forelimbs (F1,46 = 15.50, p < 0.001),
extinguish pivoting behaviour by transversing out of a 15-cm-diameter circle (F1,46 = 15.10, p <
0.001), and right themselves in the air when dropped from upside down from 5 cm (F1,46 = 23.71,
p < 0.001). A significant interaction between sex and treatment was observed for the ability of
the pup to right itself in the air when dropped (F1,46 = 7.60, p = 0.008), with control males taking
longer to right themselves than control females; however, ethanol females took longer to right
themselves than ethanol males. Ethanol pups from trimester two were significantly increased,
compared to control pups, in the time it took to surface right (F1,54 = 4.93, p = 0.03), turn 180°C
upward when placed downward on a 45° screen (F1,54 = 34.88, p < 0.001), crawl away from the
edge of a cliff (F1,54 = 25.10, p < 0.001), grasp the rod (F1,54 = 6.65, p = 0.01), transverse out of
the circle (F1,54 = 17.02, p < 0.001), right themselves in the air (F1,54 = 10.06, p = 0.003) and
open their eyes for the first time (F1,54 = 6.21, p = 0.02). Post-hoc testing using all four groups
(trimester one control and ethanol; trimester two control and ethanol) revealed that the only
developmental milestone in which trimester one and two ethanol mice were significantly
different was forelimb grasp (F3,100 = 19.66, p < 0.001).
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Table 2. Developmental milestone achievement of postnatal day ethanol and control pups.
Treatment
Sex
Milestonea
Surface righting
Negative geotaxis#
Cliff aversion
Forelimb grasp
Auditory startle
Ear twitch
Open field traversal
Eye opening
Air righting
a

Control
Male
T1
(n=11)
6.5±0.4
7.0±0.4
9.0±0.4
9.6±0.6
14.7±0.2
9.8±0.3
10.6±0.6
14.7±0.1
12.9±0.7

T2
(n=18)
8.7±0.3
6.2±0.4
7.9±0.5
10.0±0.7
13.9±0.4
9.3±0.3
10.9±0.4
13.8±0.2
12.1±0.6

Female
T1
(n=12)
6.4±0.4
7.5±0.4
9.7±0.4
9.3±0.4
13.8±0.5
9.5±0.3
11.4±0.4
14.3±0.1
11.0±0.6

T2
(n=10)

Ethanol
Male
T1
(n=13)

T2
(n=11)

Female
T1
(n=14)

T2
(n=20)

8.4±0.3 ***9.1±0.4
*8.9±0.3 ***8.7±0.5
*9.7±0.3
7.4±0.3
6.6±0.5 ***9.5±0.7
6.6±0.4 ***9.4±0.3
6.4±0.9
9.1±0.5 ***9.7±0.4
8.7±0.3 ***10.4±0.4
9.4±0.8 ***11.5±0.7
11.1±0.5 ***11.9±0.5
11.6±0.3
14.0±0.3
13.1±0.5
13.4±0.8
13.8±0.6
14.2±0.4
10.4±0.5
9.3±0.4
10.4±0.3
9.9±0.5
10.4±0.3
10.0±0.4 ***12.5±0.3 ***12.4±0.6 ***12.8±0.4 ***12.5±0.4
14.2±0.3
14.5±0.1
*14.6±0.2
14.6±0.2
*14.4±0.2
12.4±0.5 ***14.1±0.5 **14.0±0.7 ***15.2±0.4 **14.2±0.4

Mean (± SEM) number of days to complete each task was compared across males and females from trimester one (T1) and trimester two (T2) ethanol and
control pups. *p < 0.05; **p < 0.01; ***p < 0.001. Number (n) of mice used for each test are shown.
#
Negative geotaxis is the only developmental milestone in which T1 and T2 ethanol mice were significantly different (p < 0.001).
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3.2.2 Locomotor activity is altered in mice following gestational ethanol exposure
a) Daytime novel activity is increased in ethanol-treated mice
Spontaneous activity of control and ethanol juveniles (PD 28-30) from trimesters one and
two was assessed over a 15 minute period in a novel, open-field environment. Two-way
ANOVA did not result in a significant effect of sex or an interaction between sex and treatment.
Therefore, the groups were collapsed and a one-way ANOVA with “treatment” as the main
factor was applied. One-way ANOVA showed a significant effect of treatment in trimester one
(F1,46 = 6.48, p = 0.01) and trimester two (F1,54 = 69.89, p < 0.001), where the number of beam
breaks was increased in ethanol mice (T1-L: 2835.58 ± 136.81; T2-L: 3429.13 ± 93.81 beam
breaks) versus control mice (T1-L: 2332.12 ± 142.89; T2-L: 2291.54 ± 98.57 beam breaks).
There were no significant differences between T1-L and T2-L control mice. A significant
difference was found between trimester one and two ethanol mice (F3,100 = 25.22, p = 0.001),
with trimester two ethanol mice displaying increased activity compared to trimester one treated
mice (Figure 6)217.
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Figure 6. Bar graph of locomotor activity in a novel, open-field encironment in ethanol and
control mice. Mean (± SEM) infrared beam breaks (total no. beam breaks) of ethanol and
control mice from trimester one (T1) and trimester two (T2) over a 15 min period (n = 20-28
mice per group). *p < 0.05; **p < 0.01; ***p < 0.001.

55

b) Overnight home cage activity is disrupted in ethanol-treated mice
Locomotor activity in a familiar environment (home cage) was assessed in ethanol and
control mice at PD 30-35. For both groups, a two-way ANOVA for total 12-hour activity did not
identify any significant effects of treatment, sex, or an interaction between treatment and sex.
The data were further analyzed in twelve 1-hour measurements. Two-way RM-ANOVA with
“hour” as the within-subjects factor, and “sex” and “treatment” as between-subjects factors
detected significant main effects of hour and treatment. A significant main effect of treatment in
trimester one was found (F1,46 = 12.09, p = 0.001), with ethanol mice demonstrating increased
activity (4160.01 ± 192.89 beam breaks) throughout the nocturnal phase, versus control mice
(3190.38 ± 201.47 beam breaks) (Figure 7)217. The pattern in trimester two mice resulted in a
nominally significant increase in activity levels (F1,54 = 3.311, p = 0.074) in ethanol mice
(4762.62 ± 258.37 beam breaks) compared to control mice (4080.70 ± 271.47 beam breaks)
(Figure 8)217. For overnight activity levels, a comparison between trimester one and two ethanol
mice was not carried out due to observed discrepancies between males and females, and
statistical differences between control mice.
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*
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Figure 7. Line graph of locomotor activity in a familiar home-cage environment in
trimester one ethanol and control mice. Mean (± SEM) infrared beam breaks (no. beam
breaks) by ethanol and control mice from trimester one (A) females (n = 26) and (B) males (n =
20). *p < 0.05; **p < 0.01. Lights were off between 8:00 pm - 6:00 am.
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Figure 8. Line graph of locomotor activity in a familiar home cage environment in
trimester two ethanol and control mice. Mean (± SEM) infrared beam breaks (no. beam
breaks) by ethanol and control mice from trimester two (A) females (n = 28) and (B) males (n =
26). *p < 0.05; **p < 0.01. Lights were off between 8:00 pm - 6:00 am.
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3.2.3 Anxiety-related behaviours are dependent upon timing of ethanol exposure
a) Open field testing
To evaluate the effects of novelty-induced, anxiety-related traits in the open field task,
thigmotaxis was examined during open-field testing. No statistically significant effect of
treatment was observed between ethanol (214.46 ± 23.60 s) and control (185.88 ± 19.50 s) mice
in trimester one (F1,46 = 0.92, p = 0.34). A significant main effect of treatment was observed in
trimester two (F1,54 = 59.65, p < 0.001), with ethanol offspring spending significantly more time
(477.31 ± 26.94 s) in the center zone than control mice (175.52 ± 28.30 s). Trimester two ethanol
mice also spent significantly more time in the center zone (F3,100 = 34.34, p < 0.001) than ethanol
and control trimester one mice (Figure 9)217.
b) Elevated plus maze
In the EPM, there were no statistically significant differences (F1,46 = 1.109, p = 0.30) in
the amount of time spent in the open arms versus the closed arms between ethanol (94.42 ± 5.66
s) and control mice (86.94 ± 3.96 s) from trimester one. Similarly, in trimester two, there were no
significant differences (F1,54 = 0.11, p = 0.74) in the amount of time spent in the open arms
versus the closed arms of the EPM between ethanol (69.45 ± 3.89 s) and control mice (68.96 ±
4.17 s).
c) Light/dark box
A LDB was further used to evaluate anxiety-related phenotypes that have been observed
in daytime open-field activity data. Trimester one ethanol (146.12 ± 7.58 s) and control (160.90
± 7.92 s) mice were not significantly different (F1,46 = 1.82, p = 0.18). Trimester two ethanol
mice spent significantly (F1,54 = 7.08, p = 0.01) more time (average: 152.46 ± 4.65 s) in the light
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area of the box than control mice (average: 134.50 ± 4.89 s) (Figure 10)217. A comparison
between trimester one and two ethanol mice was not performed because data for trimester one
and two control mice were statistically different (p = 0.016).
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Figure 9. Bar graph of time spent in the centre of a novel, open-field environment in
ethanol and control mice. Mean (± SEM) time in seconds (s) spent in the centre of the
apparatus of ethanol and control mice from trimester one (T1) and trimester two (T2) over a 15
min period (n = 20-28 mice per group). ***p < 0.001.
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Figure 10. Bar graph of time spent in the light area of a light/dark box in ethanol and
control mice. Mean (± SEM) time in seconds (s) spent in the centre of the apparatus of ethanol
and control mice from (A) trimester one and (B) trimester two over a 5 min period (n = 20-28
mice per group). *p < 0.05.
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3.2.4 Ethanol-treated mice exhibit learning and memory deficits in the Barnes maze
a) Learning is disrupted following gestational ethanol exposure
Mixed-model ANOVA showed a significant interaction of treatment by acquisition day
on latency to reach the escape box. There was no significant effect of sex or an interaction
between sex and treatment observed for any treatment time. Trimester one ethanol mice
displayed increased latency (day 3 average: 24.81 ± 2.37; day 4 average: 24.33 ± 2.43 s) to reach
the escape box than control mice (day 3 average: 12.68 ± 2.47; day 4 average: 13.29 ± 2.54 s) on
acquisition days three (F1,46 = 12.54, p = 0.001) and four (F1,46 = 9.86, p = 0.003) (Figure
11A)217. Ethanol mice from trimester two had significantly increased latency (average: 109.09 ±
7.91 s) to reach the target hole on day one (F1,54 = 10.60, p = 0.002) versus control mice
(average: 71.74 ± 8.31 s), but performed similarly to control mice on days two to four (Figure
11B)217. A comparison between trimester one and two ethanol mice revealed significant
differences on learning days three (F3,100 = 10.01, p < 0.001) and four (F3,100 = 14.36, p < 0.001),
with trimester two ethanol mice displaying increased latency to the target hole versus trimester
one treated mice.
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Figure 11. Line graph of latency to reach the target of the Barnes Maze in ethanol and
control mice. Average latencies in seconds (s) to the target represent mean latencies (± SEM) of
four trials per day across four acquisition days for ethanol and control mice from (A) trimester
one and (B) trimester two. Data shown are collapsed across sex (n = 20-28 mice per group). **p
< 0.01; ***p < 0.001.
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b) Short-term and long-term recall is delayed in ethanol-treated mice
Short-term and long-term retention of memory in the Barnes Maze was assessed on days
5 and 12, respectively. The number of explorations to each hole was calculated. On probe day 5
(short-term recall), trimester one ethanol mice were not significantly different from control mice
in the number of explorations to any holes. A main effect of sex (F1,46 = 5.33, p = 0.025) was
found, with females (average: 2.46 ± 0.13 explorations) exhibiting significantly more
explorations to the target hole than males (average: 2.05 ± 0.12 explorations). No significant
interaction between sex and treatment was observed (Figure 12A)217. On probe day 12 (longterm recall), a significant main effect of sex (F1,46 = 4.22, p = 0.046) was found, with females
(average: 2.64 ± 0.15 explorations) exhibiting more explorations to the target hole than males
(average: 2.21 ± 0.15 explorations). A significant effect of treatment (F1,46 = 7.17, p < 0.05) was
observed at position +2 (near the target hole), with control mice demonstrating more explorations
than ethanol mice (Figure 12B)217. There were no statistically significant differences between
trimester one and two ethanol mice.
No significant effects of sex or an interaction between sex and treatment were observed
for the number of explorations made by ethanol and control trimester two mice on probe day 5.
A significant effect of treatment was observed for the number of explorations to the adjacent
hole (position -1) to the target location (F1,54 = 14.27, p < 0.001), with control mice performing
more explorations than ethanol mice. Significant effects of treatment were also observed for
positions on the opposite side of the platform, with ethanol mice pursuing significantly more
explorations to the opposite side of the target hole than control mice (Figure 13A)217. Although
no main effects of sex were observed, a significant interaction between sex and treatment on
probe day 12 (F1,54 = 6.03, p = 0.02) was observed. Significant effects of treatment were
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observed for the explorations to the target hole (F1,54 = 12.29, p = 0.02) and the hole adjacent to
the target (position -1) (F1,54 = 6.17, p = 0.002), with control mice spending significantly more
time within the target hole area than ethanol mice (Figure 13B)217. There were no statistically
significant differences between trimester one and two ethanol mice.
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Figure 12. Line graph comparing the number of hole explorations in the Barnes Maze
between trimester one ethanol and control mice. Mean (± SEM) number of explorations to
each hole of the Barnes Maze for ethanol and control mice on (A) day 5 and (B) day 12. Data
shown here are collapsed across sex (n = 20-26 mice per group). ***p < 0.001.
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A

B

Figure 13. Line graph comparing the number of hole explorations in the Barnes Maze
between trimester two ethanol and control mice. Mean (± SEM) number of explorations to
each hole of the Barnes Maze for ethanol and control mice on (A) day 5 and (B) day 12. Data
shown here are collapsed across sex (n = 26-28 mice per group). *p < 0.05; ***p < 0.001.
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3.2.5 Summary of behavioural results
Ethanol exposure during the first and second term of gestation led to a variety of
behavioural abnormalities in offspring (Table 3). These abnormalities were dependent upon the
timing of prenatal ethanol exposure. First and second trimester ethanol exposure resulted in
developmental milestone deficits, increased activity levels, and spatial learning delays. Spatial
learning delays were not consistent between treatments. In terms of latency to the target hole in
the Barnes Maze, trimester-two-ethanol mice were able to “catch up” to control mice by the end
of the learning trials. When examining memory using the Barnes Maze, short-term and long-term
recall (probe) trials demonstrated that the initial learning delays were persistent in ethanol mice.
Trimester one ethanol mice were significantly delayed in reaching the target hole compared to
matched controls. However, memory testing revealed that these mice do not exhibit memory
deficits. When treated during the first trimester equivalent, ethanol mice were not significantly
different from control mice in anxiety-related behaviours. Ethanol exposure during the second
trimester appeared to reduce anxiety-related behaviours. These findings indicate that
neurodevelopmental timing of ethanol exposure leads to heterogeneity in behaviours reminiscent
of FASD.
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Table 3. A comparison between trimester one and two ethanol exposure on offspring
behaviours.
Behavioursa

Postnatal Day

Trimester 1b

Developmental milestones

2-21

Activity (daytime)
Activity (overnight)

28-30
30-35

Anxiety-related (Open-field)
Anxiety-related (EPM)
Anxiety-related (LDB)
Spatial learning (Barnes Maze)
Short-term memory (Barnes Maze)
Long-term memory (Barnes Maze)

35-40
35-40
35-40
45-55
50-60
57-67

Delayed
(motor skill)
Increased
Increased and
decreased
No difference
No difference
No difference
Delayed (days 3-4)
No difference
Generally no
difference

a

Trimester 2b
Delayed
(motor skill)
Increased
Mostly increased
(males)
Decreased
No difference
Decreased
Delayed (day 1)
Delayed
Delayed

Behaviours are listed by day of testing. EPM = Elevated Plus Maze. LDB = Light/Dark Box.
Results are given for ethanol mice compared to control mice. No difference = no observable differences between
ethanol and control mice for a behaviour.
b
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3.3 Changes in gene expression following prenatal ethanol exposure
3.3.1 Overall patterns of gene expression changes
The overall patterns of gene expression were assessed in each of the different groups (T2S, T1-L, and T2-L). The general trend for the Partek analysis resulted in a range from a +3.01fold increase (Odorant binding protein 2B) to a -3.01-fold decrease (Stomatin (EPB72)-like 3) in
T1-L. In T2-L, DEGs ranged from a +1.65-fold increase (Olfactory receptor, family 2, subfamily
AP, member 1) to a -1.97-fold decrease (Myosin, light chain 1, alkali; skeletal, fact). The
ANOVA gene list from T2-S ranged from a +7.49-fold increase (X (inactive)-specific transcript
(non-protein coding)) from matched controls to a -2.75-fold decrease (Carbonic anhydrase III,
muscle specific).
There was no overlap of specific genes altered between all three groups when using cutoff values of ± 1.2-fold change and p < 0.05 (Figure 14). There were no DEGs between ethanol
and control mice in any of the groups using a FDR-corrected p-value of 0.05 and a ± 1.2-fold
change cut-off. Further analysis was restricted to an unadjusted p < 0.05 with the same fold
change. Using this cut-off, one gene, Triadin (Trdn), overlapped between T1-L and T2-S
(Figure 14). Using these criteria, T2-S, T1-L, and T2-L resulted in the altered expression of 48,
55, and 68 genes, respectively (Appendices B-D). These changes ranged from a +1.43-fold
increase from matched controls (SLIT and NTRK-like family, member 2 or Slitrk2) to a -1.91-fold
decreased (Trdn). In T1-L, the range was from a +1.44-fold increase from matched controls
(Predicted gene 3696) to a -1.39-fold decrease (Proliferating cell nuclear antigen or Pcna) in
T1-L. In T2-L, the range was between a +1.34-fold increase from matched controls (Predicted
gene 9875) to a -1.78-fold decrease (Stromal cell-derived factor 2-like-1 or Sdf2l1). In this
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assessment, the distribution of upregulated and downregulated genes was not equal across
groups. In T1-L, 10 genes (18.2%) were increased. In T2-L, 27 genes (39.7%) were increased.
And, in group T2-S, 30 genes (62.5%) were increased. Apart from gene annotations identified on
the Mouse Gene 1.0 ST arrays, there were various miRNAs discovered. T2-S gene expression
analysis resulted in differential expression of Mir-380, Mir-540, Mir-99a, Mir-337 and Mir-665
(Appendix B). As part of the long-term gene lists for T1-L and T2-L, Mir-451 and Mir-342 were
identified, respectively (Appendices C-D).
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Figure 14. A venn diagram of overlapping differentially-expressed genes (DEGs) compared
across trimester two short-term (T2-S), trimester one long-term (T1-L), and trimester two
long-term (T2-L) treatments. Adapted from GeneVenn® (http://genevenn.sourceforge.net/).
Gene lists included T2-S (pink), T1-L (blue) and T2-L (green). No genes were in common
between T2-S, T1-L, and T2-L (purple), or between T1-L and T2-L (dark blue), or between T2-S
and T2-L (dark green). One gene (Triadin) is in common between T2-S and T1-L (dark pink).
ANOVA lists generated from Partek Genomics Suite software using a cut-off of p < 0.05 and ±
1.2-fold change.
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3.3.2 Molecular analysis of short-term (T2-S) DEGs
a) Immediate effects of ethanol on cellular functions
Functional analysis of T2-S was completed using DAVID, Partek (GE), and IPA. Using
DAVID, T2-S data resulted in two significant categories (Table 4). Genes identified in the
keyword, “Nucleus” are involved in DNA or RNA binding, regulation of p53 transcription and
apoptosis, and mismatch repair. The SMART term, Dual specificity phosphatase, catalytic
domain (“DSPc”) included genes involved in protein-tyrosine phosphorylation, which can affect
protein interactions, cellular localization, protein stability, and enzymatic activity.
Analysis of genes disrupted in T2-S using GE revealed 63 significantly disrupted
molecular functions. Here, the GO categories were primarily associated with the top function,
protein phosphorylation (Table 5). These GE results are complementary to DAVID analysis,
which implicated Dual specificity phosphatase 19 (Dusp19) and Slingshot homolog 2
(Drosophila) (Ssh2) in the “DSPc” SMART term. Generally, the GE processes altered in the
fetal brain are involved in mitogen-activated protein kinase (MAPK) activity, including calcium
stimulation of MAPK. Two processes are involved in each of G-protein coupled receptor
activity, and lipid transport. The last three of the top 10 processes are involved in stress response,
chromatin binding, and actin cytoskeleton development.
Functional analysis of T2-S using IPA resulted in the identification of five functions in
each of three categories: Diseases and Disorders, Molecular and Cellular Functions, and
Physiological System Development and Function (Table 6). Two miRNAs appear in each of the
top five functions of Diseases and Disorders, and are involved in post-transcrpitional regulation
of gene expression by affecting the stability and translation of mRNAs.
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Table 4. Top significant annotation clusters resulting from The Database for Annotation,
Visualization and Integrated Discovery (DAVID) functional analysis of trimester two shortterm (T2-S) differentially-expressed genes (DEGs).
Categorya Term
SP PIR
Nucleus
SMART
a

DSPc

p-value Genesb
0.039
Gpkow, Jmy, Rybp, Crem, Ccnt1, Zfp600, Magohb, Nol4,
Nap1l3, Zc3h18, Tdg, Zmat5
0.043
Dusp19, Ssh2

Category includes information from the Swiss-Prot and Protein Information Resource (SP PIR keyword) and
Simple Modular Architecture Research Tool (SMART) genomic database.
b
Genes included G patch domain and KOW motifs (Gpkow), Junction mediating protein, p53 cofactor (Jmy), RING1
and YY1 binding protein (Rybp), cAMP responsive element modulator (Crem), Cyclin T1 (Ccnt1), Zinc finger
protein 600 (Zfp600), Mago-nashi homolog B (Drosophila) (Magohb), Nucleolar protein 4 Nucleosome assembly
protein 1-like-3 (Nol4), Zinc finger CCCH-type containing 18 (Zc3h18), Thymine-DNA glycosylase (Tdg), Zinc
finger, matrin-type 5 (Zmat5), Dual specificity phosphatase 19 (Dusp19), and Slingshot homolog 2 (Drosophila)
(Ssh2).
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Table 5. Top ten functions of short-term (T2-S) differentially-expressed genes (DEGs)
identified using Gene Ontology Enrichment (GE).
Gene Ontology Function

Typea

Protein tyrosine/serine/threonine
phosphatase activity
Regulation of DNA-dependent
transcription in response to stress
Calcium-dependent protein kinase C
activity
Bombesin receptor signaling pathway
Bombesin receptor activity
Negative regulation of chromatin binding
Protein tyrosine/threonine phosphatase
activity
Glycolipid transporter activity
Glycolipid transport
Regulation of lemellipodium assembly

MF

Enrichment p-value Genesc
Scoreb
6.25
0.002
Dusp19, Ssh2

BP

5.13

0.006

Jmy

MF

5.13

0.006

Ccl3

BP
MF
BP
MF

5.13
5.13
5.13
5.13

0.006
0.006
0.006
0.006

Nmbr
Nmbr
Tdg
Dusp19

MF
BP
BP

4.85
4.85
4.85

0.008
0.008
0.008

Gltpd1
Gltpd1
Ssh2

a

Type indicates a biological process (BP), cellular component (CC), or molecular function (MF).
Enrichment score = Significant genes in a category/All significant genes, vs All genes in the category/All genes on
the chip.
c
Genes included Dual-specificity phosphatase 19 (Dusp19), Slingshot homolog 2 (Drosophila) (Ssh2), Junction
mediating protein, p53 cofactor (Jmy), Chemokine (C-C motif) ligand 3 (Ccl3), Neuromedin B receptor (Nmbr),
Thymine-DNA glycosylase (Tdg), and Glycolipid transfer protein domain containing 1 (Gltpd1).
b
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Table 6. Functional characterization of short-term (T2-S) differentially-expressed genes (DEGs) using Ingenuity Pathway
Analysis (IPA).
Diseases and Disorders
Name
Developmental Disorder

p-value
1.14E-03 – 3.29E-02

Hereditary Disorder
Skeletal and Muscular Disorder

1.14E-03 – 2.29E-03
1 .14E-03 – 4.12E-02

Connective Tissue Disorder
1.34E-03 – 4.12E-02
Dermatological Diseases
1.34E-03 – 1.34E-03
Molecular and Cellular Functions
Name
p-value
Cell Cycle
2.10E-03 – 4.93E-02
Cellular Assembly/Organization 2 .10E-03 – 2.29E-02
Cellular Function/Maintenance
2.10E-03 – 3.11E-02
Antigen Presentation
4 .20E-03 – 8.38E-03
Cellular Movement
4.20E-03 – 4.93E-02
Physiological System Development and Function
Name
p-value
Nervous System
Development/Function
2.10E-03 – 1.05E-02
Tissue Development
2.10E-03 – 2.70E-02
Hematological System
Development/Function
4.20E-03 – 4.93E-02
Hematopoiesis
4 .20E-03 – 1.05E-02
Immune Cell Trafficking
4 .20E-03 – 4.93E-02
a

# genes Genesa
5
mir-379, mir-99, Tdg,
Trdn, Crem
2
mir-379, mir-99
5
mir-379, mir-99, Trdn,
Crem, Ccl3
3
mir-379, mir-99, Ccl3
2
mir-379, mir-99
# genes
1
1
2
1
2

Genesa
Crem
Pip5k1b
Pip5k1b, Ccl3
Ccl3
Ccl3, Ccnt1

Function Annotation
Hypertrophy of skeletal muscle
Nemaline myopathy
Muscular hypertrophy
Adjuvant arthritis
Dermatomyositis
Function Annotation
Arrest in G2/M phase
Formation of actin comet
Formation of microvilli
Migration of dendritic precursors
Th1 cell transmigration

# genes Genesa

Function Annotation

1
3

Ccl3
Ccl3, Bcap31, mir-99

Astrocyte/microglia accumulation
Embryonic stem cell adhesion

3
1
2

Ccl3, Ccnt1, Lair1
Ccl3
Ccl3, Ccnt1

T lymphocyte trafficking
Migration of dendritic precursors
Natural Killer cell migration

Genes included microRNA-379 (mir-379), microRNA-99a (mir-99), Thymine-DNA glycosylase (Tdg), Triadin (Trdn), cAMP responsive element modulator
(Crem), Chemokine (C-C motif) ligand 3 (Ccl3), Phosphatidylinositol-4-phosphate 5-kinase, type I, beta (Pip5k1b), Cyclin T1 (Ccnt1), B-cell receptorassociated protein 31 (Bcap31), and Leukocyte-associated immunoglobulin-like receptor 1 (Lair1).
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b) Immediate effects of ethanol on cellular pathways
Pathway analysis of T2-S was performed using Pathway Express, Pathway Enrichment,
and IPA. T2-S analysis did not result in any statistically significant KEGG pathways in Pathway
Express. The top nominally significant pathway “regulation of actin cytoskeleton” (Impact factor
= 2.72, p = 0.066), was consistent with functional analysis that implicated Dusp19 and Ssh2 in
actin cytoskeleton development.
As with Pathway Express, there were no statistically significant T2-S pathways found
using PE. The top nominally significant pathways that were identified included: “regulation of
actin cytoskeleton” (p = 0.066), with Phosphatidylinositol-4-phosphate 5-kinase, type I, beta
(Pip5k1b) and Ssh2, “base excision repair” (p = 0.069), with Thymine-DNA glycosylase (Tdg),
and “nicotine addiction” (p = 0.080), with Hippocalcin (Hpca).
T2-S exposure was not significantly associated with any canonical pathways in IPA
(Table 7). However, the top associated pathway, termed, Actin Cytoskeleton Signaling, was
nominally significant (p = 7.04E-02), with Pip5k1b and Ssh2. Other pathways that included
immune cell communication, natural killer cell signaling, and p53 signaling were not statistically
significant. However, these pathways were complementary to IPA functional analysis (Table 6),
which implicated each of the genes listed in Table 7 in such processes.
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Table 7. Top canonical pathways resulting from Ingenuity Pathway Analysis (IPA) of
short-term (T2-S) differentially-expressed genes (DEGs).
Canonical Pathway Namea
Actin Cytoskeleton Signaling
Communication between Innate and Adaptive Immune Cells
Regulation of Actin-based Motility by Rho
p53 Signaling
Natural Killer Cell Signaling
a

p-value
7.04E-02
1.26E-01
0.15
0.17
0.173

Genesb
Pip5k1b, Ssh2
Ccl3
Pip5k1b
Jmy
Lair1

Canonical pathways were identified in Ingenuity Pathway Analysis using the Core Analysis feature. The list of
DEGs was generated using Partek software, using a ± 1.2 fold change and p < 0.05.
b
Genes included Phosphatidylinositol-4-phosphate 5-kinase, type I, beta (Pip5k1b), Slingshot homolog 2
(Drosophila) (Ssh2), Chemokine (C-C motif) ligand 3 (Ccl3), Junction mediating protein, p53 cofactor (Jmy), and
Leukocyte-associated immunoglobulin-like receptor 1 (Lair1).
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c) Immediate effects of ethanol on cellular networks
Network analysis for T2-S was completed using GeneMANIA and IPA’s Core Analysis
network feature. However, there were no significant GeneMANIA networks identified. The top
T2-S IPA networks with a network score > 3 are reported in Table 8. The top network was
termed: Inflammatory Disease, Neurological Disease, Skeletal and Muscular Disorders (Figure
15), and included 13 DEGs out of 34 network genes. Of the DEGs, six genes are downregulated
while seven genes are upregulated. The second network, termed, Cellular Development, Cellular
Growth and Proliferation, Hematological System Development and Function, was comprised of
35 network genes (Figure 16). More genes were upregulated than downregulated in this
network, with a 3:2 ratio. The top significant IPA networks from T2-S were merged into one
large interacting network to identify “hub” genes. Figure 17 shows the identified hub molecules
that have > 10 interactions with other genes, including those that were differentially-expressed in
the fetal brain following GD 16 ethanol exposure.
d) Candidate gene selection and confirmation of specific genes disrupted following
immediate ethanol exposure
Based on the criteria given in the Methods and Materials section (Figure 1), the selected
candidates for confirmation are reported in Table 9. Here, the functional (NCBI, DAVID, GO
Enrichment, GeneMANIA), pathway (IPA, Partek Pathway, Pathway Express), and network
(IPA) characterization of genes was summarized. The resulting expression changes and p-values
for the eight T2-S genes chosen for confirmation are shown in Table 10. No genes from T2-S
were confirmed. A series of box plots illustrating the variability across biological replicates in
qRT-PCR demonstrates the similarity in ∆CT values across replicates (Figure 18).
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Table 8. Top Ingenuity Pathway Analysis (IPA) networks identified in short-term (T2-S)
analysis of differentially-expressed genes (DEGs).
Network No. Focus Top Functionb
Moleculesa
1
13
Cellular Compromise, Cell
Death, Free Radical Scavenging

2

a

5

Cellular Development, Cellular
Growth and Proliferation,
Hematological System
Development and Function

Input Genesc

Scored

Bcap31, Hpca, Tdg, mir99, Zc3h18, Crem, mir379, mir-337, Lair1, Jmy,
Ccl3, Nmbr, Rybp
Ccnt1, Zmat5, Trdn,
Sprr2a, Pip5k1b

28

8

Number (No.) Focus Molecules indicates the number of genes that were differentially expressed (Partek: ± 1.2 fold
change, p < 0.05) in fetal brain (GD 16) as a result of ethanol exposure in the second trimester equivalent.
b
Top Function represents the name of the network in IPA.
c
Input genes included B-cell receptor-associated protein 31 (Bcap31), Hippocalcin (Hpca), Thymine-DNA
glycosylase (Tdg), microRNA 99a (mir-99), Zinc finger CCCH-type containing 18 (Zc3h18), cAMP responsive
element modulator (Crem), microRNA 379 (mir-379), microRNA 337 (mir-337), Leukocyte-associated
immunoglobulin-like receptor 1 (Lair1), Junction mediating protein, p53 cofactor (Jmy), Chemokine (C-C motif)
ligand 3 (Ccl3), Neuromedin B receptor (Nmbr), RING1 and YY1 binding protein (Rybp), Cyclin T1 (Ccnt1), Zinc
finger, matrin-type 5 (Zmat5), Triadin (Trdn), Small proline-rich protein 2A (Sprr2a), and Phosphatidylinositol-4phosphate 5-kinase, type I, beta (Pip5k1b).
d
Score is equal to the negative exponent of the respective p-value such that a score of 3 corresponds to a p-value of
10E-3. Network 1 score of 28 is equivalent to p = 10E-28. Network 2 score of 8 is equivalent to p = 10E-8.
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Figure 15. First network resulting from Ingenuity Pathway Analysis (IPA) of short-term
(T2-S) differentially-expressed genes (DEGs). Network name: Cellular Compromise, Cell
Death, Free Radical Scavenging. Highlighting (red and green) represents input genes. Red
indicates downregulation and green indicates upregulation in ethanol mice versus control mice.
DEGs were identified using Partek Genomics Suite with a ± 1.2 fold change and p < 0.05. A
single-headed arrow indicates the action of one gene on another. A double arrow-headed line
indicates that the two genes act on each other. Dashed lines indicate an indirect interaction, and
solid lines indicate direct interactions. E = expression, L = proteolysis, LO = localization, PD =
protein-DNA binding, A = activation, P = phosphorylation/dephosphorylation, PR = proteinRNA binding, PP = protein-protein interaction, I = inhibition, M = biochemical modification, RB
= regulation of binding, T = transcription, TR = translocation. Refer to Appendix F for a full
IPA legend on relationship types, molecular shapes, and relationships.
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Figure 16. Second network resulting from Ingenuity Pathway Analysis (IPA) of short-term
(T2-S) differentially-expressed genes (DEGs). Network term: Cellular Development, Cellular
Growth and Proliferation, Hematological System Development and Function. Highlighting (red
and green) represents input genes. Red indicates downregulation and green indicates
upregulation in ethanol mice versus control mice. DEGs were identified using Partek Genomics
Suite with a ± 1.2 fold change and p < 0.05. A single-headed arrow indicates the action of one
gene on another. A double arrow-headed line indicates that the two genes act on each other.
Dashed lines indicate an indirect interaction, and solid lines indicate direct interactions. E =
expression, L = proteolysis, LO = localization, PD = protein-DNA binding, A = activation, P =
phosphorylation/dephosphorylation, PR = protein-RNA binding, PP = protein-protein
interaction, I = inhibition, M = biochemical modification, RB = regulation of binding, T =
transcription, TR = translocation. Refer to Appendix F for a full IPA legend on relationship
types, molecular shapes, and relationships.
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Figure 17. A merged network from Ingenuity Pathway Analysis (IPA) of short-term (T2-S)
differentially-expressed genes (DEGs). Highlighting (red and green) represents input genes.
Red indicates downregulation and green indicates upregulation in ethanol mice versus control
mice. DEGs were identified using Partek Genomics Suite with a ± 1.2 fold change and p < 0.05.
A single-headed arrow indicates the action of one gene on another. A double arrow-headed line
indicates that the two genes act on each other. Dashed lines indicate an indirect interaction, and
solid lines indicate direct interactions. E = expression, L = proteolysis, LO = localization, PD =
protein-DNA binding, A = activation, P = phosphorylation/dephosphorylation, PR = proteinRNA binding, PP = protein-protein interaction, I = inhibition, M = biochemical modification, RB
= regulation of binding, T = transcription, TR = translocation. Refer to Appendix F for a full
IPA legend on relationship types, molecular shapes, and relationships.
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Table 9. Candidate gene selection criteria for confirmation of specific short-term (T2-S)
differentially-expressed genes (DEGs).
Candidate
Neurodevelopment and/or behaviour
Genesa
Ccl3
facioscapulohumeral musclular dystrophy;
microglia, astrocyte and dendrite development;
ethanol and taste aversion; immune response
osteoclast differentiation218
Ccnt1
immune cell trafficking; cellular movement
snRNA binding
Gpr50
component of adaptive thermogenesis219
K/O mice have increased activity levels220
Lair1
Natural Killer cell signaling
feeding behaviour and body weight regulation221

Toolb

Pip5k1b

IPA,
P. Express
PubMed
Partek GE
PubMed
PubMed

Rybp
Slitrk2

Trdn
a

regulation of actin cytoskeleton
associated with autism222
histone H2A monoubiquitination
required for mouse eye development223
excitatory and inhibitory synapse formation224
candidate for schizophrenia225 and bipolar
disorder226
hypoplasia of forebrain; hypertrophy of skeletal
muscle

IPA

PubMed
IPA
Partek GE
PubMed
PubMed
IPA
PubMed

PubMed
IPA

Network
(IPA)c
1

2
None
1

2

1
None

2

Genes are listed alphabetically. Genes include SLIT and NTRK-like family, member 2 (Slitrk2), Cyclin T1 (Ccnt1),
Leukocyte-associated immunoglobulin-like receptor 1 (Lair1), RING1 and YY1 binding protein (Rybp), G proteincoupled receptor 50 (Gpr50), Triadin (Trdn), Chemokine (C-C motif) ligand 3 (Ccl3), Phosphatidylinositol-4phosphate 5-kinase, type I, beta (Pip5k1b).
b
Tools used to analyse candidate genes (by neurodevelopment and behaviour) include PubMed, Ingenuity Pathway
Analysis (IPA), Partek Gene Ontology Enrichment, and Pathway Express.
c
IPA networks are shown in Figures 15-16.
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Table 10. A comparison between short-term (T2-S) qRT-PCR and microarray results for
candidate genes.
Genesa
Ccl3
Ccnt1
Gpr50
Lair1
Pip5k1b
Rybp
Slitrk2
Trdn
a

Array
Fold Change
1.22
1.22
1.34
1.25
-1.22
1.35
1.43
-1.91

Array
p-value
0.034
0.014
0.020
0.019
0.014
0.030
0.046
0.032

qRT-PCR
Fold Change
-1.16
-0.99
-1.06
-0.92
-1.35
-1.01
-0.99
N/A

qRT-PCR
p-value
0.414
0.541
0.670
0.355
0.307
0.218
0.684
N/A

Genes are listed alphabetically. Genes include SLIT and NTRK-like family, member 2 (Slitrk2), Cyclin T1 (Ccnt1),
Leukocyte-associated immunoglobulin-like receptor 1 (Lair1), RING1 and YY1 binding protein (Rybp), G proteincoupled receptor 50 (Gpr50), Triadin (Trdn), Chemokine (C-C motif) ligand 3 (Ccl3), Phosphatidylinositol-4phosphate 5-kinase, type I, beta (Pip5k1b).
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Figure 18. Box plot analysis of qRT-PCR
results for trimester two short-term (T2S) genes using Statistical Package for the
Social Sciences v.16.6. All control and
ethanol replicates were included in the
analysis. Data are represented by average
∆CT per treatment, generated using StepOne
Real-time PCR software. An “o" represents
a minor outlier (± 1.5 interquartile range).
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3.3.3 Molecular analysis of first trimester long-term (T1-L) DEGs

a) First-trimester effects of ethanol on cellular functions
As outlined for the short-term experiment (T2-S), T1-L gene lists were subjected to
functional analysis using DAVID, GE, and IPA. Functional annotation clustering was performed
on T1-L DEGs using DAVID (Table 11). The SP PIR keyword, “coenzyme A”, emphasized a
role for synthesis and oxidation of fatty acids in FASD. The three genes that are part of this
keyword are involved in processes including ketogenesis and antioxidant detoxification. One of
these genes, N-acetyltransferase 1 (Nat1), is involved in folate catabolism. Two of the five
categories listed in Table 11 include genes involved in ribosomal functions. “Base excision
repair” was previously identified in T2-S analysis of pathways, albeit not statistically significant.
GO Enrichment was used to evaluate over-represented molecular functions, cellular
components, and biological processes using Partek. T1-L GE analysis returned a list of 104
significant functions. The top 10 significant GO categories and shown in Table 12. The gene,
Cleavage and polyadenylation factor I subunit 1 (Clp1), was identified in three of the top 10
functions, and involved tRNA splicing and mRNA 3’end formation. The gene, SET domain
containing 2 (Setd2), was involved in two of the top 10 processes, one of which included histone
methylation. In general, the top 10 GE functions were involved in cellular maintenance and
protein kinase activity.
Using the Core Analysis tool within IPA, a list of T1-L processes was generated for three
different categories: Diseases and Disorders, Molecular and Cellular Functions, and
Physiological System Development and Function (Table 13). Carcinoembryonic antigen-related
cell adhesion molecular 1 (biliary glycoprotein) (Ceacam1) was the only significant gene in
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Diseases and Disorders. Ceacam1 was also identified in the second significantly GE function,
“positive regulation of MAP kinase activity” (Table 12). Other genes in this category were
previously identified in DAVID analysis (Table 4): Methyl-CpG binding domain protein 4
(Mbd4) was part of the GO BP “base excision repair”, and Pleiotropic regulator 1 (Plrg1) was
involved in the GO CC “ribonucleoprotein”; Mitogen-activated protein kinase kinase kinase, E3
ubiquitin protein ligase (Map3k1) and Activating transcription factor 1 (Atf1) were involved in
“TNF/Stress related signaling”. Ceacam1, Map3k1, Eomesodermin (Xenopus laevis) homolog
(Eomes), and pre-B lymphocyte 1 (Vpreb1) appear in at least three of the five top disrupted
processes, adding to their importance in cellular disruption following prenatal ethanol exposure
in the first trimester equivalent. The function with the highest number of genes implicated in this
category included “Tissue Morphology”.
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Table 11. Top significant annotation clusters resulting from The Database for Annotation,
Visualization and Integrated Discovery (DAVID) functional analysis of trimester one longterm (T1-L) differentially-expressed genes (DEGs).
Categorya
SP PIR keyword
GO MF
BIOCARTA
GO CC
GO BP
a

Term
Coenzyme A
Structural constituent of
ribosome
TNF/Stress related
signaling
Ribonucleoprotein
complex
Base-excision repair

p-value
0.035

Genesb
Hmgcs2, Atf1, Nat1

0.037

Rpl36a, Gm12191, Gm4987

0.042

Map3k1, Atf1

0.043
0.048

Gm12191, Gm4987, Rpl36a,
Sfrs1, Clp1, Nat1, Rcl1, Plrg1
Mbd4, Pcna

Category includes information from the Swiss-Prot and Protein Information Resource (SP PIR keyword), Gene
Ontology’s (GO) molecular function (MF), cellular component (CC) and biological process (BP), BioCarta
references, and Simple Modular Architecture Research Tool (SMART) genomic database.
b
Genes included 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) (Hmgcs2), Activating transcription
factor 1 (Atf1), N-acetyltransferase 1 (arylamine N-acetyltransferase) (Nat1), Ribosomal protein L36a (Rpl36a),
predicted genes Gm12191 and Gm4987, Mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein
ligase (Map3k1), Serine/arginine-rich splicing factor 1 (Sfrs1), Cleavage and polyadenylation factor I subunit 1
(Clp1), RNA terminal phosphate cyclase-like 1 (Rcl1), Pleiotropic regulator 1 (Plrg1), Methyl-CpG binding domain
protein 4 (Mbd4), and Proliferating cell nuclear antigen (Pcna).
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Table 12. Top ten significant functions of trimester one long-term (T1-L) differentiallyexpressed genes (DEGs) from Gene Ontology Enrichment (GE).
Gene Ontology Function

Typea

p-value

Genesc

BP

Enrichment
Scoreb
7.23

Homeostasis of number of cells

0.0007

Positive regulation of MAP kinase activity

BP

5.43

0.004

Histone H3-K36 methylation
Mesoderm morphogenesis
G-protein coupled receptor signaling
pathway, coupled to cyclic nucleotide second
messenger
tRNA-intron endonuclease complex
Targeting of mRNA for destruction involved
in RNA interference
ATP-dependent polydeoxyribinucleotide 5’hydroxyl-kinase activity
mRNA 5’-splice site recognition
Type 1 melanocortin receptor binding

BP
BP
BP

4.96
4.96
4.96

0.007
0.007
0.007

Vpreb1,
Gcnt4
Ceacam1,
Map3k1
Setd2
Setd2
Htr5a

CC
BP

4.96
4.96

0.007
0.007

Clp1
Clp1

MF

4.96

0.007

Clp1

BP
MF

4.96
4.96

0.007
0.007

Srsf1
Mrap2

a

Type indicates a biological process (BP), cellular component (CC), or molecular function (MF).
Enrichment score = Significant genes in a category/All significant genes, vs All genes in the category/All genes on
the chip.
c
Genes included pre-B lymphocyte 1 (Vpreb1), Glucosaminyl (N-acetyl) transferase 4, core 2 (Gcnt4),
Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (Ceacam1), Mitogen-activated
protein kinase kinase kinase 1, E3 ubiquitin protein ligase (Map3k1), Serine/arginine-rich splicing factor 1 (Sfrs1),
Cleavage and polyadenylation factor I subunit 1 (Clp1), SET domain containing 2 (Setd2), 5-hydroxytryptamine
(serotonin) receptor 5A, G protein-coupled (Htr5a), and Melanocortin 2 receptor accessory protein 2 (Mrap2).
b
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Table 13. Functional characterization of trimester one long-term (T1-L) differentially-expressed genes (DEGs) using Ingenuity
Pathway Analysis (IPA).
Diseases and Disorders
Name
p-value
Inflammatory Response
5.87E-03 – 4.32E-02
Connective Tissue Disorders 1.17E-02 – 1.17E-02
Hematological Disease
1.17E-02 – 1.17E-02
Infectious Disease
1.17E-02 – 4.32E-02
Developmental Disorder
1.75E-02 – 3.19E-02
Molecular and Cellular Functions
Name
p-value
Cell Death/Survival
6.49E-04 – 3.17E-02
Cell-To-Cell Signaling and
2.94E-03 – 5.87E-03
Interaction
Cellular Assembly and
2.94E-03 – 8.80E-03
Organization
Cellular Development
2.94E-03 – 4.04E-02
Cellular Growth/Proliferation 2.94E-03 – 4.04E-02
Physiological System Development and Function
Name
p-value
Connective Tissue
6.49E-04 – 2.90E-02
Development/Function
Hematological System
2.94E-03 – 4.32E-02
Development/Function
Hematopoiesis
2.94E-03 – 4.04E-02
Humoral Immune Response
2.94E-03 – 1.46E-02
Tissue Morphology
2.94E-03 – 4.60E-02
a

# genes
1
1
1
1
2

Genesa
Ceacam1
Ceacam1
Ceacam1
Ceacam1
Setd2, Trdn

Function Annotation
Priming of Th1 helper cells
Infection of blood
Infection of blood
Infection of blood, spleen, liver
Hypoplasia of forebrain

# genes
4
2

Genesa
Map3k1, Mbd4, Plrg1, Atf1
Map3k1, Ceacam1

Function Annotation
Cervical ganglion neuron apoptosis
Intercellular junction restoration

1

Map3k1

Permeability of mitochondria

3
2

Eomes
Eomes, Vpreb1

Expansion of pre-B2 lymphocytes
Expansion of thymocytes

# genes
4

Genesa
Mbd4, Ceacam1, Map3k1,
Plrg1
Vpreb1, Ceacam1, Eomes,
mir-451, H2-T23
Eomes, Vpreb1, mir-451
Vpreb1, Map3k1
Adamts9, Vpreb1, Eomes,
Ceacam1, Map3k1

Function Annotation
Cell viability of fibroblasts

5
3
2
5

Function of memory T lymphocytes
Expansion of thymocytes
Expansion of pre-B2 lymphocytes
Abnormal morphology of
trophoectoderm

Genes from Partek Genomics Suite, ± 1.2 fold change, p < 0.05; Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (Ceacam1),
SET domain containing 2 (Setd2), Triadin (Trdn), Mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase (Map3k1), Methyl-CpG binding
domain protein 4 (Mbd4), Pleiotropic regulator 1 (Plrg1), Activating transcription factor 1 (Atf1), Eomesodermin (Eomes), pre-B lymphocyte 1 (Vpreb1),
microRNA 451 (mir-451), Major histocompatibility complex, class I, E (H2-T23), and ADAM metallopeptidase with thrombospondin type 1 motif, 9 (Adamts9).
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b) First-trimester effects of ethanol on cellular pathways
As in T2-S analysis, the list of T1-L DEGs was subjected to pathway analysis using
Pathway Express, PE and IPA’s canonical pathway tool. The gene list was subjected to Pathway
Express to observe which pathways were enriched. For T1-L, the only significant KEGG
pathway was “base excision repair” (Impact factor = 5.92, p = 0.003), with 2 input genes: Mbd4
and Pcna. Mbd4 and Pcna were also identified in DAVID analysis under the GO BP “base
excision repair”. Given MBD4’s role in DNA mismatch repair, and PCNA’s role in increasing
DNA polymerase processibility, it stands to reason that these two genes play an important role in
regulating DNA repair. Of note, the nominally significant pathway “mismatch repair” (Impact
factor = 2.99, p = 0.05) was listed as the second pathway altered in the adult brain as a result of
trimester one ethanol exposure, with Pcna as the only gene implicated in this pathway.
Next, Partek’s Pathway Enrichment tool was used to generate KEGG pathways that were
significantly altered as a result of prenatal ethanol exposure. The enrichment results for T1-L are
presented in Table 14, and include four significant pathways. The top pathway was “base
excision repair”, with Mbd4 and Pcna. Pcna was also part of the second significant pathway,
“HTLV-I infection”, with Major histocompatibility complex, class I, E (H2-T23). Given its role
in cell immunity, H2-T23 was previously identified in IPA functional analysis as the driver
behind, “function of memory T lymphocytes” (Table 13). Meanwhile, 3-hydroxy-3methylglutaryl-CoA synthase 2 (mitochondrial) (Hmgcs2) was implicated in the last pathway,
“synthesis and degradation of ketone bodies”. Hmgcs2’s role in fatty acid synthesis complements
results from DAVID that identified this gene in “coenzyme A” function (Table 11).
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Lastly, using IPA, significant canonical pathways altered in T1-L were identified (Table
15). Four of the five pathways were involved in lipid synthesis and other fatty-acid-related
processes. The second top pathway, IL-1 Signaling, included Map3k1, which has been
implicated in PE analysis under “HTLV-I Infection” (Table 14). Map3k1’s prominence in these
pathways signifies its role in immune system response.
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Table 14. Significant pathways resulting from Pathway Enrichment (PE) analysis of
trimester one long-term (T1-L) differentially-expressed genes (DEGs).
p-value

Genesb

Base excision repair
HTLV-I infection

Enrichment
Scorea
5.11
4.48

0.006
0.011

Caffeine metabolism
Synthesis and degradation of ketone bodies

3.54
3.44

0.029
0.032

Mbd4, Pcna
Atf1, H2-T23,
Map3k1, Pcna
Nat1
Hmgcs2

Pathway Name

a

Enrichment score = Significant genes in a category/All significant genes vs All genes in the category/All genes on
the chip.
b
Genes included Methyl-CpG binding domain protein 4 (Mbd4), Proliferating cell nuclear antigen (Pcna),
Activating transcription factor 1 (Atf1), Major histocompatibility complex, class I, E (H2-T23), Mitogen-activated
protein kinase kinase kinase 1, E3 ubiquitin protein ligase (Map3k1), N-acetyltransferase 1 (arylamine Nacetyltransferase) (Nat1), and 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) (Hmgcs2).

95

Table 15. Top canonical pathways resulting from Ingenuity Pathway Analysis (IPA) of
trimester one long-term (T1-L) differentially-expressed genes (DEGs).
Canonical Pathway Namea
Pentose Phosphate Pathway (Nonoxidative Branch)
IL-1 Signaling
Ketogenesis
Pentose Phosphate Pathway
Mevalonate Pathway I
a

p-value
1.75E-02

Genesb
Rpe

2.81E-02
2.9E-02
2.9E-02
3.47E-02

Map3k1, Gng4
Hmgcs2
Rpe
Hmgcs2

Canonical pathways were identified in Ingenuity Pathway Analysis using the Core Analysis feature. The list of
DEGs was generated using Partek Genomics Suite, using a ± 1.2 fold change and p < 0.05.
b
Genes included Ribulose-5-phosphate-3-epimerase (Rpe), Mitogen-activated protein kinase kinase kinase 1, E3
ubiquitin protein ligase (Map3k1), Guanine nucleotide binding protein (G protein), gamma 4 (Gng4), and 3hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) (Hmgcs2).
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c) First-trimester effects on ethanol on cellular networks
The T1-L gene list was subjected to analysis by the publically available tool,
GeneMANIA, to identify disrupted networks. T1-L GeneMANIA analysis resulted in two
significant network functions including, “olfactory bulb development” (p = 0.012) and “olfactory
lobe development” (p = 0.012), both with Eomes as the only DEG. The nominally significant
function, “forebrain development” (p = 0.059) included Eomes and Setd2.
Network analysis was also completed using IPA using the Core Analysis function to
identify enriched networks of interest based on literature review. Only one network with a score
> 3 was identified from T1-L analysis. This network was termed, Infectious Disease, Organismal
Injury and Abnormalities, Cellular Development (score = 22), and was comprised of 11 focus
molecules. Focus molecules included: Hmgcs2, Pcna, Atf1, Ceacam1, Eomes, Map3k1, Hla-e,
Tumor necrosis factor receptor superfamily, member 19 (Tnfrsf19), RAS p21 protein activator 2
(Rasa2), CDGSH iron sulfur domain 1 (Cisd1), and Major urinary protein 5 (Mup5) (Figure
19). Because there were no other significant networks, a merged analysis could not be
performed. Instead, this network was analyzed for the presence of any hub molecules that had >
10 interactions with other genes. Hub analysis resulted in three molecules with interactions.
These included interferon-gamma (IFNG), peroxisome proliferator-activated receptor gamma
(PPARG) and peroxisome proliferator-activated receptor alpha (PPARA). Involved in
immunoregulation, IFNG has indirect relationships with HLA-E (H2-T23), MAP3K1 and
CEACAM1, which are all downregulated (Figure 19).
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Figure 19. Network resulting from Ingenuity Pathway Analysis (IPA) of trimester one longterm (T1-L) differentially-expressed genes. Network name: Infectious Disease, Organismal
Injury and Abnormalities, Cellular Development. Highlighting (red and green) represents input
genes. Red indicates downregulation and green indicates upregulation in ethanol mice versus
control mice. DEGs were identified using Partek Genomics Suite with a ± 1.2 fold change and p
< 0.05. A single-headed arrow indicates the action of one gene on another. A double arrowheaded line indicates that the two genes act on each other. Dashed lines indicate an indirect
interaction, and solid lines indicate direct interactions. E = expression, LO = localization, PD =
protein-DNA binding, A = activation, P = phosphorylation/dephosphorylation, PP = proteinprotein interaction, T = transcription, TR = translocation. Refer to Appendix F for a full IPA
legend on relationship types, molecular shapes, and relationships.
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d) Candidate gene selection and confirmation of specific genes disrupted following firsttrimester ethanol exposure
Based on the criteria given in the Methods and Materials section (Figure 1), T1-L
candidate genes were selected for confirmation by qRT-PCR. The functional (NCBI, DAVID,
GE, GeneMANIA), pathway (IPA, PE, Pathway Express), and network (GeneMANIA and IPA)
characterizations of DEGs are summarized in Table 16. For T1-L, the downregulation of
Tnfrsf19, Eomes, Map3k1, and Synaptoporin (Synpr) was confirmed in six control and six
ethanol samples. While the difference between ethanol and control subjects was significant for
each of these genes, their degree of fold change was not identical between qRT-PCR are array
results (Table 17). A series of box plots illustrating the variability across biological replicates in
qRT-PCR demonstrates the similarity in ∆CT values across replicates for Atf1, Ceacam1, Htr5a,
and Stxbp6 (Figure 20). Also, given the number of biological replicate outliers present in various
samples (eg. Htr5a), this may add to properly confirm genes by qRT-PCR.
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Table 16. Candidate gene selection criteria for confirmation of specific trimester one longterm (T1-L) differentially-expressed genes (DEGs).
Genesa

Neurodevelopment and/or behaviour

Toolb

Atf1

TNF/Stress related signaling
miRNA:gene (miR-1192 and miR-532-5p)
regulation of MAP kinase activity
inflammatory response
olfactory bulb development; forebrain
development
embryonic placenta morphogenesis and
development
serotonin signaling
suicide attempts and mood disorders227

DAVID
IPA
Partek GE
IPA
GeneMANIA

Ceacam1
Eomes

Htr5a

Map3k1

Stxbp6

Synpr
Tnfrsf19
a

TNF/Stress related signaling
visual system development and function
loss enhances proliferation and apoptosis during
retinal development228
linked to ADHD229
implicated in bipolar disorder230
miRNA:gene (miR-532-5p)
intrinsic to small synaptic vesicles
major depressive disorder link231
Regulates differentiation of stromal stem cells232

Network
(IPA)c
1
1
1

Partek GE
Partek GE
PubMed
DAVID
IPA
PubMed
PubMed
PubMed
IPA
PubMed
PubMed
PubMed

None

1

None

None
1

Genes are listed alphabetically. Genes included Activating transcription factor 1 (Atf1), Carcinoembryonic antigenrelated cell adhesion molecule 1 (biliary glycoprotein) (Ceacam1), Eomesodermin (Eomes), 5-hydroxytryptamine
(serotonin) receptor 5A, G protein-coupled (Htr5a), Mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin
protein ligase (Map3k1), Syntaxin binding protein 6 (amisyn) (Stxbp6), Synaptoporin (Synpr), and Tumor necrosis
factor receptor superfamily, member 19 (Tnfrsf19).
b
Tools used to analyse candidate genes (by neurodevelopment and behaviour) include PubMed, Ingenuity Pathway
Analysis (IPA), Partek Gene Ontology Enrichment, GeneMANIA (www.genemania.org) and The Database for
Annotation, Visualization and Integrated Discovery (DAVID).
c
IPA network shown in Figure 19.
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Atf1

control

Ceacam1

(± 1.5
interq
Eomes
uartile
range)

(± 1.5
Htr5a
interq
uartile
range)

(± 1.5
interq
Stxbp6
uartile
range)

(± 1.5
interq
Synpr
uartile
range)

ethanol

control

Figure 20. Box plot analysis of qRT-PCR results
for trimester one long-term genes (T1-L) using
Statistical Package for the Social Sciences v.16.6.
All control and ethanol replicates were included in
the analysis. Data are represented by average ∆CT
per treatment, generated using StepOne Real-time
PCR software. An “o” represents a minor outlier (±
1.5 interquartile range). A * represents a major
outlier (± 3.0 interquartile range).

Map3k1

(± 1.5
interq
Tnfrsf19
uartile
range)

ethanol

control

ethanol
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Table 17. A comparison between trimester one long-term (T1-L) qRT-PCR and microarray
results for candidate genes.
Genesa
Atf1
Ceacam1
Eomes
Htr5a
Map3k1
Stxbp6
Synpr
Tnfrsf19
a

Array
Fold change
-1.32
-1.21
-1.20
-1.24
-1.25
-1.22
-1.25
-1.20

Array
p-value
0.012
0.038
0.039
0.022
0.043
0.028
0.038
0.024

qRT-PCR
Fold change
-0.93
-0.80
-2.21
-1.42
-1.36
-0.67
-1.29
-1.19

qRT-PCR
p-value
0.655
0.481
0.013
0.374
0.010
0.592
0.004
0.024

Genes are listed alphabetically. Genes in bold font are those that showed differential expression between ethanol
and control samples on the array and by qRT-PCR. Genes included Activating transcription factor 1 (Atf1),
Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (Ceacam1), Eomesodermin
(Eomes), 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled (Htr5a), Mitogen-activated protein
kinase kinase kinase 1, E3 ubiquitin protein ligase (Map3k1), Syntaxin binding protein 6 (amisyn) (Stxbp6),
Synaptoporin (Synpr), and Tumor necrosis factor receptor superfamily, member 19 (Tnfrsf19).
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e) MiRNAs altered in the adult brain following first-trimester ethanol exposure
The results from the mouse miRNA arrays were assessed using Partek. In the global
analysis of T1-L, fold change ranged from -12.07-fold (miR-429) to +2.51-fold (miR-21). Of the
1411 miRNAs that were specific to Mus Musculus, the ANOVA resulted in 671 miRNAs that
were < 1 (47.6%), eight that were unchanged (0.6%) and 732 that were > 1 (51.9%). For
consistency with gene expression data, miRNA arrays were assessed using a ± 1.2-fold change
cut-off and p < 0.05. Table 18 shows a list of differentially-expressed miRNAs at PD 70, as a
result of prenatal ethanol exposure during the first trimester equivalent. Using the established
criteria for significance, these results show a total of eight miRNAs that were differentially
expressed between control and ethanol samples. These miRNAs include: miR-1192, miR-202,
miR-339, miR-532, miR-680, miR-695, miR-743 and miR-764. Their fold changes ranged from
-1.46-fold to +1.73-fold. Six of the eight miRNAs (75%) were upregulated in ethanol mice
compared to control mice. Detecting upregulation of miRNAs is reasonable given that miRNAs
are involved in degradation of messenger RNAs (mRNAs) and are likely to be disrupted in the
opposite manner of mRNAs.
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Table 18. A list of differentially-expressed microRNAs in trimester one long-term (T1-L)
array analysis.
MicroRNAa
miR-1192
miR-202
miR-339
miR-532
miR-680
miR-695
miR-743a
miR-764
a

Fold change
1.43
-1.46
-1.30
1.26
1.38
1.24
1.26
1.73

p-value
0.028
0.033
0.019
0.040
0.049
0.017
0.044
0.016

MicroRNAs are listed by numerical ordering. Data generated using a ± 1.2-fold change and p < 0.05 in Partek
Genomics Suite.
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f) Identification and confirmation of specific miRNAs in T1-L and their gene targets
The lists of DEGs from gene expression array analysis (n = 63) and differentiallyexpressed miRNAs (n = 8) from T1-L were subjected to IPA miRNA and gene interaction
analysis using the Target Filter function. Results for T1-L analysis of gene and miRNA
interactions are shown in Table 19. Genes and miRNA fold changes are shown with their
respective expressions. The results demonstrated that only two microRNAs, miR-1191 and miR532-5p, were implicated in inverse relationships with specific gene targets. Out of the 11 genes
implicated in this analysis, Atf1, Syntaxin binding protein 6 (amisyn) (Stxbp6), and Centrosome
and spindle pole associated protein 1 (Cspp1) were inversely expressed with both miRNAs. The
relationship between an upregulated miRNA and a downregulated target mRNA is of interest in
this study (Figure 1). The microRNAs that were in opposing expression to their target genes
were used for confirmation by qRT-PCR. This included miR-1192 and miR-532-5p (Table 19).
The upregulation of miR-532-5p was confirmed using qRT-PCR (-0.45-fold change, p = 7.97e-5;
Figure 21).
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Table 19. Ingenuity Pathway Analysis (IPA) target filtering of differentially-expressed
genes (DEGs) and microRNAs from the trimester one long-term (T1-L) group.
Genesa
Symbol
Atf1
Cspp1
Gng4
Map3k1
Rpe
Setd2
Stxbp6
Trdn
Zc3h6
Atf1
Cspp1
Itpripl2
Nat2
Stxbp6
a

Fold change

MicroRNAsb
Symbol

Fold change

-1.319
1.217
-1.344
-1.247
-1.206
-1.202
-1.225
1.308
-1.232
-1.319
1.217
-1.211
1.307
-1.225

miR-1192
miR-1192
miR-1192
miR-1192
miR-1192
miR-1192
miR-1192
miR-1192
miR-1192
miR-532-5p
miR-532-5p
miR-532-5p
miR-532-5p
miR-532-5p

1.432
1.432
1.432
1.432
1.432
1.432
1.432
1.432
1.432
1.263
1.263
1.263
1.263
1.263

Expressionc
(gene:miRNA)
↓↑
↑↑
↓↑
↓↑
↓↑
↓↑
↓↑
↑↑
↓↑
↓↑
↑↑
↓↑
↑↑
↓↑

Confidenced
(predicted)
High
High
Moderate
High
High
Moderate
Moderate
High
High
Moderate
Moderate
Moderate
Moderate
Moderate

Genes included Activating transcription factor 1 (Atf1), Centrosome and spindle pole associated protein 1 (Cspp1),
Guanine nucleotide binding protein (G protein), gamma 4 (Gng4), Mitogen-activated protein kinase kinase kinase 1,
E3 ubiquitin protein ligase (Map3k1), Ribulose-5-phosphate-3-epimerase (Rpe), SET domain containing 2 (Setd2),
Syntaxin binding protein 6 (amisyn) (Stxbp6), Triadin (Trdn), Zinc finger CCCH-type containing 6 (Zc3h6), Inositol
1,4,5-trisphosphate receptor interacting protein-like 2 (Itpripl2), and N-acetyltransferase 2 (arylamine Nacetyltransferase) (Nat2). DEGs are based on Partek Genomics Suite analysis with ± 1.2-fold change and p < 0.05
b
MicroRNAs are listed by numerical order. MicroRNAs were differentially expressed based on Partek analysis with
± 1.2-fold change and p < 0.05.
c
Expression (gene:miRNA) is highlighted in red if an inverse relationship between gene:miRNA was identified.
d
Confidence is predicted based on IPA’s Target Filter function.
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Figure 21. Bar graph of relative expression of microRNA 532-5p (miR-532-5p) between
ethanol and control samples. Relative expression is shown. Error bars represent relative
expression ± SEM. Statistical significance assessed using a two-tailed t-test with ***p < 0.001.
Biological replicates n = 6 control, n = 6 ethanol. Technical replicates: n = 3.
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3.3.4 Molecular analysis of second-trimester long-term (T2-L) DEGs
a) Second-trimester effects of ethanol on cellular functions
Functional analysis of T2-L DEGs was completed by inputting the gene list into three
databases: DAVID, GE, and IPA. The top ten DAVID clusters from T2-L are shown in Table
20. Three of the top 10 annotations were involved in endoplasmic reticulum (ER)-related
functions. Several genes were also implicated in two top functions: “melanosome” and “pigment
granule”. Two of the top 10 functions also included cellular reduction-oxidation (redox) reaction
processes. Another two of the top 10 functions involved chromatin-related processes.
T2-L GE analysis returned a list of 132 significant functions, with the top 10 listed in
Table 21. Notably, Protein disulfide isomerase family A, member 4 (Pdia4) and 6 (Pdia6) were
present in four of the top 10 pathways, which included ER-related isomerase activity. In fact,
five of the ten categories were involved in ER-related activity, as identified in DAVID functional
analysis (Table 20). Three of the 10 processes were involved in cellular redox reactions and
metabolic processes, which were, again, consistent with DAVID analysis. Together, Heat shock
70kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5) and Heat shock protein 90kDa
alpha (cytosolic), class A member 1 (Hsp90aa1) were identified in six of the top 10 GE
processes. Such processes were involved in ER-related functions including unfolded protein
response (UPR), protein folding, and ion channel binding.
Lastly, in T2-L IPA functional analysis, the top affected process in Diseases and
Disorders, Molecular and Cellular Functions, and Physiological System Development and
Function are given in Table 22. “Systemic lupus erythematosus” (SLE) has been previously
identified as a top function in DAVID annotation clustering (Table 20). In the top three
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significant Diseases and Disorders, the genes, Hspa5, X-box binding protein 1 (Xbp1), Early
growth response 3 (Egr3), DnaJ (Hsp40) homolog, subfamily B, member 11 (Dnajb11), Protein
tyrosine phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), and Integrin, alpha 4 (antigen
CD49D, alpha 4 subunit of VLA-4 receptor) (Itga4) appeared in each of these categories. Egr3
seemed to be a key player in the Diseases and Disorders category, and along with its role in
muscle spindle development, it serves as an important regulator of transcription. The term, SLE,
included Ptpn22, which was also identified in a KEGG pathway in DAVID analysis (Table 20).
Of all the implicated genes, Hspa5 was the only gene appearing in all five significant Diseases
and Disorders, which complemented the results of DAVID analysis that implicated Hspa5 in the
top five annotations (Table 20). Because Hspa5 was identified using three different methods of
analysis, this signifies the importance of Hspa5 in ER-related processes including folding and
assembly of proteins. The top T2-L process under Molecular and Cellular Functions included the
genes: Ptpn22, Xbp1, and Cyclin-dependent kinase inhibitor 1a (Cdkn1a) (Table 22). Given
their roles in cell cycle response, unfolded protein response, and T cell signaling, respectively,
these genes are key factors responsible for the development and maintenance of critical cell
processes. The top T2-L Physiological System Development and Functions implicated Cdkn1a,
Ptpn22, Xbp1, Thromboxane A2 receptor (Tbxa2r), Peroxiredoxin 1 (Prdx1), Sprouty-related,
EVH1 domain containing 2 (Spred2), and Core-binding factor, runt domain, alpha subunit 2;
translocated to, 3 (Cbfa2t3) in the top three functional categories (Table 22).
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Table 20. Top ten significant annotation clusters resulting from the Database for
Annotation, Visualization and Integrated Discovery (DAVID) functional analysis of
trimester two long-term (T2-L) differentially-expressed genes (DEGs).
Categorya

Term
Endoplasmic
reticulum lumen

p-value

GO CC

Melanosome

2.9e-5

GO CC

Pigment granule

7.9e-5

GO CC

INTERPRO
GO CC

a

Endoplasmic
reticulum, targeting
sequence
Endoplasmic
reticulum part

1.3e-6

7.9e-5
1.9e-4

KEGG PATHWAY

Systemic lupus
erythematosus

3.7e-4

INTERPRO

Thioredoxin-like

2.7e-3

GO BP

Chromatin assembly
3.9e-3
or disassembly

SP PIR keyword

Redox-active center

4.3e-3

INTERPRO

Histone core

5.1e-3

Genesb
Dnajb11, Hspa5, Pdia4,
P4ha1, Pdia6, Sdf2l1
Hsp90aa1, Gchfr, Hspa5,
Prdx1, Pdia4, Pdia6
Hsp90aa1, Gchfr, Hspa5,
Prdx1, Pdia4, Pdia6
Sdf2l1, Hspa5, Pdia4, Pdia6
Dnajb11, Hspa5, Pdia4,
P4ha1, Pdia6, Serinc2, Sdf2l1
Hist1h2bm, Hist1h3a,
Hist1h3g, Hist1h3f, Hist1h3d,
Hist2h3b, Ighg, Ptpn22
Pdia6, Prdx1, Pdia4
Hist1h3g, Hist1h3f, Hist1h2bm,
Hist1h3a, Smarca5, Hist1h3d,
Hist2h3b
Pdia6, Prdx1, Pdia4
Hist1h3a, Hist1h3g,
Hist1h2bm, Hist1h3f, Hist1h3d,
Hist2h3b

Category includes information from the Swiss-Prot and Protein Information Resource (SP PIR keyword), Gene
Ontology’s (GO) cellular component (CC) and biological process (BP), InterPro keywords
(www.ebi.ac.uk/interpro/), and Kyoto Encyclopedia of Genes and Genomes (KEGG) database.
b
Genes included DnaJ (Hsp40) homolog, subfamily B, member 11 (Dnajb11), Heat shock 90kDa protein 5 (glucoseregulated protein, 78kDa) (Hspa5), Protein disulfide isomerase family A, member 4 (Pdia4), Prolyl 4-hydroxylase,
alpha polypeptide I (P4ha1), Protein disulfide isomerase family A, member 6 (Pdia6), Stromal cell-derived factor 2like 1 (Sdf2l1), Heat shock protein 90kDa (cytosolic), class A member 1 (Hsp90aa1), GTP cyclohydrolase I
feedback regulator (Gchfr), Peroxiredoxin 1 (Prdx1), Serine incorporator 2 (Serinc2), Histone cluster 1, H2bm
(Hist1h2bm), Histone cluster 1, H3a (Hist1h3a), Histone cluster 1, H3g (Hist1h3g), Histone cluster 1, H3f
(Hist1h3f), Histone cluster 1, H3d (Hist1h3d), Histone cluster 2, H3b (Hist2h3b), Immunoglobulin heavy chain
(gamma polypeptide) (Ighg), Protein tyrosine phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), and SWI/SNF
related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 (Smarca5).
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Table 21. Top ten significant functions of trimester two long-term (T2-L) differentiallyexpressed genes (DEGs) from Gene Ontology Enrichment (GE).
Gene Ontology Function

Typea

p-value

Genesc

CC

Enrichment
Scoreb
8.49

Endoplasmic reticulum lumen

0.0002

Protein disulfide isomerase activity
Glycerol ether metabolic process
Unfolded protein binding

MF
BP
MF

8.05
7.28
6.19

0.0003
0.0007
0.002

Protein disulfide oxidoreductase
activity
Isomerase activity

MF

6.12

0.002

Hspa5, Pdia4,
Pdia6
Pdia4, Pdia6
Pdia4, Pdia6
Dnajb11, Hspa5,
Hsp90aa1
Pdia4, Pdia6

MF

5.37

0.005

Endoplasmic reticulum-Golgi
intermediate compartment
Protein folding

CC

5.35

0.005

BP

5.23

0.007

Positive regulation of fibroblast
proliferation
Ion channel binding

BP

4.94

0.009

MF

4.76

0.009

a

Dnajb11,
Hsp90aa1, Fkbp2
Hspa5, Pdia6
Dnajb11,
Hsp90aa1, Fkbp2
Cdkn1a, Fosl2
Homer1,
Hsp90aa1

Type indicates a biological process (BP), cellular component (CC), or molecular function (MF).
Enrichment score = Significant genes in a category/All significant genes, vs All genes in the category/All genes on
the chip.
c
Genes included Heat shock 90kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5), Protein disulfide
isomerase family A, member 4 (Pdia4), Protein disulfide isomerase family A, member 6 (Pdia6), DnaJ (Hsp40)
homolog, subfamily B, member 11 (Dnajb11), Heat shock protein 90kDa (cytosolic), class A member 1 (Hsp90aa1),
FK506 binding protein 2, 13kDa (Fkbp2), Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), FOS-like
antigen 2 (Fosl2), and Homer homolog 1 (Drosophila) (Homer1).
b
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Table 22. Functional characterization of trimester two long-term (T2-L) differentially-expressed genes (DEGs) using Ingenuity
Pathway Analysis (IPA).
Diseases and Disorders
Name
p-value
Inflammatory Disease
8.78E-05 – 3.11E-02

# genes
9

Neurological Disease

8.78E-05 – 2.20E-02

13

Skeletal and Muscular
Disorders

8.78E-05 – 4.33E-02

14

Cancer

8.78E-05 – 4.93E-02

8

Hematological Disease 2.78E-03 – 4.93E-02
Molecular and Cellular Functions
Name
p-value
Cellular Development
5.24E-04 – 4.93E-02

6
# genes
12

Cellular Function and
Maintenance

5.24E-04 – 4.63E-02

10

Cell Cycle

6.28E-04 – 4.33E-02

3

Cell Death

8.15E-04 – 4.93E-02

14

Cellular Compromise

1.44E-03 – 4.33E-02

5

Genesa
Dnajb11, Hspa5, Itga4, Ptpn22, Xbp1, Prdx1,
Fosl2, Egr3, mir-342
Egr3, Galnt7, Hist1h2bm, Homer1, Xbp1,
Dnajb11, Hspa5, Itga4,
Ptpn22, Dynlt1, Hsp90aa1, Tufm, P4ha1
Egr3, mir-342, Ptpn22, Hsp90aa1, Prdx1,
Cdkn1a, Fosl2, Tbxa2r,
Dnajb11, Hspa5, Itga4, Xbp1, Dynlt1,
Homer1, P4ha1
Cdkn1a, Prdx1, Itga4, mir-342, Hsp90aa1,
Hist1h3a, Hspa5, Ccdc6
Cdkn1a, Itga4, Prdx1, Hspa5, Xbp1, Tbxa2r

Function Annotationb
SLE; Multiple sclerosis

Genesa
Cdkn1a, Ccdc6, Xbp1, Tbxa2r, Egr3,
Smarca5, Klk1b11, Hsp90aa1,
Itga4, Ptpn22, Fosl2, Cbfa2t3
Egr3, Cdkn1a, Hsp90aa1, Itga4, Ptpn22,
Hspa5, Tbxa2r, Slc9a3r2,
Xbp1, Prdx1
Cdkn1a, Ptpn22, Xbp1

Function Annotationb
Plasmacytoid dendritic
cell development

Smarca5, Cdkn1a, Hspa5, Xbp1, Egr3,
Tbxa2r, Ptpn22, Ccdc6, Itga4, Prdx1,
Slc9a3r2, Camk1g, Manf, Hsp90aa1
Hspa5, Cdkn1a, Prdx1, Hsp90aa1, Xbp1

Neuromuscular disease;
Schizophrenia
SLE; osteosarcoma

Incidence of lymphoma
Chronic B-cell leukemia

ER-stress response

Polyploidization of
hepatocytes
Cell death of immune
cells
Stress response of cells
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Physiological System Development and Function
Name
p-value
# genes
Lymphoid Tissue
4.30E-04 – 3.84E-02
10
Structure/Development
Organ Morphology

4.30E-04 – 4.93E-02

13

Tissue Morphology

4.30E-04 – 4.93E-02

12

Cell-mediated Immune
Response
Embryonic
Development

5.24E-04 – 2.19E-02

5

5.24E-04 – 4.93E-02

10

a

Genesa
Egr3, Cdkn1a, Hsp90aa1, Itga4, Ptpn22,
Xbp1, Tbxa2r, Spred2, Cbfa2t3, Prdx1
Cbfa2t3, Cdkn1a, Prdx1, Ptpn22, Tbxa2r,
Fosl2, Tnnc1, Hspa5, Spred2, Homer1,
Xbp1, Klk1b11, Itga4
Itga4, Xbp1, Tbxa2r, Smarca5, Cdkn1a,
Fosl2, Klk1b11, Ptpn22, Spred2, Cbfa2t3,
Prdx1, Egr3
Cdkn1a, Egr3, Hsp90aa1, Itga4, Ptpn22
Cdkn1a, Spred2, Smarca5, Itga4, Egr3,
Ptpn22, Fosl2, Xbp1, Hspa5, Otub2

Function Annotation
Development of
plasmacytoid dendritic
cells
Organization of
cerebellum
Abnormal morphology
of cholinergic neurons
Metabolism of
thymocytes
Cell death of embryonic
tissue

Genes from Partek Genomics Suite (± 1.2 fold change, p < 0.05). Genes included DnaJ (Hsp40) homolog, subfamily B, member 11 (Dnajb11), Heat shock
90kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5), Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) (Itga4), Protein tyrosine
phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), X-box binding protein 1 (Xbp1), Peroxiredoxin 1 (Prdx1), FOS-like antigen 2 (Fosl2), Early growth
response 3 (Egr3), microRNA 342 (mir-342), UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GaINAc-T7) (Galnt7),
Histone cluster 1, H2bm (Hist1h2bm), Homer homolog 1 (Drosophila) (Homer1), Dynein, light chain, Tctex-type 1 (Dynlt1), Heat shock protein 90kDa
(cytosolic), class A member 1 (Hsp90aa1), Tu translation elongation factor, mitochondrial (Tufm), Prolyl 4-hydroxylase, alpha polypeptide I (P4ha1), Cyclindependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), Thromboxane A2 receptor (Tbxa2r), Histone cluster 1, H3a (Hist1h3a), Coiled-coil domain containing 6
(Ccdc6), SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 (Smarca5), Kallikrein 1-related peptidase b11
(Klk1b11), Core-binding factor, runt domain, alpha subunit 2; translocated to, 3 (Cbfa2t3), Solute carrier family 9, subfamily A (NHE3, cation proton antiporter
3), member 3 regulator 2 (Slc9a3r2), Calcium/calmodulin-dependent protein kinase IG (Camk1g), Mesencephalic astrocyte-derived neurotrophic factor (Manf),
Sprouty-related, EVH1 domain containing 2 (Spred2), Troponin C type 1 (slow) (Tnnc1), and OTU domain, ubiquitin aldehyde binding 2 (Otub2).
b
Functional annotation s: SLE = Systemic Lupus Erythematosus; ER = endoplasmic reticulum.
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b) Second-trimester effects of ethanol on cellular pathways
As in the previous pathway analyses for T2-S and T1-l, Pathway Express, PE, and IPA’s
canonical pathway tool were used to identify T2-L pathways. T2-L DEGs were inputted into the
freely available tool, Pathway Express. The top significant KEGG pathway was “systemic lupus
erythematosus” (Table 23), which agreed with the T2-L functional analysis results. This
pathway included six histone genes, along with Immunoglobulin heavy chain (gamma
polypeptide) (Ighg). The other four disrupted processes were involved in cellular signaling and
maintenance.
Partek was used to identify relevant pathways using Pathway Enrichment. PE data for
T2-L analysis are shown in Table 24. This analysis resulted in six pathways, the top being
“systemic lupus erythematosus”, with nine histones. Finding SLE using PE complements the
Pathway Express results (Table 23). The next two pathways also involved all histones (Table
24). “Transcriptional regulation of cancer” included the cell cycle regulator, Cdkn1a. As with
functional analysis, two of the five significant pathways from PE implicated ER-related
functions that were disrupted in the adult brain following prenatal ethanol exposure during the
second trimester equivalent. Hspa5 is present in three of the five top functions, which mostly
include ER-related processes.
IPA using the canonical pathway tool was used to identify relevant pathways in T2-L
(Table 25). Canoonical pathways are consistent with GE and PE results, and support the finding
that second trimester ethanol exposure was most significantly associated with ER-related damage
(Tables 21, 24). Hspa5, Hsp90aa1, and Cdkn1a each appeared in more than one of the five
canonical pathways. Xbp1 was present in the top disrupted pathway, Endoplasmic Reticulum
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Stress

Response.

The

previously

unmentioned

genes,

UDP-N-acetyl-alpha-D-

galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GaINAc-T7) (Galnt7) and 9
(Galnt9) comprised the second significant pathway, O-glycan Biosynthesis. These results reveal
the importance of altered ER-related stress response following trimester two long-term ethanol
exposure. Cdkn1a was also an important factor, present in two of the five canonical pathways
involved in cell signaling. Previously, Cdkn1a was identified in IPA functional analysis as one of
the three genes that implicated “Cell Cycle” as a significant Molecular and Cellular Function
upon trimester two long-term alcohol exposure (Table 22).
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Table 23. Top five pathways resulting from Pathway Express analysis of trimester two
long-term (T2-L) differentially-expressed genes (DEGs).
Pathway Name
Systemic lupus erythematosus
Calcium signaling pathway
Hematopoietic cell lineage
Antigen processing and
presentation
Prostate cancer
a

Genesc

Impact
Factora
17.06

Corrected
p-valueb
3.89e-8

4.14
3.71
3.69

0.016
0.025
0.025

Hist2h3b, Hist1h2bm, Ighg, Hist1h3g,
Hist1h3f, Hist1h2d, Hist1h3a
Ighg, Tbxa2r, Tnnc1
Itga4, Ighg
Hsp90aa1, Hspa5

3.58

0.028

Hsp90aa1, Cdkn1a

Impact factor = a probabilistic term that takes into consideration the proportion of DEGs on the pathway and gene
perturbation factors of all genes in the pathway.
b
Corrected p-value is based on a False-Discover-Rate correction.
c
Genes were differentially expressed based on Partek Genomics Suite (± 1.2-fold change, p < 0.05). Genes included
Histone cluster 2, H3b (Hist2h3b), Histone cluster 1, H2bm (Hist1h2bm), Immunoglobulin heavy chain (gamma
polypeptide) (Ighg), Histone cluster 2, H3g (Hist1h3g), Histone cluster 2, H3f (Hist1h3f), Histone cluster 2, H3d
(Hist1h3d), Histone cluster 2, H3a (Hist1h3a), Thromboxane A2 receptor (Tbxa2r), Troponin C type 1 (slow)
(Tnnc1), Integrin, alpha 4 (antigen CD49D, alpha subunit of VLA-4 receptor) (Itga4), Heat shock protein 90kDa
alpha (cytosolic), class A member 1 (Hsp90aa1), Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
(Hspa5), and Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a).
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Table 24. Significant pathways resulting from Pathway Enrichment (PE) analysis of
trimester two long-term (T2-L) differentially-expressed genes (DEGs).
Enrichment
Scorea
18.63

p-value

Genesb

8.08E-9

Transcriptional
misregulation in cancer

16.56

6.44E-8

Alcoholism

16.00

1.12E-7

Protein processing in
endoplasmic reticulum
Protein export
Antigen processing and
presentation

9.24

9.74E-5

4.89
3.15

0.008
0.043

Hist1h2bm, Hist1h3a, Hist1h3b,
Hist1h3c, Hist1h3d, Hist1h3e,
Hist1h3g, Hist1h3h, Hist1h3i
Cdkn1a, Hist1h3a, Hist1h3b,
Hist1h3c, Hist1h3d, Hist1h3e,
Hist1h3g, Hist1h3h, Hist1h3i
Hist1h2bm, Hist1h3a, Hist1h3b,
Hist1h3c, Hist1h3d, Hist1h3e,
Hist1h3g, Hist1h3h, Hist1h3i
Dnajb11, Hsp90aa1, Hspa5, Pdia4,
Pdia6, Xbp1
Hspa5, Immp1l
Hsp90aa1, Hspa5

Pathway Name
Systemic lupus
erythematosus

a

Enrichment score = Significant genes in a category/All significant genes vs All genes in the category/All genes on
the chip.
b
Genes included Histone cluster 1, H2bm (Hist1h2bm), Histone cluster 2, H3a (Hist1h3a), Histone cluster 2, H3b
(Hist1h3b), Histone cluster 2, H3c (Hist1h3c), Histone cluster 2, H3d (Hist1h3d), Histone cluster 2, H3e (Hist1h3e),
Histone cluster 2, H3g (Hist1h3g), Histone cluster 2, H3h (Hist1h3h), Histone cluster 2, H3i (Hist1h3i), Cyclindependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), DnaJ (Hsp40) homolog, subfamily B, member 11 (Dnajb11),
Heat shock protein 90kDa alpha (cytosolic), class A member 1 (Hsp90aa1), Heat shock 70kDa protein 5 (glucoseregulated protein, 78kDa) (Hspa5), Protein disulfide isomerase family A, member 4 (Pdia4), Protein disulfide
isomerase family A, member 6 (Pdia6), X-box binding protein 1 (Xbp1), and IMP1 inner membrane peptidase-like
(S. cerevisiae) (Immp1l).
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Table 25. Top canonical pathways resulting from Ingenuity Pathway Analysis (IPA) of
trimester two long-term (T2-L) differentially-expressed genes (DEGs ).
Canonical Pathway Namea
Endoplasmic reticulum stress pathway
O-glycan biosynthesis
PI3K/AKT Signaling
Aldosterone Signaling in Epithelial Cells
Prostate Cancer Signaling
a

p-value
1.44E-03
4.26E-03
4.98E-03
0.0115
0.0245

Genesb
Xbp1, Hspa5
Galnt7, Galnt9
Cdkn1a, Hsp90aa1, Itga4
Dnajb11, Hspa90aa1, Hspa5
Cdkn1a, Hsp90aa1

Canonical pathways were identified in Ingenuity Pathway Analysis® using the Core Analysis feature. The list of
DEGs was generated using Partek Genomics Suite using a ± 1.2 fold change and p < 0.05.
b
Genes included X-box binding protein 1 (Xbp1), Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
(Hspa5), UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GaINAc-T7)
(Galnt7), UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GaINAc-T9)
(Galnt9), Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), Heat shock protein 90kDa alpha (cytosolic),
class A member 1 (Hsp90aa1), Integrin, alpha 4 (antigen CD49D, alpha subunit of VLA-4 receptor) (Itga4), and
DnaJ (Hsp40) homolog, subfamily B, member 11 (Dnajb11).
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c) Second-trimester effects of ethanol on cellular networks
The DEG list from T2-L was subjected to network analysis using GeneMANIA and IPA.
The results from GeneMANIA are shown in Table 26. All six significant functions were
involved in ER-related processes, which further indicate the importance of ER-related cellular
responses that are altered following second trimester ethanol exposure. The results of
GeneMANIA are comparable to DAVID analysis that identified the GO CCs “endoplasmic
reticulum lumen” and “endoplasmic reticulum part” (Table 20). Hspa5, Hsp90aa1, and Dynein,
axonemal, heavy chain 3 (Dnahc3) are present in all five GeneMANIA functions. Additionally,
Pdia6 and Xbp1 are each present in two of the five functions.
Network analysis of DEGs in T2-L was performed using the Core Analysis function in
IPA. Only those networks with score > 3 are presented (Table 27). The T2-L top network was
termed: Inflammatory Disease, Neurological Disease, Skeletal and Muscular Disorders. This
network included 11 downreguated genes and two upregulated genes out of a total of 35 network
genes (Figure 22). The second network was termed, Cardiovascular System Development and
Function, Cellular Movement, Cell-To-Cell Signaling Interaction. This network included 11
differentially-expressed genes out of 36 network genes, nine of which were downregulated and
two of which were upregulated (Figure 23). The third network was termed, Amino Acid
Metabolism, Lipid Metabolism, Molecular Transport. This network included nine DEGs out of
35 network genes, seven of which were downregulated and two of which were upregulated
(Figure 24). Similar to their implication in two of the six ER-related GeneMANIA functions,
Hspa5 and Pdia6 were implicated in the first IPA network. As part of the first IPA network,
Xbp1 was also identified in two of the six GeneMANIA functions that involved “response to
unfolded protein” and “response to topologically incorrect protein” (Table 27). As part of the

119

second IPA network, Hsp90aa1 and Dnahc3 were also implicated in all six GeneMANIA
functions involved in UPR and other ER functions (Table 27). The three significant T2-L
networks were merged in order to identify relevant hub molecules associated with T2-L ethanol
exposure. The merged analysis resulted in one hub molecule in common with trimester one:
IFNG. In total, there were 17 hubs with > 10 gene interactions (Figure 25). Of the differentiallyexpressed gene list, XBP1 and CDKN1A were hubs in the merged T2-L network. Hubs common
to trimester two ethanol exposure (T2-S and T2-L) included: huntingtin (HTT), FBJ murine
osteosarcoma viral oncogene homolog (FOS), and nuclear factor-kappaB (NFkB).
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Table 26. Significant network functions resulting from GeneMANIA analysis of trimester
two long-term (T2-L) differentially-expressed genes (DEGs).
Network Functionsa

a

Endoplasmic reticulum lumen

p-value
(FDRcorrected)
1.12e-5

Response to unfolded protein

1.36e-3

Response to topologically incorrect
protein
Endoplasmic reticulum part

1.75e-3

Endoplasmic reticulum membrane

8.51e-3

Nuclear outer membrane-endoplasmic
reticulum membrane network

0.012

2.67e-3

Genesa

Erp44, Dnahc3, Hspa5, Hsp90aa1,
Pdia6, Calr
Erp44, Dnahc3, Hspa5, Hsp90aa1,
Xbp1
Erp44, Dnahc3, Hspa5, Hsp90aa1,
Xbp1
Erp44, Dnahc3, Hspa5, Hsp90aa1,
Ostc, Magt1, Calr, Pdia6
Erp44, Dnahc3, Hspa5, Hsp90aa1,
Ostc, Magt1, Calr
Erp44, Dnahc3, Hspa5, Hsp90aa1,
Ostc, Magt1, Calr

Network functions were identified by inputting the T2-L DEG list generated from Partek Genomics Suite (± 1.2fold change and p < 0.05).
b
Genes in bold font indicate those present in the inputted gene list (DEGs). DEGs included Dynein, axonemal, heavy
chain 3 (Dnahc3), Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5), Heat shock protein
90kDa alpha (cytosolic), class A member 1 (Hsp90aa1), Protein disulfide isomerase family A, member 6 (Pdia6),
and X-box binding protein 1 (Xbp1).
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Table 27. Top Ingenuity Pathway Analysis (IPA) networks identified in trimester two longterm (T2-L) analysis of differentially-expressed genes (DEGs).
Network No. Focus Top Network Functionb
Moleculesa
1
13
Inflammatory Disease,
Neurological Disease,
Skeletal and Muscular
Disorders
2
11
Cardiovascular System
Development and Function,
Cellular Movement, CellTo-Cell Signaling and
Interaction
3
9
Amino Acid Metabolism,
Lipid Metabolism,
Molecular Transport
a

Input Genesc

Scored

Cdkn1a, Dnajb11, Hist1h3a,
Hspa5, Itga4, Pdia4, Pdia6,
Ptpn22, Sdf2l1, Smarca5,
Spred2, Xbp1, Fkbp2
Hsp90aa1, Dynlt1, Cbfa2t3,
Prdx1, Dnahc3, P4ha1,
Manf, Tbxa2r, Gchfr,
Hist3h3, Slc9a3r2

24

Zhx2, Fosl2, Tufm, Homer1,
Klk1b11, Vps13b, Camk1g,
Egr3, Tnnc1

15

20

Number (No.) Focus Molecules indicates the number of genes that were differentially expressed (Partek Genomics
Suite: ± 1.2 fold change, p < 0.05) in adult brain (GD 14 and 16) as a result of ethanol exposure in the second
trimester equivalent.
b
Top Function represent the name of the network in IPA.
c
Input genes included Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), DnaJ (Hsp40) homolog,
subfamily B, member 11 (Dnajb11), Histone cluster 1, H3a (Hist1h3a), Heat shock 90kDa protein 5 (glucoseregulated protein, 78kDa) (Hspa5), Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) (Itga4),
Protein disulfide isomerase family A, member 4 (Pdia4), Protein disulfide isomerase family A, member 6 (Pdia6),
Protein tyrosine phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), Stromal cell-derived factor 2-like 1
(Sdf2l1), SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
(Smarca5), Sprouty-related, EVH1 domain containing 2 (Spred2), X-box binding protein 1 (Xbp1), FK506 binding
protein 2, 13kDa (Fkbp2), Heat shock protein 90kDa (cytosolic), class A member 1 (Hsp90aa1), Dynein, light
chain, Tctex-type 1 (Dynlt1), Core-binding factor, runt domain, alpha subunit 2; translocated to, 3 (Cbfa2t3),
Peroxiredoxin 1 (Prdx1), Dynein, axonemal, heavy chain 3 (Dnahc3), Prolyl 4-hydroxylase, alpha polypeptide I
(P4ha1), Mesencephalic astrocyte-derived neurotrophic factor (Manf), Thromboxane A2 receptor (Tbxa2r), GTP
cyclohydrolase I feedback regulator (Gchfr), Histone cluster 3, H3 (Hist3h3), Solute carrier family 9, subfamily A
(NHE3, cation proton antiporter 3), member 3 regulator 2 (Slc9a3r2), Zinc fingers and homeboxes 2 (Zhx2), FOSlike antigen 2 (Fosl2), Tu translation elongation factor, mitochondrial (Tufm), Homer homolog 1 (Drosophila)
(Homer1), Kallikrein 1-related peptidase b11 (Klk1b11), Vacuolar protein sorting 13 homolog B (yeast) (Vps13b),
Calcium/calmodulin-dependent protein kinase IG (Camk1g), Early growth response 3 (Egr3), and Troponin C type
1 (slow) (Tnnc1).
d
Score is equal to the negative exponent of the respective p-value such that a score of 3 corresponds to a p-value of
10E-3. Network 1 score of 24 is equivalent to p = 10E-24. Network 2 score of 20 is equivalent to p = 10E-20.
Network 3 score of 15 is equivalent to p = 10E-15.
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Figure 22. First network resulting from Ingenuity Pathway Analysis of trimester two longterm (T2-L) differentially-expressed genes (DEGs). Network name: Inflammatory Disease,
Neurological Disease, Skeletal and Muscular Disorders. Highlighting (red and green) represents
input genes. Red indicates downregulation and green indicates upregulation in ethanol mice
versus control mice. DEGs were identified using Partek Genomics Suite with a ± 1.2 fold change
and p < 0.05. A single-headed arrow indicates the action of one gene on another. A double
arrow-headed line indicates that the two genes act on each other. Dashed lines indicate an
indirect interaction, and solid lines indicate direct interactions. E = expression, L = proteolysis,
LO = localization, PD = protein-DNA binding, A = activation, P =
phosphorylation/dephosphorylation, PR = protein-RNA binding, PP = protein-protein
interaction, I = inhibition, M = biochemical modification, RB = regulation of binding, T =
transcription, TR = translocation. Refer to Appendix F for a full IPA legend on relationship
types, molecular shapes, and relationships.
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Figure 23. Second network resulting from Ingenuity Pathway Analysis of trimester two
long-term (T2-L) differentially-expressed genes (DEGs). Network name: Cardiovascular
System Development and Function, Cellular Movement, Cell-To-Cell Signaling and Interaction.
Highlighting (red and green) represents input genes. Red indicates downregulation and green
indicates upregulation in ethanol mice versus control mice. DEGs were identified using Partek
Genomics Suite with a ± 1.2 fold change and p < 0.05. A single-headed arrow indicates the
action of one gene on another. A double arrow-headed line indicates that the two genes act on
each other. Dashed lines indicate an indirect interaction, and solid lines indicate direct
interactions. E = expression, L = proteolysis, LO = localization, PD = protein-DNA binding, A =
activation, P = phosphorylation/dephosphorylation, PR = protein-RNA binding, PP = proteinprotein interaction, I = inhibition, M = biochemical modification, RB = regulation of binding, T
= transcription, TR = translocation. Refer to Appendix F for a full IPA legend on relationship
types, molecular shapes, and relationships.
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Figure 24. Third network resulting from Ingenuity Pathway Analysis of trimester two longterm (T2-L) differentially-expressed genes (DEGs). Network name: Amino Acid Metabolism,
Lipid Metabolism, Molecular Transport. Highlighting (red and green) represents input genes.
Red indicates downregulation and green indicates upregulation in ethanol mice versus control
mice. DEGs were identified using Partek Genomics Suite with a ± 1.2 fold change and p < 0.05.
A single-headed arrow indicates the action of one gene on another. A double arrow-headed line
indicates that the two genes act on each other. Dashed lines indicate an indirect interaction, and
solid lines indicate direct interactions. E = expression, L = proteolysis, LO = localization, PD =
protein-DNA binding, A = activation, P = phosphorylation/dephosphorylation, PR = proteinRNA binding, PP = protein-protein interaction, I = inhibition, M = biochemical modification, RB
= regulation of binding, T = transcription, TR = translocation. Refer to Appendix F for a full
IPA legend on relationship types, molecular shapes, and relationships.
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Figure 25. A merged network from Ingenuity Pathway Analysis (IPA) of trimester two
long-term (T2-L) differentially-expressed genes (DEGs). Highlighting (red and green)
represents input genes. Red indicates downregulation and green indicates upregulation in ethanol
mice versus control mice. DEGs were identified using Partek Genomics Suite with a ± 1.2 fold
change and p < 0.05. A single-headed arrow indicates the action of one gene on another. A
double arrow-headed line indicates that the two genes act on each other. Dashed lines indicate an
indirect interaction, and solid lines indicate direct interactions. E = expression, L = proteolysis,
LO = localization, PD = protein-DNA binding, A = activation, P =
phosphorylation/dephosphorylation, PR = protein-RNA binding, PP = protein-protein
interaction, I = inhibition, M = biochemical modification, RB = regulation of binding, T =
transcription, TR = translocation. Refer to Appendix F for a full IPA legend on relationship
types, molecular shapes, and relationships.
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d) Candidate gene selection and confirmation of specific genes disrupted following
second-trimester ethanol exposure
The selected T2-L gene candidates are shown in Table 28, which specifies the criteria
used for qRT-PCR confirmation experiments. The criteria were based on functional analysis
(DAVID, GE, IPA), pathway analysis (Pathway Express, PE, canonical pathways), and network
analysis (GeneMANIA, IPA). Selected genes were subjected to qRT-PCR for confirmation, and
the results are shown in Table 29. The downregulation of T2-L genes including,
Calcium/calmodulin-dependent protein kinase IG (Camk1g), Coiled-coil domain containing 6
(Ccdc6), Mesencephalic astrocyte-derived neurotrophic factor (Manf), Cdkn1a, Egr3, Hspa5,
and Xbp1 was confirmed. Homer homolog 1 (Drosophila) (Homer1) and Hspa90aa1 qRT-PCR
fold-changes, albeit statistically significant, were opposite to the array fold-changes. A series of
box plots illustrating the variability across biological replicates in qRT-PCR demonstrates the
similarity in ∆CT values across replicates, and the presence of major and minor outliers, for
Tbxa2r samples (Figure 26). Comparing the Tbxa2r box plot to those of other genes, the data
suggest that all other genes from this group show between-group variability in order to reach
statistical significance.
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Table 28. Candidate gene selection criteria for confirmation of specific trimester two longterm (T2-L) differentially-expressed genes (DEGs).
Genesa

Neurodevelopment and/or behaviour

Toolb

Camk1g
Ccdc6

pathophysiology of sleep disorders233
responsive to genotoxic stress (DNA damage)234
miRNA:gene (miR-302c)
PI3K/AKT signaling; prostate cancer signaling
misregulation in cancer
attack behaviour235
neuromuscular synaptic transmission
association with schizophrenia236
working memory; navigation
skeletal muscle contraction
enhanced behavioural despair and anxiety237
protein refolding; nitric-oxide synthase regulator
altered expression in autism post-mortem brains238
ER response (to unfolded proteins)
pathogenesis of spinocerebellar ataxis239
reduces ER stress (neuroprotective); recovery of
motor functions240
contraction of skeletal muscle
asthma-related symptoms241
ER stress response

PubMed
PubMed
IPA
IPA
GE
IPA, PubMed
GE
PubMed
IPA
GE
NCBI
P.Express
PubMed
DAVID
PubMed
PubMed

Cdkn1a
Egr3

Homer1

Hsp90aa1
Hspa5
Manf
Tbxa2r
Xbp1

UPR in neurites242
association with schizophrenia243
a

IPA
PubMed
IPA,
GeneMANIA
PubMed

Network
(IPA)c
3
None
1
(hub)
3

3

2
1
2
2
1
(hub)

Genes listed alphabetically; DEGs: Calcium/calmodulin-dependent protein kinase IG (Camk1g), Coiled-coil
domain containing 6 (Ccdc6), Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), Early growth response 3
(Egr3), Homer homolog 1 (Drosophila) (Homer1), Heat shock protein 90kDa (cytosolic), class A member 1
(Hsp90aa1), Heat shock 90kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5), Mesencephalic astrocytederived neurotrophic factor (Manf), Thromboxane A2 receptor (Tbxa2r), and X-box binding protein 1 (Xbp1).
b
Tools used to analyse candidate genes (by neurodevelopment and behaviour) include PubMed, Ingenuity Pathway
Analysis, Partek Gene Ontology Enrichment (GE), National Center for Biotechnology Information (NCBI),
GeneMANIA (www.genemania.org), The Database for Annotation, Visualization and Integrated Discovery
(DAVID), and Pathway Express (P. Express).
c
IPA networks listed are shown in Figure 22-24. “Hub” = molecule that appears in a top IPA network with strong
intramodule connectivity to all other genes in the same network. Connectivity of a hub > 10 interaction.
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Table 29. A comparison of trimester two long-term (T2-L) qRT-PCR and microarray
results for candidate genes.
Genesa
Camk1g
Ccdc6
Cdkn1a
Egr3
Homer1
Hsp90aa1
Hspa5
Manf
Tbxa2r
Xbp1
a

Array
Fold change
-1.27
-1.25
-1.43
-1.21
-1.20
-1.21
-1.36
-1.35
1.21
-1.37

Array
p-value
0.023
0.019
0.021
0.040
0.021
0.041
0.005
0.009
0.033
0.028

qRT-PCR
Fold change
-1.66
-1.19
-2.23
-1.29
-0.74
-0.89
-1.61
-1.70
-1.18
-1.54

qRT-PCR
p-value
3.0e-4
0.049
0.003
0.026
0.005
0.025
0.029
0.006
0.079
0.018

Genes are listed alphabetically. Genes included Calcium/calmodulin-dependent protein kinase IG (Camk1g),
Coiled-coil domain containing 6 (Ccdc6), Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a), Early growth
response 3 (Egr3), Homer homolog 1 (Drosophila) (Homer1), Heat shock protein 90kDa (cytosolic), class A
member 1 (Hsp90aa1), Heat shock 90kDa protein 5 (glucose-regulated protein, 78kDa) (Hspa5), Mesencephalic
astrocyte-derived neurotrophic factor (Manf), Thromboxane A2 receptor (Tbxa2r), and X-box binding protein 1
(Xbp1). Genes with bold font represent those that were differentially expressed in array and qRT-PCR results. An
underline indicates opposing results between array and qRT-PCR results.
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Camk1g

Egr3

Hspa5

control

Ccdc6

Cdkn1a

Homer1

Hsp90aa1

Manf

ethanol

control

Figure 26. Box plot analysis
of qRT-PCR results for
trimester two long-term
genes
(T2-L)
using
Statistical Package for the
Social Sciences v.16.6. All
control and ethanol replicates
were included in the analysis.
Data are represented by
average ∆CT per treatment,
generated using StepOne
Real-time PCR software. An
“o” represents a minor outlier
(± 1.5 interquartile range). A
* represents a major outlier
(± 3.0 interquartile range).

Tbxa2r

ethanol

control

ethanol

Xbp1

control

ethanol
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e) MiRNAs altered in the adult brain following second-trimester ethanol exposure
In the global analysis of T2-L miRNAs, fold change ranged from -476-fold (miR-704) to
+1.96-fold (miR-467e). Of the 1407 miRNAs on the T2-L arrays that were specific to Mus
Musculus, the ANOVA resulted in 790 that were < 1 (56.2%), four that were unchanged (0.3%)
and 613 that were < 1 (43.6%). T2-L analysis resulted in 20 differentially-expressed miRNAs (±
1.2-fold change, p < 0.05) listed in Table 30. Only seven of 20 (35%) were found to be
upregulated in ethanol mice compared to control mice. None of the miRNAs found in T2-L were
in common with those in T1-L. However, miR-342-5p, identified in miRNA T2-L analysis (±
1.2-fold change, p < 0.05), was also found in the T2-L long-term gene list (Appendix D).
f) Identification and Confirmation of Specific MiRNAs in T2-L and their Gene Targets
For T2-L analysis of miRNA and gene expression levels, the target filtering results are
shown in Table 31. Six miRNAs were implicated in the results including: miR-146b, miR-208b,
miR-302c, miR-335, miR-449 and miR-455. Contrary to T1-L, all miRNAs except for miR-302c
were downregulated, which was surprising since it opposes the notion that an upregulated
miRNA(s) leads to decreased expression of mRNAs. There were 10 genes identified in target
filtering analysis, which were all downregulated. The only miRNA:gene inverse relationship
included miR-302c and Ccdc6. Mir-302c was subjected to confirmation by qRT-PCR. The
upregulation of miR-302c ― along with the previously mentioned corresponding
downregulation of its target gene, Ccdc6 ― was confirmed (Figure 27).
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Table 30. A list of differentially-expressed microRNAs in trimester two long-term (T2-L)
array analysis.
MicroRNAa
miR-10b
miR-1194
miR-146b
miR-184
miR-1942
miR-1952
miR-1964
miR-208b
miR-2145
miR-302c
miR-335-5p
miR-342-5p
miR-343
miR-369-5p
miR-449b
miR-455
miR-466b-3p
miR-466c-3p
miR-466e-3p
miR-684
a

Fold change
-1.47
-1.30
-1.24
-1.44
1.38
1.25
1.26
-1.37
1.39
1.27
-1.35
-1.27
1.27
1.29
-1.27
-1.48
-1.35
-1.90
-1.49
-1.28

p-value
0.002
0.006
0.049
0.001
0.029
0.018
0.032
0.040
0.029
0.011
0.038
0.025
0.018
0.003
0.043
0.037
0.038
0.030
2.5e-4
0.021

MicroRNAs are listed by numerical ordering. Data generated using a ± 1.2-fold change and p < 0.05 in Partek
Genomics Suite.

132

Table 31. Ingenuity Pathway Analysis (IPA) target filtering of differentially-expressed
genes (DEGs) and microRNAs from the trimester two long-term (T2-L) group.
Genesa
Symbol
Ccdc6
Cdkn1a
Dynlt1
Ccdc6
Fam107b
Ptpn22
Cbfa2t3
Galnt7
Xbp1
Zhx2
Cdkn1a
Otub2
a

Fold change

MicroRNAb
Symbol

Fold change

-1.254
-1.425
-1.208
-1.254
-1.245
-1.216
-1.203
-1.212
-1.367
-1.221
-1.425
-1.314

miR-146b
miR-208b
miR-208b
miR-302c
miR-335-5p
miR-335-5p
miR-449b
miR-449b
miR-449b
miR-449b
miR-455
miR-455

-1.243
-1.373
-1.373
1.265
-1.349
-1.349
-1.268
-1.268
-1.268
-1.268
-1.477
-1.477

Expressionc
(gene:miRNA)
↓↓
↓↓
↓↓
↓↑
↓↓
↓↓
↓↓
↓↓
↓↓
↓↓
↓↓
↓↓

Confidenced
(predicted)
High
Moderate
High
Moderate
High
Moderate
High
High
Moderate
High
Moderate
Moderate

Genes included Coiled-coil domain containing 6 (Ccdc6), Cyclin-dependent kinase inhibitor 1A (p21, Cip1)
(Cdkn1a), Dynein, light chain, Tctex-type 1 (Dynlt1), Family with sequence similarity 107, member B (Fam107b),
Protein tyrosine phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), Core-binding factor, runt domain, alpha
subunit 2; translocated to, 3 (Cbfa2t3), UDP-N-acetyl-alpha-D-galactosamine:polypeptide-Nacetylgalactosaminyltransferase 7 (GaINAc-T7) (Galnt7), X-box binding protein 1 (Xbp1), Zinc fingers and
homeboxes 2 (Zhx2), and OUT domain, ubiquitin aldehyde binding 2 (Otub2). DEGs are based on Partek Genomics
Suite analysis with ± 1.2-fold change and p < 0.05
b
MicroRNAs are listed by numerical order. MicroRNAs were differentially expressed based on Partek analysis with
± 1.2-fold change and p < 0.05.
c
Expression (gene:miRNA) is highlighted in red if an inverse relationship between gene:miRNA was identified.
d
Confidence predicted based on IPA’s Target Filter function.
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Figure 27. Bar graph of relative expression of miR-302c between ethanol and control
samples. Error bars represent relative expression ± SEM. Statistical significance assessed using a
two-tailed t-test with *p < 0.05. Biological replicates: n = 5 control, n = 6 ethanol. Technical
replicates: n = 3.
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4. Discussion
My central hypothesis stated that, prenatal alcohol exposure during the first and second
term of gestation causes FASD-related behavioural abnormalities and may involve immediate
and lifelong changes in brain gene expression, affecting specific pathways. The results presented
in this thesis show that B6 mice exhibit behavioural delays and alterations to the brain
transcriptome, both immediately following ethanol treatment and into adulthood, regardless of
neurodevelopmental timing. More specifically, I established that prenatal ethanol exposure alters
developmental milestones, particularly those associated with motor skill, and leads to learning
abnormalities associated with FASD. Immediate (fetal) and long-term (adult) effect of binge-like
exposure in B6 mice involves genome-wide gene expression in the brain. Such changes are
specific to cellular pathways and networks related to neurodevelopment and FASD-relevant
behaviours. I also investigated a role for miRNAs in the long-term maintenance of gene
expression changes in response to prenatal ethanol exposure.
The discussion interprets the behavioural and transcriptomic results in the context of
neurodevelopment and FASD. In the behaviour section of the discussion, long-term effects
(treated during trimester one or two) phenotypic explanations are organized by specific
behaviours analysed comparatively to the results. In the molecular section of the discussion, an
interpretation of the immediate effects of prenatal alcohol exposure (T2-S) is presented. Next,
the long-term effects (T1-L and T2-L) on mRNA and miRNA changes resulting from prenatal
ethanol exposure are reported. For each of the groups in the molecular section (T2-S, T1-L, and
T2-L), the discussion includes the interpretation of functions, pathways, and networks, and their
importance to specific cellular processes.
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4.1 Binge-like prenatal ethanol exposure leads to behavioural alterations in exposed
offspring
4.1.1 Gestational ethanol exposure leads to motor skill deficits
The results from behavioural analysis demonstrate that ethanol exposure during the first
and second trimester equivalent may cause delays in specific developmental milestones. When
pups are exposed during the first trimester equivalent, the effects appear to be subtle, with four of
the nine milestones affected. Trimester-one-exposed males and females show significant deficits
in surface righting, forelimb grasping, open-field traversal, and air righting, which follows the
literature8. Such phenotypes are early indicators of the rostro-caudal gradient of limb
coordination maturation244. Limb and musculoskeletal defects have been reported in children
with FASD, at early infancy245. Poor limb coordination has been observed in ethanol-affected
animals, including mice91,246. Ethanol exposure during the second trimester equivalent produces
delays in six of nine developmental milestones in males and females including: surface righting,
negative geotaxis, cliff aversion, open-field traversal, eye opening, and air righting. Trimester
two ethanol mice are delayed in reflex (eg. negative geotaxis) and sensory coordination (eg. cliff
aversion). Similar to trimester one results, motor skill and coordination deficits are persistent in
trimester two ethanol mice compared to control mice. Trimester two ethanol mice were
significantly delayed in forelimb grasping (which measures balance, coordination, and motoric
strength) compared to trimester one ethanol mice.
The reported motor strength, reflex, and coordination deficits have been observed in other
studies assessing developmental milestones in FASD247,248. These patterns may suggest that the
brain regions responsible for the development of these neuro-motor skills may be sensitive to
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ethanol at early stages of development, at which time neurulation and cell proliferation occur2.
Motor activity behaviours have been closely correlated with serotonin function249. Serotonin
function is important for neurogenesis; and, its levels are altered by alcohol exposure250.
Serotonin may be important in the disrupted development of motor skills. Fetal ethanol exposure
can cause cell death and neuronal reduction, which may lead to motor impairments61,93,251,252.
The impairments caused by late gestation ethanol exposure may be attributed to interference
during specific brain region development including synapse formation in the cerebellum and
prefrontal cortex93,253–256. Such results are relevant to FASD, as young children with FASD show
delayed motor development and fine-motor dysfunction including weak grasp, poor hand-eye
coordination, and poor balance19,257,258. Deficits in fine-motor skills are thought to result from
damage to the cerebellum, due to its involvement in motor learning259. The cerebellum is also
sensitive to the apoptotic effects of ethanol, particularly during later neurodevelopmental
stages53. My results support these findings, and suggest that ethanol exposure, particularly when
given at late gestation, may be detrimental to the development of motor skills, reflexes, and
coordination.
4.1.2 Prenatal ethanol exposure leads to increased activity
The literature is divided on the impact of prenatal alcohol exposure on activity
levels1,78,260,261. In my study, novelty-based activity levels (movements) are increased in
trimesters one and two ethanol mice compared to control mice, which follows the
literature1,68,262. Trimester two ethanol mice were significantly more active than trimester one
ethanol mice (Figure 6), suggesting that second trimester ethanol exposure may lead to more
severe deficits in activity levels in offspring than early ethanol exposure. Increased activity are
common in children with FASD, and in animal models of FASD1,14,263,264.
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In the open-field activity analysis, I sought to differentiate the effects of alcohol on
activity versus novelty-induced stress by measuring overnight activity of the mouse. Overnight
activity levels, plotted hour-by-hour, were not consistent between males and females from
trimesters one and two. Results suggest that alterations to activity levels in a familiar
environment may be due, at least in part, to the timing of exposure during neurodevelopment.
Trimester one ethanol females were significantly less active than control females at three timepoints during the night; whereas, at one time-point, ethanol females were more active than
control females (Figure 7A). Trimester one ethanol males were significantly more active than
control males at the beginning and ending time-points of overnight testing; ethanol males were
significantly less active than control males for one hour during the night (Figure 7B). The results
suggest that prenatal ethanol exposure during the first trimester equivalent results in generally
altered (whether increased or decreased) levels of activity in ethanol mice. The results also point
to the complexity of locomotor behaviours associated with FASD. These findings are consistent
with studies that have observed differences in activity in animals following ethanol
administration during early stages of fetal development1,68,262,263. Trimester two ethanol females
were hyper-active for two hours during the nocturnal phase, and hypo-active for one hour
(Figure 8B). Ethanol males showed altered activity levels compared to their control counterparts
at certain peaks throughout the night. Trimester two ethanol males displayed increased activity
for four hours, and significantly decreased activity for two hours (Figure 8A). Such disturbances
in activity levels follow the results from trimester one. Ultimately, both early- and mid-gestation
ethanol exposures led to changes in nocturnal behaviour in ethanol-exposed adolescent mice.
These abnormalities may represent sporadic alterations in activity following prenatal ethanol
exposure.
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Researchers have reported on altered locomotor activity of mice, and its association with
5-hydroxytryptophan

(5-HT)

transporter

mRNA

levels

in

neurons266.

Serotonin,

a

neurotransmitter involved in behaviour and CNS development, is decreased in the forebrains of
ethanol mice compared to control counterparts267. Prenatal ethanol exposure leads to differential
long-term effects on 5-HT-mediated neuroendocrine function in males and females268. Timester
one is important for neural progenitor development and forebrain development64,65. Altered
activity levels in ethanol mice could be maintained into adulthood due to altered serotonin
signaling in the brain. Trimester two is a critical period for neuroepithelial cell proliferation,
differentiation, and migration69. Ethanol exposure during this stage alters neuronal migration
and, similar to first trimester exposure, reduces the number of neurons and glial cells in the
neocortex, hippocampus, and sensory nucleus64,70; these reductions are associated with
alterations in locomotor activity269. A correlation between neuronal reduction and disturbed
locomtor activity is logical, given that the hippocampus ― one of the prominent limbic system
structures ― contributes to exploratory locomotion behaviour270. Prenatal ethanol exposure has
been reported to lead to a 25-30% decline in the number of hippocampal cornu ammonis area 1
(CA1) pyramidal cells, which corresponded to a significant increase in activity levels in ethanol
subjects269. Long-term abnormalities in the cerebral cortex, a region important for the control of
voluntary movement, have been noted in motor-impaired individuals with FAS and FASD48,271.
4.1.3 Ethanol leads to changes in anxiety-related traits when offspring are exposed
during the second trimester
The results from anxiety testing indicate that anxiety-related traits may confound analysis
of locomotor behaviours in FASD models, particularly when assessed in novel environments. In
my study, three measures of anxiety-related traits were used including an open field test, a LDB,
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and an EPM. Thigmotaxis is an index of anxiety in mice, and is observed when a mouse has a
tendency to remain close to walls or in the dark, i.e., away from open and light areas272.
Trimester one ethanol mice and control mice were not significantly different, which suggests that
mice exposed to ethanol during the beginning of gestation have no observable anxiety-related
deficits. Although others have agreed that there may be no changes in anxiety-related traits
following prenatal alcohol exposure102, they have not focussed on the first trimester, leading to
the novelty of the findings in this thesis.
Trimester two ethanol mice showed significantly lower levels of thigmotaxis, indicated
by significantly increased time, compared to control mice, in the center zone and light arena of
the open-field test and LDB, respectively (Figures 9-10). Additionally, trimester two ethanol
mice show lower levels of thigmotaxis in the open field than trimester one ethanol mice. No
changes in activity between trimester two ethanol and control mice were observed in the EPM. It
is possible that using multiple anxiety tests may lead to unreliable estimates of the similarities
between the tests; a physical integration of these tests into one apparatus may prove to be more
useful in the assessment of anxiety-related traits115. From the open field and LDB results, one
can infer that second-trimester ethanol mice show significantly lower levels of anxiety-related
traits than control mice. A decrease in anxiety-related behaviour does not follow previous reports
in the literature. However, it is possible that trimester two exposure may not reduce anxiety in
offspring, per se, but may instead increase the risk of other FASD-related phenotypes, such as
impulsivity273. In such a way, the lowered anxiety-related phenotype may actually represent high
impulsivity or risk-taking behaviour, which have been reported in animal models of FASD274,275.
Children with FASD are known to be impulsive and to take risks11,276–278. Risky behaviour and
low impulse control is associated with damage to the ventromedial prefrontal cortex (VPC)279,280.
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The VPC undergoes massive neuronal migration of cells, which may contribute to this
phenotype281. The second possibility to observing lowered anxiety-like behaviours is an
anxiolytic effect of alcohol during the second trimester. Previous studies have identified a similar
phenomenon resulting in anxiolytic effects in prenatally ethanol mice282. Such findings give
evidence to the sedative effects of ethanol283. Further behavioural testing ― that deciphers
between anxiety-related behaviours and impulsivity or risky behaviour ― would allow for more
comprehensive conclusions regarding the results of anxiety-related behaviours during second
trimester ethanol exposure.
4.1.4 Deficits in spatial learning and memory result from prenatal ethanol exposure
Ethanol mice from trimester one and two showed impairments in spatial learning and
memory, albeit not to the same degree. Trimester one ethanol mice did not learn the location of a
target hole by the final learning day (Figure 11A). During short-term recall trials, ethanol mice
made the same number of explorations around the target hole than control mice (Figure 12A).
No changes in exploration indicates the adsence of short-term memory deficits in trimester one
ethanol mice. Control mice displayed an increased number of explorations to a position near the
target hole in long-term recall trials (Figure 12B). Although there was a general trend of
increased explorations to the target hole by control mice versus ethanol mice, the findings were
not significant. These results indicate the presence of learning deficits in ethanol mice; however,
trimester one exposed mice do not have severe memory delays. My results on learning trials
support those from other studies, which have demonstrated that ethanol mice show significant
impairments in spatial learning78,91,284. Observing no memory deficits following early-gestational
alcohol exposure is novel in the literature. However, the results should be interpreted with
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caution. A general trend of increased latency to the target hole was observed in ethanol mice, and
these results may be significant with increased sample size.
Young adults with FASD often have cognitive functioning abnormalities in the following
areas: intellectual ability, attention and speed of information processing, executive functioning,
language, visual perception and visual construction, number processing, and learning9,285–288.
Akin to mice that did not learn the spatial orientation of the target in the Barnes Maze,
individuals with FASD may have difficulty in developing spatial navigation and require
consistent repetition to reinforce learning15. Ethanol decreases the spatial specificity of
hippocampal place cells, suggesting that ethanol affects learning and memory by altering,
directly or indirectly, neuronal activity in the hippocampus and related structures289. The
hippocampus is critical for spatial information in guiding and organizing behaviours290. Given
that the hippocampus becomes visible during the first trimester and is vulnerable to external cues
(eg. ethanol), hippocampal abnormalities may lead to the observed spatial learning deficits291.
Although second trimester ethanol mice took longer than control mice to reach the target
on the first learning day, they were able to “catch up” by the end of the trials (Figure 11B). On
learning days three and four, trimester two ethanol mice spent signifcnatly less time searching
for the target hole than trimester one ethanol mice. The difference between early- and lategestational alcohol exposures suggests that reinforced learning in the Barnes Maze allowed
trimester-two-exposed mice to catch up to control mice by the final trial day. On the other hand,
early-gestational alcohol exposure impairs learning in offspring into adulthood, even with
repeated trials. Others have agreed that repeated learning can result in ethanol animals reaching a
similar performance level to that of control animals292. Repeated learning in children with FASD
may help to improve spatial learning when children are given an implicit learning strategy15,293.
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The late second trimester is the beginning of rapid brain growth, a time when neuroteratogens
can exert adverse effects294. Ethanol exposure during the second trimester leads to reductions in
the number of neurons and glial cells in the hippocampus2,70,295. Any spatial deficits resulting
from ethanol exposure during this time may result from hippocampal neuronal damage. In the
Barnes Maze, short-term recall trials resulted in lower numbers of explorations to the target area
by trimester two ethanol mice than control mice. Ethanol mice also made more explorations to
the opposite side of the maze than control mice (Figure 12A). Long-term recall trials resulted in
lower numbers of explorations in the target area by ethanol mice compared to control mice
(Figure 12B). These findings are contradictory, since repeated learning led to an improvement in
learning performance in ethanol mice. However, the results suggest that even repeated learning
trials may not necessarily lead to improved short-term or long-term memory following midgestational ethanol exposure.
4.1.5 Caveats to behaviour modeling of complex disorders
a) General use of mice as a model
Modeling complex disorders using the mouse is not without limitations. The first caveat
to mouse behavioural phenotyping is the resulting comparison to human subjects. This limitation
represents an issue pertaining to face validity in animal models, which addresses the extent to
which a test is subjectively viewed as covering the concept it purports to measure186. Essentially,
there must be similarity between the behaviour exhibited by the animal model, and the specific
symptom of the human condition. Establishing face validity of a model is impossible, because
claims for face validity of a model almost invariably involve subjective arbitrary arguments that
are not necessarily accepted by all investigators in the field186. As proper characterization of
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many complex disorders still remains to be properly elucidated in human studies, the validity of
specific behavioural tests to measure animal behaviour will also require revision. Another aspect
of animal model validity includes predictive validity. Predictive validity involves the
identification of potential treatments or pharmacotherapies for reducing physical or behavioural
abnormalities186. This feature of animal model validity was not addresses in my thesis, and
remains to be observed in future studies. Lastly, construct validity must be established in an
animal model of human complex disorders in order to remain valid. Construct validity refers to
whether a test measures that which it is intended to measure186. Although a necessary component
in establishing the reliability and validity of animal models, it is rarely established. For instance,
I measured anxiety-related traits using three testing apparatuses for mice, with inconsistent
results. Given this, complex behaviours may not be properly characterized using available testing
apparatuses, and the results could be misrepresented.
Other than addressing the validity of mouse models of complex disorders, there are other
limitations to behavioural research on animals. These may include: 1. varying results across
different labs using the same behavioural test, 2. experimenter’s influence (eg. odour cues) on
animal performance, 3. early-life environment of the mouse (eg. stress, maternal care), 4.
variation across mouse strains, 5. influences from previous behaviour tests . Each of these factors
may alter the outcome of behavioural analysis. However, although these issues may confound
behavioural testing, the mouse was chosen for this project based on the extensive availability of
behavioural and analytical tools.
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b) Technical considerations in the FASD project
In my project, the first caveat was the use of cardboard material in the construction of the
LDB (enclosure), EPM (closed arms), and Barnes Maze (hole covers). Cardboard has been used
by other researchers in construction of behavior apparatuses100. However, odour cues are used as
scent marks for communication between mice296. It is possible that olfactory cues could have
remained on the testing apparatus and influenced the results. Another limitation to behaviour
testing involves measurement of human traits in animal models. In my study, I found
inconsistent results across three tests that apparently measure anxiety-related behaviours (open
field, LDB, EPM). Such discrepancies may have been due to the mouse’s familiarization to
anxiety-related experiments with time, or the inability of the apparatuses to reliably measure the
same aspect of anxiety. A final source of concern in behaviour testing included reliance on
previous BAC studies in B6 mice. Given the amount of ethanol injected, I can predict that BACs
remained above a critical threshold of neurodegeneration, described by Ikonomidou and
colleagues21. However, because the exact BACs were unknown, there may be inconsistencies in
the treatments. Such caveats are intrinsic to behavioural testing, and the results from my studies
should be interpreted with caution.
4.1.6 Prenatal ethanol exposure leads to behavioural disabilities in mice
Prenatal ethanol exposure in the first and second trimester equivalents in mice leads to
delays in the achievement of developmental milestones, increased activity levels in a novel
environment, altered activity in a home cage environment, and deficits in spatial learning and
memory. However, abnormalities in anxiety-related behaviours are dependent on the timing of
gestational alcohol exposure. Mice treated at the second trimester equivalent show decreased
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anxiety-like traits compared to matched control mice. Whereas, mice treated at the first trimester
equivalent are not statistically different from matched controls. Given the nature of the
neurodevelopmental processes that occur during each stage, it is likely that behavioural
abnormalities are resultant from differential timing of gestational ethanol exposure. However, the
results also provide evidence that neither time is safe from the teratogenic effects of alcohol on
the developing brain. Herein, the timing of gestational ethanol exposure is an important factor in
the development of a spectrum of abnormalities associated with FASD.
4.2 Molecular search for the mechanisms that may govern FASD
4.2.1 Prenatal ethanol exposure leads to gene expression changes that are subtle, timingdependent, and developmental stage-specific
The developing brain is highly susceptible to the teratogenic effects of ethanol54,297.
Researchers have demonstrated that prenatal ethanol exposure can lead to long-term behavioural
abnormalities that characterize FASD7,17,91,217. These long-term behavioural consequences are
associated with changes in gene expression that are maintained into adulthood158,217. The
mechanisms maintaining alterations in gene expression may be a result of epigenetic
mechanisms, including “fine tuning” of the genome by miRNAs95,165. In my thesis, I took a novel
approach by comparing the short-term (fetal) and long-term (adult) transcriptomic changes
resulting from gestational ethanol exposure during the second trimester equivalent in the B6
mouse. I also compared the long-term changes in gene expression between two time points: first
trimester and second trimester. Furthermore, the role of miRNAs was explored in the
maintenance of the observed long-term (T1-L and T2-L) gene expression changes.
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The resulting list of T1-L and T2-L DEGs from microarray analysis provides evidence
that ethanol exposure during neurodevelopment significantly alters the transcriptome of the adult
brain, regardless of timing. In addition, prenatal ethanol exposure at T2-S also produces subtle,
immediate changes in the transcriptome of the fetal brain. Researchers argue that subtle changes
to the transcriptome are relevant to the idenitification of altered biological processes298. Because
there was close to no gene overlap across groups, this may suggest that major contributors to the
DEGs ― aside from ethanol itself ― are the timing and developmental stage of ethanol
exposure. Gestational timing may result in different sets of genes being implicated due to
changes that occur in the transcriptome as the brain develops. The resulting affected gene-sets
are based on the biological processes occuring at the time of exposure. Depending on the timing
(i.e. trimester), ethanol would likely disrupt different sets of biological pathways. Depending on
the developmental stage (fetal brain versus adult brain), the genes and pathways corresponding to
these stages will reflect differences in ethanol’s targets during brain development in the womb
versus in adulthood. Changes in gene expression could result from ethanol-induced apoptosis of
specific cell types, which may lead to an overall change in the cellular composition of the brain
and, subsequently, the overall pattern of brain gene expression21,53,54,297,299. Ethanol may disrupt
specific developmental processes that are sensitive to external cues, such as cell growth,
proliferation, migration, or differentiation10,300,301. These mechanisms may represent immediate
effects of ethanol. Ethanol may not directly alter gene expression, but rather, it may act indirectly
by altering cellular identity or physiology of the brain such that the appropriate balance of neural
gene expression is not maintained. If proper patterning is not maintained into adulthood, this may
explain why gene expression changes are still persistent in adult mice, thereby leaving a
molecular “footprint”158. Interestingly, even low blood alcohol levels can trigger apoptosis in the
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developing brain54. Also, FASD-relevant behaviours are observed in individuals with no obvious
brain abnormalities27. These observations suggest that a reduction in brain cell populations does
not account for all of the variation in FASD. Epigenetic modification may be another mechanism
responsible for altered gene expression following prenatal ethanol exposure.
It is important to note that the overall patterns of gene expression in T1-L and T2-L have
inverse numbers of upregulated versus downregulated genes from T2-S. More genes (~63%)
from T2-S analyses were upregulated than downregulated. In agreement with this finding, others
have shown that more transcripts are upregulated than downregulated as a result of inhibition of
proteins related to cell growth, differentiation, and modification302. This is reasonable given that
the second trimester is important for cell growth, proliferation, migration, and differentiation2,69.
Also, the higher percentage of upregulated genes in T2-S may be a result of an immediate
compensatory response to fetal teratogen (i.e. ethanol) exposure. More genes from T1-L (~82%)
and T2-L (~60%) were downregulated than upregulated. These overall patterns represent
developmental-stage-specific changes in the transcriptomes. Downregulation and upregulation of
different sets of genes and pathways likely depends on which biological processes are affected
by prenatal alcohol exposure at two developmental times. Ethanol has been shown to result in
downregulation of neurotransmitter-related genes in the brain, even in adult mice91,102. The
results suggest that certain genes remain dysregulated into adulthood, leading to long-term
maintenance of FASD-related behavioural abnormalities.
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4.2.2 The effects of second-trimester ethanol exposure on molecular processes in the fetal
brain (T2-S)
a) Short-term (T1-S) process 1: neuroinflammation
Functional, pathway, and network characterization of T2-S genes resulted in
neurinflammation as an affected process. The neutrophil-derived, Chemokine (C-C motif) ligand
3 (CCL3), is essential for the rapid recruitment of dendritic cells to sites of microbial
infection303. Given its role in inflammation of the nervous system, Ccl3 may have an integral and
immediate reaction to ethanol. Another gene, Leukocyte-associated immunoglobulin-like
receptor 1 (Lair1) was implicated in natural killer cell proliferation, and is involved in inhibitory
regulation of the immune system to prevent cell lysis304. Studies show that in utero alcohol
exposure can result in immune deficiencies, including impaired adaptive immune responses to
influenza virus infection, in neonates and adults305,306. Immune system-related genes affected
immediately following gestational ethanol exposure can lead to compromised immune system
response into adulthood. An ongoing neuroinflammatory process in the cerebral cortex and
cerebellum of post-mortem autistic brain samples307. Comorbidity of cognitive and behavioural
deficits in autistic children and individuals with FASD is quickly becoming a new avenue of
investigation. FASD and autism share similarities with regard to social and communicative
functioning308. Researchers have also supported the position of compromised immunity and
neuroinflammation in the autistic brain309. Of the two networks identified by IPA analysis, the
top pathway included Lair1 and Ccl3 (Figure 15). Ccl3 and Lair1 may be upregulated
immediately following prenatal ethanol exposure in an attempt to mediate the effects of
neuroinflammation by alcohol on the sensitive brain. A loss of LAIR1 results in altered immune
cell phenotypes310. CCL3 functions to traffic inflammatory cells across the blood brain barrier in
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CNS inflammation311. As a result, Lair1 and Ccl3 expression may increase in order to facilitate
proper immune function in an attempt to elicit a response following ethanol-induced
inflammation. It is possible that neuroinflammation could be a potential cause of cognitive
decline in individuals with neurodevelopmental disorders194.
b) Short-term (T2-S) process 2: chromatin stability
A second process that is disrupted in the fetal brain following acute ethanol
administration in the second trimester is chromatin stability. GE analysis identified chromatin
stability, specifically histone-related processes, with Tdg and RING1 and YY1 binding protein
(Rybp) (Table 4). Given that Tdg’s main function is repairing DNA mismatches, the finding of
“base excision repair” as the top pathway (albeit not statistically significant) from Pathway
Express is reasonable. Base excision repair mechanisms must function correctly to enable
efficient repair, and subsequent repackaging of DNA into nucleosomes312. Network analysis
using IPA showed Tdg and Rybp involved in the top network (Figure 15). Given its association
with TP53, Tdg may be upregulated immediately following fetal ethanol exposure in order to
compensate for cell death. The upregulated Rybp, involved in degradation of TP53, may
additionally compensate for the damaging effects of ethanol on the developing brain. Damage to
DNA resulting from oxidation generates single stranded breaks that must be repaired313.
Chromatin instability could be promoted if these breaks are left unrepaired. RYBP interacts with
E2 transcription factors (E2fs). E2fs play a major role in the cell cycle as checkpoint regulators
and DNA repair and replication proteins314,315. These factors also interact with histone
acetyltransferases to facilitate proper gene expression in the cell cycle316. An alteration in
transcript levels of Rybp, whether increased or decreased, may interrupt histone interaction and
lead to improper chromatin regulation. Improper chromatin regulation may lead to a loss in
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control of gene regulation and cell cycle response. Another gene, Jmy, was also identified in T2S functional and pathway analysis as a regulator of DNA-dependent transcription in response to
stress (Tables 3-6). As a transcriptional cofactor, Jmy is a key player that can impact p53
activity317. If disrupted, the DNA damage response may be altered, which could impact the
regulation of a variety of genes involved in cell cycle control and apoptosis. Ethanol exposure
can lead to DNA damage, specifically by disrupting chromatin remodeling318. Given that
chromatin remodeling is important in the regulation, unfolding, and activity of genes, any
deficiencies in this process may have severe implications on neural development and
plasticity319.
c) Short-term (T2-S) process 3: signal transduction
Another disrupted process in the fetal brain immediately following second trimester
ethanol administration is signal transduction. In the second trimester, neuroepithelial cell
proliferation and migration occurs2,69. Hence, cell-to-cell communication via signalling pathways
may be impacted as a result of ethanol exposure. Functional analysis using DAVID resulted in
the keyword, Dual specificity phosphatase (catalytic domain) or “DSPc” (Table 3). DSPcs are
key regulatory components in signal transduction pathways (eg. MAPK pathway) involved in
cellular localisation, growth, proliferation, differentiation, and transformation320. In this DAVID
category, Dusp19 and Ssh2 were implicated (Table 3). A knock down of SSH2 was found to
induce apoptotic cell death through cell cycle arrest321. Apoptotic cell death may be mediated by
changes in chromatin, resulting from damage to the DNA-histone interactions322,323. DSPcs, such
as Dusp19, have been previously implicated in major depressive disorder (MDD)324. MDD and
other depressive disorders often occur comorbid with anxiety325. These disorders may also share
similar phenotypes with FASD. Of the canonical pathways identified in IPA, “p53 signaling”,
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driven by Jmy, is associated with signal transduction pathways that mediate apoptosis. Jmy and
Bcap31 are identified in the top network from IPA (Figure 15). The downregulation of Bcap31
and Jmy may be a result of ethanol’s effect on signaling, leading to cellular compromise in the
fetal brain. Signaling pathways, including MAPK, are involved in synaptic plasticity and
learning326,327. Ethanol’s immediate effects may disrupt genes relevant to these processes.
Differential regulation of cell signaling, specifically MAPK1/ERK2 signaling, may contribute to
genetic susceptibility to FASD328. Other studies agree with my findings that signaling pathways
are disrupted following prenatal ethanol exposure in the fetal brain.
d) Short-term (T2-S) process 4: actin cytoskeleton development
Another process disrupted immediately following second trimester ethanol exposure is
actin cytoskeleton development. Specifically, Trdn was identified in the IPA function,
hypertrophy of skeletal muscle; Crem (cAMP responsive element modulator) and Trdn were both
involved in muscular hypertrophy (Table 5). Given that actin cytoskeleton development has
been identified as a disrupted process in a mouse model of FAS82, these results are relevant to
my model. Thyroid hormone and its receptor, TRDN, have been implicated in limb
development329. Other factors involved in cytoskeleton development are miRNAs; miRNA
importance in cytoskeleton development is supported in the literature330. In the top IPA network,
Hpca is upregulated while Crem, miR-397 and miR-99 are downregulated (Figure 15). Although
mature miRNAs are usually upregulated in order to downregulate their target mRNAs, they
themselves can be downregulated following prenatal ethanol exposure331. Skeletal abnormalities
are often observed in children with FAS46,332–334. Also, deformities of the joints, limbs, and
fingers have been observed in individuals with FAS257. It is presumable that genes involved in
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cytoskeleton development are altered immediately following prenatal ethanol exposure in this
model.
e) Inability to confirm short-term genes using qRT-PCR
None of the selected genes from T2-S analysis were confirmed by qRT-PCR. The
inability of qRT-PCR to detect low-fold changes is a possibility335. The likelihood that all eight
genes may be false positives is questionable, especially given that four of the genes have a
relatively high (±1.34) fold change. There was no bias in confirmation of upregulated versus
downregulated genes. An important next step to determining the problem with confirmation
would be to repeat the microarray experiment and confirm specific genes. Another step could be
to use a newer technology such as RNA sequencing (RNAseq) to further investigate candidate
genes. Another idea could be to use a more rigorous method to quantify mRNA transcript levels,
particularly if some of the genes were false positives. This could be achieved using wellestablished technology such as, Northern Blotting, ribonuclease protection assays, or droplet
digital PCR, which can confirm low fold-changes336. Using a different algorithm to assess
microarray data is another possibility. Dallas and colleagues reported a high correlation of
microarray and qRT-PCR experiments using Partek’s RMA algorithm337. The RMA algorithm
could be applied to my dataset, and the top DEGs could then be confirmed by qRT-PCR.
4.2.3 Ethanol exposure during trimester one (T1-L) leads to long-term changes to the
adult brain transcriptome
a) Long-term (T1-L) process 1: tissue morphology
Functional, pathway, and network characterization of T1-L ethanol-responsive genes
resulted in the disruption of a variety of cellular processes. One of these processes included
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tissue morphology. Gastrulation ― the early phase in embryonic development during which
germ layers begin to form ― takes place during trimester one2. Herein, it is reasonable that the
embryonic stage is disrupted following early prenatal alcohol exposure. Functional
characterization of significant genes using GE resulted in “mesoderm morphogenesis” with
Setd2 and Eomes implicated (Table 11). Eomes interacted with an interleukin in the only
significant IPA network (Figure 19). Studies have shown that Eomes is required for trophoblast
differentiation and mesoderm formation during gastrulation338. This lends credence to the
likelihood that first trimester ethanol exposure interferes with tissue morphology in the fetus,
which could be mediated by tissue-specific genes such as Eomes. Another gene, Map3k1, was
implicated in IPA functional analysis, in “Tissue Morphology” (Table 12). Loss of MAP3K1, an
enzyme involved in cellular responses to stimuli, enhances proliferation and apoptosis during
retinal morphology339. A role in developmental eyelid closure during fetal development is among
the most obvious functions of MAP3K1340. The only significant T1-L IPA network included nine
downregulated genes (Figure 19), including RAS p21 protein activator 2 (Rasa2), which is part
of several known Ras GTPase activating proteins involved in tissue distribution341. Spruce and
colleagues have implicated Rasa2, along with Eomes, in mouse embryogenesis342. Children with
FASD are often characterized with malformations of various organs, facial abnormalities, and
malformations of the optic discs and retinal vessels25. Previous mouse models have consistently
resulted in craniofacial malformations and anomalies of the face and eyes following trimester
one ethanol exposure334,343–345. It is logical that biological processes involved in tissue
morphology and organogenesis are disrupted following early gestational ethanol exposure in this
model.
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b) Long-term (T1-L) process 2: adaptive immunity
Similar to T2-S, genes and pathways disrupted in T1-L were also involved in immune
system response. Functional characterization of gene annotations using DAVID resulted in a
significant term, “TNF/stress related signaling”, with Map3k1 and Atf1 implicated. Various
Tumor necrosis factor (TNF) receptor family members are involved in lymphoid development
and/or peripheral immune system response346. One of the essential roles of Map3k1 includes
regulation of immune system development and function347,348. Given the diverse roles of
Map3k1, its disruption in the brain following ethanol exposure in the first trimester leads to
compromised immune system response. Eomes also plays a role in cell immunity, as per its
interaction with interleukin 5 (IL5) in the IPA network (Figure 19). Interleukins are cytokines
that regulate immune and inflammatory responses. Eomes controls IL5 production in memory T
helper 2 cells; T helper 2 cells play an important role in the clearance of different pathogens,
including toxins349. The downregulation of Eomes may directly impact immunity to infection by
disrupting interleukins, such as IL5. GE analysis complemented DAVID analysis, with the
identification of H2-T23 in T cell proliferation (Table 10). Given that B and T lymphocytes have
central roles in cell-mediated immunity, their identification in T1-L is well-founded. H2-T23 is a
homologue of Major histocompatibility complex, class I molecule human leukocyte antigen, E
(HLA-E), which is involved in the innate and adaptive immune systems350. My findings are
consistent with animal models of FASD that have identified deficits in adaptive immunity
following prenatal ethanol exposure351,352. Individuals with FAS can exhibit immune
deficiencies, specifically decreased lymphocytes, and diminished mitogen-induced stimulation
responses to mitogens353. It is possible that defects in host defense to infection could be
attributable to prenatal exposure to high levels of ethanol during early gestation. Tnfrsf19 also
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plays a role in immunotoxicity. Tnfrsf19 is downregulated by Aryl hydrocarbon receptor (AhR)
(Figure 19), which mediates biochemical and toxic effects of halogenated aromatic
hydrocarbons354. AhR is also involved in cell cycle regulation and development and maturation
of many tissues. The disruption of AhR by Tnfrsf19 may lead to compromised immune system
following toxicity. Ceacam1, identified in functional analysis, is responsible for a variety of
functions, one of which includes modulation of innate and adaptive immune responses. Given its
disruption following ethanol exposure, Ceacam1 may lead to lifelong changes in dendritic and
natural killer cells, which are part of the innate immune system. Adaptive immunity refers to the
adaptability of cells to infectious agents, mediated by B or T lymphocytes. Both processes may
be altered into adulthood following exposure to toxins, such as ethanol.
c) Long-term (T1-L) process 3: fatty acid synthesis
Lipid synthesis is another process that is disrupted in the adult brain following first
trimester ethanol exposure. The top functional annotation from DAVID analysis was “coenzyme
A”, with Hmgcs2 (Table 10). PE identified Hmgcs2 in the significant pathway, “synthesis and
degradation of ketone bodies”. Meanwhile, three of five top IPA canonical pathways were
relevant to fatty acid synthesis, with Rpe and Hmgcs2 included as key players. HMGCS2 is
known to regulate mitochondrial fatty acid oxidation355. Hmgcs2’s downregulation in the T1-L
network suggests that ethanol may inhibit lipid synthesis. Fatty acids contribute to regulation of
hepatic acid oxidation and synthesis in adults; fatty acids also accumulate in fetal and infant liver
in variable amounts depending on maternal diet fat composition356. My results suggest that
disruption in fatty acid production during the first trimester may lead to lifelong impairments to
similar processes in the adult. Furthermore, the role of fatty acids in FASD is recognized.
Placental fatty acid ethyl esters (FAEEs) are well-known biomarkers of heavy prenatal ethanol
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exposure357. FAEEs may be a useful screening tool for the identification of newborns at risk for
FASD358. This screening tool would be a biological attempt to facilitate proper characterization
of FASD. Results from my study are in-line with previous reports that have identified fatty acid
biosynthesis as a disrupted process following in utero ethanol exposure, and may help to
elucidate the key players involved in FASD.
d) Long-term (T1-L) process 4: DNA repair
An analysis of T1-L ethanol exposure has also implicated DNA repair as a disrupted
process. DAVID clustering of functional annotations resulted in “base-excision repair” as a
significantly affected process dependent on two genes: Mbd4 and Pcna (Table 10). “Baseexcision repair” was also the top pathway resulting from PE analysis, and also included Mbd4
and Pcna (Table 13). It is well known that ethanol is a toxic substance. The most obvious line of
evidence that ethanol produces DNA damage is the positive association between alcohol intake
and an increased risk for cancer359. Brooks and colleagues were the first to provide direct
evidence that neurons in the adult mammalian brain have the capacity to carry out DNA
mismatch repair360. Formation of the neural plate begins on GD 7 in mice345, which allows for
the compairons of these reports to my findings. Genes involved in DNA mismatch repair have
decreased expression following hypoxic stress in mammalian cells361. Herein, one can speculate
that perhaps mismatch repair proteins, i.e. PCNA are dysregulated upon gestational insults (i.e.
ethanol) and remain decreased even into adulthood362. By doing so, such proteins maintain
changes in the brain resulting from abnormalities in DNA repair.
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e) Confirmation of T1-L-specific genes using qRT-PCR
The qRT-PCR results for T1-L included the confirmation of four genes: Tnfrsf19, Eomes,
Synpr, and Map3k1 (p < 0.05). The differential expressions of Atf1, Stxbp6, Ceacam1 and 5hydroxytryptamine (serotonin) receptor 5A, G-protein coupled (Htr5a) were not reproducible by
qRT-PCR (Table 16). Given that the gene lists generated from microarray analysis did not
correct for a FDR, there may be false positives in the results, particularly for genes at low-fold
changes.
f) Alteration of miRNAs following first-trimester ethanol exposure
i.

General trends in alteration of mouse-specific miRNAs

Mouse miRNA arrays were completed on the long-term (T1-L and T2-L) samples. The
results from T1-L mouse miRNA arrays demonstrate that ethanol exposure during early
neurodevelopment affects miRNA expression in the adult brain. Since only eight mouse-specific
miRNAs out of ~1000 were significantly affected (± 1.2-fold change, p < 0.05), the results are
not stringent enough to make conclusions on array data. The findings from the miRNA arrays
should be examined with caution. It is important to note that others have also observed low
numbers of miRNAs disrupted using expression arrays363,364. Given that one miRNA has the
potential to downregulate hundreds of target mRNAs365, my findings may be relevant. In fact, a
miRNA:mRNA relationship may result in subtle, rather than drastic, changes to the
transcriptome366. A disruption in miRNAs usually leads to low-fold changes in gene expression.
Such an association is why miRNAs are often referred to as, “fine turners of gene expression”165.
Although global miRNA profiling has not been widely-used in FASD research, recent studies
report that ethanol does alter miRNA expression175,176,182,367. In my study, miRNA analysis was
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undertaken at postnatal day 70, i.e. young adulthood; therefore, the disrupted miRNAs represent
altered biological processes that are maintained into adulthood. These altered miRNAs and
processes may have lasting effects on gene expression and behavioural phenotypes.
ii.

Candidate mouse-specific miRNAs in T1-L

In general, if a miRNA is upregulated, its target gene(s) is likely to be posttranscriptionally downregulated. IPA target filtering was performed on the eight T1-L
differentially-expressed miRNAs, along with their respective DEGs to identify potential targets
of the miRNAs. Two miRNAs, miR-1192 and miR-532-5p were identified in target filtering,
along with 11 genes (Table 18). Downregulation of miR-532-5p is reported to alter the
macrophage inflammatory response to lipopolysaccharide stimulation368. MiR-532-5p is also
involved in suppression of a Runt-related transcription factor (RUNX), which is involved in a
variety of cellular processes including: cell differentiation, development, angiogenesis, cell
adhesion and invasion, DNA repair, and immunity369,370. A RUNX transcription factor (TF) is a
downstream effector of the Transforming growth factor beta (TGF-β) signaling pathway371. The
role of miR-532-5p may be relevant to the development and/or maintenance of
neurodevelopmental abnormalities, specifically those that are related to cellular maintenance and
signal transduction, particularly if its target gene is involved in one of these processes. In my
thesis, the upregulation of miR-532-5p was confirmed using qRT-PCR. The second disrupted
miRNA, miR-1192, was previously reported to be upregulated in PPARγ dominant negative
individuals372. PPARs are involved in lipid metabolism; PPARγ and PPARα are hubs in T1-L
network analysis (Figure 19). Given that I have identified fatty acid synthesis as a disrupted
process following trimester one ethanol exposure, the involvement of miR-1192 in FASD is
intriguing. However, miR-1192 was not confirmed using qRT-PCR.
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Of the 14 miRNA:mRNA interactions, ten of these have decreased mRNA fold changes
and increased miRNA fold changes (Table 18). These results demonstrate that one microRNA
(i.e. miR-532-5p) has the potential to target multiple genes (i.e. Atf1, Cspp1, Itpripl2, Nat2,
Stxbp6). Similarly, one gene (i.e. Atf1) can be targeted by multiple miRNAs (i.e. miR-1192 and
miR-532-5p). Other researchers have found that a single gene can be targeted by various
miRNAs373. Predicted genes that may be disrupted by miR-1192 and miR-532-5p include Atf1,
Itpripl2, and Stxbp6. From gene functional analysis, Atf1 was found to be involved in TNF/stress
related signaling (Tables 10). Atf1’s role in cell differentiation, immunity, cell survival, and
neurite outgrowth during early mouse development is well-established in the literature374,375.
Atf1’s function is relevant to the elucidated roles of miR-532-5p, and was a meaningful candidate
for confirmation by qRT-PCR. Another role for Atf1 is its involvement in the cellular fatty acid
homeostasis376. Atf1’s downregulation ― particularly in the context of upregulation of miR1192, which is involved in fatty acid biosynthesis ― would be relevant to FASD. However,
given that miR-1192 was not confirmed by qRT-PCR, no direct conclusions can be made. A
model for the molecular interaction between each of miR-1192 and miR-532-5p with Atf1,
Itpripl2, and Stxbp6 is shown in Figure 28.
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Figure 28. The molecular interaction between each of miR-1192 and miR-532-5p with Atf1,
Itpripl2, and Stxbp6, and their potential implication for FASD-relevant cellular processes
and behaviours. Alignment sequences of microRNAs 1192 (miR-1192) and 532-5p (miR-5325p) with Activating transcription factor 1 (Atf1), Inositol 1,4,5-triphosphate receptor interacting
protein-like 2 (Itpripl2), and Syntaxin binding protein 6 (amisyn) (Stxbp6) were idenitifed using
the
microRNA.org
–
Targets
and
Expression
database
(http://www.microrna.org/microrna/home.do/). Prediction of binding between microRNAs and
targets was performed using microRNA.org. Red arrows indicate expression. A red “X”
indicated blocking. Dashed arrows indicate a potential correlation. UTR = untranslated region.
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4.2.4 Ethanol exposure during trimester two (T2-L) leads to long-term maintenance of
molecular changes in the adult brain
a) Long-term (T2-L) process 1: unfolded protein response
Functional, pathway, and network analysis of T2-L ethanol-responsive genes resulted in
a variety of disrupted biological processes. Second trimester treatment with ethanol resulted in
alterations to UPR, which occurs in the ER. The ER quality control system recognizes unfolded
or misfolded proteins and activates stress-signaling pathways (UPR pathways) via ER stress
sensors377. Altered ER stress response signaling, resulting from promoter polymorphisms in
HSPA5, has been previously implicated in bipolar disorder378. Changes in ER-related stress
response have also been implicated in a variety of other neurodevelopmental disorders including
myopathy and Alzheimer’s Disease379,380. Presence of Homer1 in the third IPA network (Figure
24), along with Homer1’s vast roles in working memory and spatial navigation, make this gene a
suitable candidate for FASD. Isoforms of Homer1 are involved in mediation of behaviour,
maintenance of basal extracellular glutamate, and regulation of the prefrontal cortex (PFC)
glutamate release relevant to schizophrenia and stimulant abuse comorbidity381. Modulation of
glutamatergic transmission by ethanol has also been demonstrated in a rat model of FASD 382.
Perinatal alcohol exposure induces subtle differences in hippocampus-dependent spatial learning,
accompanied by glutamate transmission-related gene expression in the adult hippocampus383.
The UPR regulates glutamate receptor export in the ER384; glutamate regulation is important for
FASD-related behaviours. Genes such as Homer1 are relevant in the maintenance of FASDrelated phenotypes, such as spatial learning. The ER is also involved in storing and releasing
calcium for the biosynthesis of lipids and sterols. This is relevant given that calcium signaling
was identified as a disrupted process in T2-L using IPA and Pathway Express. Tbxa2r, Ighg, and
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Troponin C type 1 (slow) (Tnnc1) are each implicated in calcium signaling. Calcium signaling is
related to FASD since prenatal ethanol exposure alters calcium signaling in neurons that are
responsible for directing cellular activity and survival, thereby leading to apoptosis in the
developing brain385. Given that neural cell proliferation and migration occurs in the second
trimester, it is likely that calcium signaling may be disturbed. The top IPA network contains
most of the genes that were characterized in ER- and protein-related functions including: Hspa5,
Dnajb11, Pdia4, Pdia6, Xbp1, and FK506 binding protein 2, 12kDa (Fkbp2) (Figure 22). In this
network, it appears that the downregulation of Xbp1 may lead to the downregulation of other
genes including, Hspa5, Sdf2l1, Pdia4, Pdia6, Dnajb11 and Fkbp2. Given these interactions,
Xbp1’s regulation may be important in the maintenance of FASD-related phenotypes. A
network-based model for this interaction is shown in Figure 29. XBP1 is reported to regulate a
subset of ER resident chaperone genes, including Hsp40-like genes (Dnajb11), in the UPR386.
Given that Xbp1 is highly expressed in neurites during neurodevelopment, through the induction
of Brain-derived neurotropic factor (BDNF)387, its role in the maintenance of FASD is possible.
ER stress plays a role in the pathogenesis of several other neurological diseases such as
Alzheimer’s Disease and Parkinson’s Disease388,389. As a key TF in the UPR pathway, XBP1 has
been implicated in the pathophysiology of many neurodevelopmental disorders, such as
schizophrenia390. Another gene, Manf, is downregulated in the second IPA network (Figure 23).
Given that MANF acts as a neuroprotective molecule by reducing ER stress240, MANF’s
downregulation could contribute to maintenance of FASD-related features impacted by ER
stress.
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Figure 29. A network-based model for the interaction of second-trimester disrupted
molecules and their implication in FASD-relevant cellular processes and behaviours. Black
arrows indicate a molecule’s interaction. A dashed arrow represents a correlation between a
molecule and a behaviour. Red arrows indicate downregulation. Redox = reduction/oxidation.
ER = endoplasmic reticulum. Molecular symbols are generated from Ingenuity Pathway Analysis
(IPA). Refer to Appendix F for a full legend of molecular shapes from Ingenuity Pathway
Analysis. X-box binding protein (XBP1) is represented by a “transcription factor” IPA symbol.
FK506 binding protein 2, 13kDa (FKBP2), Protein disulfide isomerase family A, member 6
(PDIA6), Protein disulfide isomerase family A, member 4 (PDIA4), and Heat shock 70kDa
protein 5 (glucose-regulated protein, 78kDa) (HSPA) are represented by an “enzyme” IPA
symbol. Stromal cell-derived factor 2-like 1 (SDF2L1) and DnaJ (Hsp40) homolog, subfamily B,
member 11 (DNAJB11) are represented by an “other” IPA symbol.
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b) Long-term (T2-L) process 2: immunity
Immune system response is another disrupted process following second trimester ethanol
exposure. Given that the immune response is also compromised following ethanol treatment in
the first trimester (T1-L), and immediately following ethanol administration in the second
trimester (T2-S), this may represent a general process that is disputed no matter the timing or
developmental stage of exposure. Figure 30 illustrates the T2-S, T1-L, and T2-L DEGs that
were involved in immune response. DAVID clustering analysis resulted in “systemic lupus
erythematosus” as a significantly affected KEGG pathway, which included several histone
genes, Ighg, and Ptpn22 (Table 19). These results are consistent with IPA functional analysis
that implicated SLE as a top function under “Inflammatory Disease” (Table 21). T cells are
defective in individuals with SLE391. Researchers have reported lowered T cell numbers in fetal
mice exposed to ethanol; however, the ability of T cell levels to “catch up” to normal levels was
reinstated in adulthood392. Other have reported that, as young adults, mice prenatally exposed to
ethanol displayed immunological changes including depressed ability to produce cellular
immune responses and altered synaptic transmission393. Such studies support my hypothesis that
the immune system is compromised, even into adulthood, following in utero ethanol exposure.
Of the top three networks in T2-L, the first network is relevant to immunity, and includes,
Cdkn1a, Xbp1, Ptpn22, Hist1h3a and all other histone genes, which are all downregulated
(Figure

22).

XBP1

is

a

downstream

target

of

Inositol-requiring

transmembrane

kinase/endonuclease-1 (IRE1α), which is a UPR element that senses bacterial proteins invading
the ER to activate innate immune signaling394. Mice deficient in XBP1 show greater bacterial
burden than control mice once infected with a pathogen, which implicates XBP1 in mammalian
host defense395. Herein, Xbp1 ― possibly influenced by other factors such as IRE1α ― may be
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an important player in maintaining a compromised immune system into adulthood.
Downregulation of other genes resulting from downregulation of Xbp1 may represent an
important cascade of events that together lead to compromised immunity in FASD. Another
gene, Homer1, was downregulated in the third IPA network (Figure 24). Its interaction with IL5, which is a cytokine that participates in the regulation of immune response, may suggest that
immunity is compromised by IL-5’s action on Homer1.
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Figure 30. Immune genes altered in the fetal (immediate) and adult (late) brains following
binge ethanol exposure in the first and second trimesters. Differentially-expressed genes
identified using Partek Genomics Suite. Upregulated (green) and downregulated (red) genes are
shown for each group. T2-S = trimester two treatment, short-term exposure. Fetuses were
exposed to ethanol at gestational day (GD) 16, and fetal brains were isolated two hours post
maternal injections. T2-S genes included: Chemokine (C-C motif) ligand 3 (Ccl3), Cyclin T1
(Ccnt1), and Leukocyte-associated immunoglobulin-like receptor 1 (Lair1). T1-L = trimester one
treatment, long-term exposure. Fetuses were exposed to ethanol at GD 8 and 11. T1-L genes
included: (Atf1), Carcinoembryonic antigen-related cell adhesion molecular 1 (biliary
glycoprotein) (Ceacam1), Eomesodermin (Xenopus laevis) homolog (Eomes), Major
histocompatibility complex, class I, E (H2-T23), Mitogen-activated protein kinase kinase kinase,
E3 ubiquitin protein ligase (Map3k1), Tumor necrosis factor receptor superfamily, member 19
(Tnfrsf19), and pre-B lymphocyte 1 (Vpreb1). T2-L = trimester two treatment, long-term
exposure. Fetuses were exposed to ethanol at GD 14 and 16. T2-L genes included: Core-binding
factor, runt domain, alpha subunit 2; translocated to, 3 (Cbfa2t3), Cyclin-dependent kinase
inhibitor 1a (Cdkn1a), Early growth response 3 (Egr3), Homer homolog 1 (Drosophila)
(Homer1), Heat shock protein 90kDa alpha (cytosolic), class A member 1 (Hsp90aa1), Integrin,
alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) (Itga4), Protein tyrosine
phosphatase, non-receptor type 22 (lymphoid) (Ptpn22), Peroxiredoxin 1 (Prdx1), Sproutyrelated, EVH1 domain containing 2 (Spred2), Thromboxane A2 receptor (Tbxa2r), and X-box
binding protein 1 (Xbp1). Adult brains from T1-L and T2-L were isolated at postnatal day (PD)
70.

167

c) Long-term (T2-L) process 3: chromatin stability
Evidence for the role of epigenetics and histone modifications in FASD arises from T2-L
functional and pathway analysis. As identified in the fetal brain following second trimester
ethanol exposure (T2-S), chromatin stability is also a disrupted process in the adult brain
following trimester two ethanol exposure (T1-L). Along with all histone genes, SWI/SNF related,
matrix associated, actin dependent regulator of chromatin, subfamily A, member 5 (Smarca5) is
involved in the maintenance of chromatin structures during DNA replication (Table 19). The
histones, along with Cdkn1a, are also involved in “transcriptional misregulation in cancer”
(Table 23). The role of chromatin remodeling has been implicated in genome stability396, and
has been heavily discussed in terms of cancer397,398. Like cancer, damage to cellular development
and organization occurs following prenatal alcohol exposure. Identification of pathways involved
in cancer is reasonable. IPA network analysis of T2-L genes resulted in Cdkn1a, Smarca5, and
several histones implicated in the first network (Figure 22). Given each of their interactions with
the E2f transcription factor complex, their dysregulation may affect each other’s regulation.
Smarca5 is upregulated and directly acts on E2f, which leads to a downregulation in histones.
Cdkn1a indirectly acts on E2f, which may also lead to the downregulation of histones. The
combination of a decrease in Cdkn1a and an increase in Smarca5 may, through E2f, lead to a
disruption in histones. Given that E2f members play important roles in the cell cycle, it is
presumable that histones, Cdkn1a, and Smarca5 ― which are involved in chromatin formation
― would be disrupted. Mutations in SMARCB1, which is the a member from the same family as
SMARCA5, leads to epigenetic dysregulation of chromatin in individuals with intellectual
disabilities399. Similarly, Smarca5 could play a role in regulation of chromatin structure, which
may be disrupted following damage due to ethanol. The role of chromatin remodeling in
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neurodevelopmental disorders has not been extensively examined to date. Researchers have
reported disruption of chromatin-remodeling factors in studies on prenatal alcohol exposure and
FASD400,401. Only recently have researchers investigated epigenetic modification of chromatin
structure ― which controls gene transcription ― in neurons, as a mechanism in the etiology of
intellectual disability399,402. Further studies examining ethanol’s effect on chromatin stability may
offer insight into the biological underpinnings of FASD.
d) Long-term (T2-L) process 4: free radical signaling
A final mechanism that is disrupted in the adult brain following second trimester ethanol
exposure is free radical signaling. Proper cellular maintenance is disrupted following prenatal
alcohol exposure. Pdia4, Pdia6 and Prdx1 have been implicated in reduction-oxidation (redox)
processes from DAVID and GE analyses (Tables 19-20). Knockout of Prdx1 results in an
increased need for double stranded break repair due to increased accumulation of highly reactive
OH• radicals403. Given Prdx1’s role in erythrocyte antioxidant defence and tumor suppression404,
its downregulation as a result of ethanol exposure is reasonable. Researchers have yet to examine
whether ethanol disrupts Prdx1 levels directly. Polymorphisms in another gene, Itga4, have been
associated with susceptibility to multiple sclerosis (MS) and autism, which show comorbidity
with FASD405,406. Both MS and autism have been linked to oxidative damage407,408. The
PI3K/AKT signaling pathway was implicated as a top canonical pathway from IPA (Table 24).
Reactive oxygen species (ROS) via redox signaling to the PI3K/AKT pathway contribute to
mammalian growth of epithelial cells409. The PI3K/AKT pathway may be an important disrupted
process in the adult brain following gestational ethanol exposure. Alterations to free radical
signaling, associated with oxidative stress, are mechanisms by which ethanol exerts its long-term
effects on the brain following mid-gestation ethanol exposure. The role of oxidative stress in
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FASD is well-established in the literature44,45,410,411. Prenatal ethanol exposure causes an increase
in oxidative stress, particularly in the brain410,411. Even a brief exposure to ethanol during
gestation can produce an imbalance in the brain’s intracellular redox state412. Such imbalances in
proper brain-related redox maintenance correlate with FASD-relevant spatial learning deficits413.
Therefore, FASD-related behavioural deficits may result from damage to cellular redox,
including ROS.
e) Confirmation of T2-L-specific genes using qRT-PCR
Quantitative RT-PCR resulted in confirmation of DEGs from T2-L analysis (Table 28).
The downregulation of Calcium/calmodulin-dependent protein kinase 1G (Camk1g), Cdkn1a158,
Manf158, Egr3, Ccdc6, Xbp1, and Hspa5 was confirmed. Although statistically significant by
qRT-PCR, Homer1 and Hsp90aa1 were increased in ethanol samples compared to control
samples, which is opposite to the array results. Tbxa2r was the only gene that did not confirm.
Other researchers suggest that qRT-PCR is not sensitive to detect fold changes lower than
2.0414,415, which could be a potential contributing factor to these results.
f) Alteration of microRNAs following second-trimester ethanol exposure
i.

General trends in alteration of mouse-specific miRNAs

The results from mouse miRNA arrays show that second trimester ethanol exposure
affects miRNA expression in the adult brain. Since only 20 mature, mouse-specific miRNAs out
of ~1000 were significantly affected (± 1.2-fold change, p < 0.05), the results are not stringent
enough to make conclusions on array data, as discussed for T1-L. The results from T1-L and T2L analyses suggest that alterations to specific miRNAs are dependent on the timing of gestational
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ethanol exposure. There were no miRNAs in common between T1-L and T2-L, which signified
the timing-specific effects of ethanol on miRNA expression.
ii.

Candidate mouse-specific miRNAs in T2-L

In T2-L, target filtering using IPA resulted in six differentially-expressed miRNAs
known to interact with mRNAs (Table 30). Ten genes were identified to interact with these six
miRNAs, all of which were downregulated. Twelve interactions were found between genes and
miRNAs. Only one interaction exhibited an inverse relationship between mRNA and miRNA:
decreased Ccdc6 and increased miR-302c. The upregulation of miR-302c was confirmed by
qRT-PCR. Similar to T1-L, one miRNA (i.e. miR-449b) can have multiple target mRNAs (i.e.
Cbfa2t3, Galnt7, and Xbp1), and one gene (i.e. Ccdc6) can be regulated by multiple miRNAs
(i.e. miR-146b and miR-302c). Unlike T1-L miRNA results, most miRNAs in target filtering
analysis were downregulated. This inconsistency lends to the timing-specific effects of prenatal
ethanol exposure. The downregulation of miRNAs as a result of ethanol exposure has been
reported by other researchers174,367.
Given that in T2-L analysis, Ccdc6 is the only gene with an inverse relationship to a
miRNA, its confirmation by qRT-PCR was pursued. Recently, Merolla and colleagues identified
CCDC6, a pro-apoptotic phosphoroprotein, to be responsive to genotoxic stress; genotoxic stress
is defined as damage to the genome of an organism as a result of a genotoxin234. Increased
genotoxic stress has been linked to teratogenic substances, including ethanol416. Increased stress
can lead to disruption of signal transduction pathways that regulate cell cycle progression and
DNA stability417. DNA stability, specifically chromatin stability, and cellular redox, were
disrupted processes following prenatal ethanol administration during the second trimester. As the
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only target-filtered miRNA, miR-302c was confirmed using qRT-PCR (Figure 27). The miR302 cluster has been identified as a key family of miRNAs involved in embryonic stem cellspecific cell cycle regulation and reprogramming of both human and mouse embryonic
fibroblasts418,419. MiR-302c and Ccdc6 are involved in DNA damage and stability, which is
impacted in trimester two following in utero ethanol exposure; thus, their relationship is relevant
to FASD. MiR-302c directly contributes to regulation of p21 (CKDN1A) expression in human
embryonic stem cells, thus illuminating its role in governing G1/S transition checkpoint during
DNA damage420. Cdkn1a, whose expression was confirmed by qRT-PCR, was also identified in
target filtering analysis, albeit not for its relationship with miR-302c.
4.2.5 Hub genes may identify gene sets altered following prenatal ethanol exposure
Following the interpretation of specific cellular processes that are disrupted in each
treatment (T2-S, T1-L, and T2-L), I further examined the hub molecules in a merged network
analysis of each group. An investigation of these hubs, and their interactions with DEGs, may
illuminate potential cellular processes that are relevant to FASD. Some of the mechanisms of
these hub genes may overlap with processes identified in functional, pathway, and network
analyses. Examination of hubs may help to identify any overarching gene sets that are disrupted
following prenatal ethanol exposure. Identification of specific gene sets and processes via hub
molecules may help to elucidate the underlying mechanisms governing FASD.
a) Short-term hub molecules following second-trimester ethanol exposure (T2-S)
The top two merged networks from short-term analysis with > 10 genes showed that FOS
and HTT were hub molecules (Figure 17). FOS was found to directly interact with PIP5K1B,
which is involved in postsynaptic neuronal signaling and has been implicated in autism spectrum
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disorders222. HTT directly interacts with two factors: HPCA and BCAP31. Bcap31 is involved in
a variety of cellular processes including fragmentation of mitochondria, mitochondrial calcium
ion concentration, embryonic development, free radical scavenging, apoptosis, and immune
response. Given that HTT directly affects both upregulated (HPCA) and downregulated
(BCAP31) molecules, this lends to the complexity of gene expression alterations underlying
FASD. FOS and HTT are involved in apoptosis in the developing brain, and neuronal survival
during brain development, respectively; their immediate responses to heavy doses of ethanol are
expected.
Another hub molecule from T2-S is Interleukin 4 (IL-4), which is an inflammatory
interleukin linked with autism421. Disruption of proinflammatory cytokines may impair
cognition422,423. Compromised immune activity in the CNS is considered detrimental to cognitive
function. An IL-4 deficiency in mice leads to severe cognitive impairment and reductions of
BDNF mRNA production in astrocytes424. IL-4 acts on Small proline-rich protein 2A
(SPRR2A) and CCL3, which are upregulated in the merged network. Ccl3 is involved in many
functions including: muscular dystrophy; microglial, astrocyte and dendrite development; and
immune response. CCL3’s interaction with interleukins may be an important mechanism by
which ethanol exerts its effects. Or, IL-4 may result in increased expression of Sprr2a and Ccl3
as a protective mechanism against ethanol teratogenicity.
Other hubs in the T2-S network, such as TNF, NFkB, and Amyloid beta (A4) precursor
protein (APP) also act on the upregulated factor, CCL3. TNF, NFkB and APP are involved in
regulation of hippocampal synaptic plasticity and synapse formation425,426. Studies suggest that
NFkB and APP also have important roles in learning and memory in mice by modulation of
synaptic plasticity and growth of dendrites426,427. Because of their roles in hippocampal memory

173

formation, TNF, NFkB, and APP are prime candidates for FASD. Cellular processes related to
TNF, NFkB, and APP are consistent with the known processes of disrupted genes (eg. Ccl3).
APP’s well-defined role in cognitive decline in Alzheimer’s disease also makes it a suitable
candidate for other neurodevelopmental disorders428. Both TNF and NFkB also interact with
Crem, which is one of the few downregulated genes in the IPA network. The interactions
between these genes point to the complexity in immediate responses of the fetal brain as a result
of ethanol exposure. Another apoptosis factor affected in T2-S, Tumor protein 53 (TP53), has
direct effects on TDG, which is upregulated. TP53 is a tumor suppressor protein that functions in
apoptosis and genomic stability, and is often associated with cancer429. This hub directly affects
TDG, an enzyme that corrects DNA mismatches. An upregulation in Tdg likely occurs
immediately following ethanol exposure, particularly if cells are attempting to increase this
repair enzyme. Ethanol exposure can result in DNA damage430. An increase in Tdg, which
interacts with a central regulator of DNA damage (TP53), may be beneficial to the fetus, as an
attempt to decrease DNA damage.
b) Long-term hub molecules following first-trimester ethanol exposure (T1-L)
Merged network analysis of T1-L was not carried out, given that only one network with >
10 genes was implicated (Figure 19). Network one contained three hub molecules, one of which
was IFNG. IFNG has 18 interactions with other genes, three of which include the downregulated
molecules, CEACAM1, MAP3K1and HLA-E (i.e. H2-T23). H2-T23 acts indirectly on IFNG.
IFNG itself acts indirectly on CEACAM1 and MAP3K1. Along with interleukins, Interferon
gamma, an inflammatory cytokine, has been implicated in neurodevelopmental disorders
including autism and schizophrenia431–433. IFNG is increased at mid-gestation in women bearing
children with autism421. The immune system is compromised in children with FASD353,434, and in
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animal models of FASD435,436. Given its role in immunity, IFNG may be a key player in the
maintenance of alcohol-related transcriptome changes. H2-T23 and MAP3K1 are involved in
HTLV-I Infection, while CEACAM1 and MAP3K1 are involved in regulation of MAPK
activity. Downregulation of H2-T23 and MAP3K1 in this network, through IFNG, may lead to
compromised cell immunity.
Also considered as hubs in T1-L, PPARα and PPARγ have > 10 interactions with other
genes in the network. The upregulated molecule, Major urinary protein 5 (Mup5), is directly
acted upon by PPARα, whereas Mup5, itself, acts indirectly on PPARγ. PPARα and PPARγ both
act directly on HMGCS2, which is downregulated, and PPARγ also acts directly on PCNA.
PPARs function in metabolic pathways as transcription regulators of gene expression, and play
important roles in cellular differentiation, development, tumorigenesis, and metabolism437.
PPARs provide nuclear control of lipid metabolism and inflammation437,438. PPARs have been
implicated in cancer, and, most recently, childhood obesity439,440. Following prenatal ethanol
exposure, these hub molecules could disrupt other genes. In this network, PPARs may contribute
to the downregulation of HMGCS2 and PCNA. HMGCS2 and PCNA are involved in
ketogenesis (fatty acid breakdown) and base-excision repair (DNA damage, cancer),
respectively. Tumor Necrosis Factor-alpha, Extracellular signal-regulated kinases (ERK), c-Jun
NH(2)-terminal kinases (JNK) and p38 MAPKs each regulate PPARs. The regulation between
these factors adds to PPARs’ diverse roles in cell signaling441. Mup5, which is involved in fattyacid binding, is upregulated in coordination with the downregulation of PPARs. This relationship
further illustrates the complexity of adult genetic interactions disrupted following prenatal
ethanol exposure in the first trimester.
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c) Long-term hub molecules following second-trimester ethanol exposure (T2-L)
Merged network analysis of the top three networks from T2-L by IPA included a list of
11 hub molecules (Figure 25). The hubs included CDKN1A and XBP1. Previous functional
analysis identified that CDKN1A plays a role in PI3K/AKT signaling. PI3K/AKT signaling is an
important pathway for apoptosis, so CDKN1A’s importance as a central hub molecule is relevant
especially since neuronal apoptosis occurs following prenatal ethanol exposure50,53,54,442. XBP1 is
important for initiating UPR in neurites242. Dysregulation of XBP1 can affect neurite outgrowth
during the first trimester. In the merged network, CDKN1A was found to bind to HSP90AA1,
and interact indirectly with Prolyl 4-hydroxylase, alpha polypeptide I (P4HA1). XBP1 was found
to interact directly with six genes (Figure 25). The downregulation of XBP1 may be influencing
the downregulation of multiple genes, some of which are involved in ER-related functions,
particularly ER stress response. This cascade would likely contribute to ER-induced damage
following mid-gestation ethanol exposure, which is maintained into adulthood.
Similar to T1-L, IFNG is a hub molecule in T2-L analysis that includes interactions with
three downregulated genes including: GCHFR, CDKN1A, and EGR3. Given its previously
discussed role in inflammation, it is logical that prenatal ethanol exposure at any gestational time
during would compromise the immune system. Of the hub molecules in Figure 25, FOS, HTT,
ERK1/2, IL5, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neruo/glioblastoma
derived oncogene homolog (avian) (ERBB2), and Polyketide synthase (Pkc) interacted with give
or more input genes (DEGs), signifying the dynamic reach of each of these hubs. Erbb2 is a
receptor for neuregulins. Erbb2 has been implicated as a regulator of neuromuscular synapse
formation and is an essential component for muscle spindle development443. In T2-L functional
analysis, muscle spindle development was a disrupted process. As described for T1-L and T2-S,
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interleukins are important for proper immune system response431. In addition to IL-4 (T2-S), IL5 was implicated in children with autism421. Given that IL5 has been associated with
neurobehavioural and motor disturbances upon neonatal infection444, its role as a central hub
molecule in second trimester ethanol exposure is reasonable. Another set of hubs includes the
PKS genes, which are involved in fatty acid biosynthesis445,446, which is an affected process in
T1-L. The PKS hub genes may be relevant in establishing ethanol-induced abnormalities in the
fetus following both early and late-gestation exposure.
ERK1 and ERK2 are part of another hub in T2-L (Figure 25). These kinases comprise a
specific subset of MAPKs that are involved in cell proliferation and growth signaling447.
Disruption of ERK genes is common in cancers448. Trimester two is an important time for cell
growth and proliferation. Some of the merged network interactions between ERK1/2 and DEGs
involve those implicated in cellular development, cell death and cellular compromise (Xbp1,
Cdkn1a, Hspa5). The importance of the ERK pathway is relevant in the maintenance of
neurodevelopmental outcomes.
Commonly referred to as c-Fos, FOS is also a central hub molecule in this merged T2-L
network. FOS was also a hub in T2-S. Given that ethanol was administered at GD 16 for both
treatments, this similarity is understood. It is interesting to find that the same hub genes are
affected during the fetal stage, and even into the adult stage. As a proto-oncogene, c-Fos
contributes to apoptosis in the frontal cortex and hippocampus449. Apoptosis in these brain
regions is relevant to the pathogenesis of schizophrenia, particularly in negative symptoms
including decreases in reactivity, volition (will) and goal-directed activity upon stress450,451. In
the merged network, FOS interacts with XBP1, in which polymorphisms have been implicated in
the pathogenesis of schizophrenia in humans390,452 and in mouse models of schizophrenia243.
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Given that XBP1 may downregulate other genes implicated in neurodevelopmental disorders, it
is reasonable that its apoptotic properties are important in the development and maintenance of
FASD.
Another interesting hub molecule in T2-L, HTT, interacts directly with five DEGs, and
binds with P4HA1 (Figure 25). HTT is involved in neuronal migration and survival during
brain development453; its implication as a central hub in FASD is both novel, and not surprising,
given its brain-related role. Its interaction with HOMER1, which is involved in working memory
and spatial navigation, along with its implication in behavioural despair and anxiety, further adds
to the evidence surrounding its importance in the pathogenesis of neurodevelopmental
disorders237. Each of the T2-L hub molecules play relevant roles in brain-related functions and
their implications in FASD are well-founded.
4.3 Limitations of molecular studies on FASD
Using a mouse model to study molecular mechanisms underlying complex disorders, i.e.
FASD, has limitations. Although minimal guidelines are set out for microarray-based gene
expression studies454,455, it is difficult to find consistency in array design. For instance, I used two
biological replicates (arrays) for my experimental design, whereas three biological replicates are
considered as the minimum standard amongst researchers. To overcome such limitations, I
pooled three samples on each array. In addition to biological replicates, the industry standard
requires technical replicates. It was not feasible to include more than one technical replicate in
the array design. However, qRT-PCR of specific genes included three technical replicates per
biological sample, which offers reproducibility of results456. Another caveat to my study includes
the exclusion of one biological replicate (ethanol, T2-L) in qRT-PCR confirmation experiments.
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I chose to discount this sample due to a low A260/A280, indicating possible contamination or
degradation of RNA. Given that six samples are standard in qRT-PCR confirmation456, my
results from this analysis do not meet industry guidelines. A final caveat to molecular studies
includes disuse of a FDR-corrected p-value to create the ANOVA gene lists. A FDR is a
standard correction for multiple testing (i.e. false positives), which is a key issue in
microarrays457. The exclusion of a FDR was necessary in my study because there were no
differentially-expressed genes using a 1.1-fold change cut-off with an FDR-corrected p < 0.05.
Because I did not use a multiple testing correction strategy, my array results likely contain > 5%
false positives. Although these sources of error may impact the results, I have attempted to
overcome these limitations, and caution the reader on the existence of such caveats.
Other than the technical limitations of my study, it should also be noted that a different
set of genes was identified in a downstream analysis of 12 arrays. These 12 arrays included my
eight long-term arrays (n=4 trimester one, n=4 trimester two) that were analyzed in Partek with
another set of four long-term (trimester three) arrays. A 12-array analysis was pubished by our
group in the Journal of Neurodevelopmental Disorders (see Co-authorship statement for
details)158. Although the methods in this publication included the use of the same eight long-term
arrays that were discussed in this thesis, the 12-array analysis resulted in the identification of
substantially more DEGs. Since 12-array data was included in a single analysis in the publication
― whereas data from each trimester was generated separately for this thesis ― the results
differ. Even with a FDR correction for multiple testing, our publication reported 195 and 231
DEGs in trimester one and two, respectively, using the same cut off criteria (p < 0.05, ± 1.2-fold
change). Given the inconsistency of the results, it is relevant to comment on why such
differences may be observed. A 12-array comparison across ethanol and control arrays would
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provide greater statistical power to generate real differences between groups. The specific genes
that were differentially-expressed were largely different from those reported in this thesis. This
inconsistency reflects increased statistical power in detecting real differences that resulted from
increased sample size (3-fold). It must also be noted that, although the number of DEGs was
increased in our publication, the fold-changes were subtle (most 1.1-1.5-fold), which is similar to
the pattern of differential expression in my thesis. Also, a 12-array comparison is more robust
than a 4-array comparison. The findings from our publication may represent a more robust geneset, whereas those from my thesis may represent a more relaxed gene-set, with increased
potential for false positives.
It is difficult to rectify the discrepany across results from two different sets of analyses.
However, although different gene-sets were established, a comparison at the network-level (IPA)
may offer an encouraging explanation. In both 12-array and 4-array analyses, trimester one
pathways and networks were involved in cellular development, cell death, G-protein coupled
receptor signaling, and fatty acid biosynthesis. Again in both sets of analyses, trimester two
networks were involved in neurological disease, with APP, HTT and FOS as hub molecules.
Furthermore, common trimester two canonical pathways included ER stress response and
calcium signaling. Given the comprehensive nature of the results using a 12-array analysis, one
may expect larger networks with a greater number of hub genes. The results from my thesis are
functionally similar to those in our publication, but on a smaller scale. The downstream network
analyses in my thesis are therefore consistent with those in our publication. It should also be
noted that the results from both sets of analyses represent subtle changes to the brain
transcriptome, affecting similar functions, pathways, networks, and cellular processes. Given the
robust nature of our publication results, one might expect that confirmation of specific genes
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using qRT-PCR would be more in-line with our publication results. However, the opposite may
also be true. Comparing my 4-array analyses with the 12-array analysis, there were four genes
(Tnfrsf19, Trdn, Vpreb1, Zfp763) in common for trimester one, and three genes (Cdkn1a,
Hist1h2bm, Manf) in common for trimester two. Therefore, one must interpret microarray data
with caution, no matter the stringency of the criteria. It is possible that false positives may occur
regardless of statistical procedures. Given the inconsistent nature of microarray data,
confirmation techniques are necessary to provide reliable and reproducible results. Ultimately,
the main goal of microarrays is to identify functional relationships and cellular processes that are
disrupted following a specific treatment, and not necessarily the identification of specific genes.
4.4 Prenatal ethanol exposure and its relevance to behaviours, genes, and miRNAs
In the long-term analyses, a relationship between FASD-relevant behaviours and changes
in the transcriptome can be inferred. Behavioural deficits including, developmental milestones,
activity, and spatial learning are generally impaired no matter the timing of gestational ethanol
exposure. However, there are some behavioural differences. Trimester two ethanol exposure
resulted in timing-specific behaviours including decreased anxiety-like behaviours and consistent
spatial learning deficits in ethanol versus control mice. Whereas, trimester one ethanol mice had
no changes in anxiety-related behaviours compared to control counterparts. In T1-L, specific
genes (Atf1 and Stxbp6) were found to have an inverse relationship with miR-532-5p. Given that
miR-532-5p is involved in inflammatory response368, and may downregulate a variety of genes
including Atf1, Stxbp6, and Itpripl2, this may lead to the overwhelming support for compromised
immune system following early gestational ethanol exposure. Compromised immune system has
been associated with a range of cognitive and emotional effects in offspring458. Given the
disruptions in activity-related traits in trimester one ethanol mice, these results may point to
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maintained transcriptome changes, including specific miRNAs, which may govern these
behaviours into adulthood. In T2-L, only one gene, Ccdc6, was found to have an inverse
relationship with the upregulated miRNA, miR-302c. Given miR-302c’s role in DNA damage,
specifically in the maintenance of embryonic stem-cell cycle regulation of fibroblasts419,459, this
miRNA can interfere with second trimester specific processes that involve cellular maintenance
and development. Also, the upregulation of miR-302c could lead to a downregulation in specific
genes such as Ccdc6. Given Ccdc’s role as a pro-apoptotic phosphoprotein in response to
genotoxic (i.e. ethanol) stress234, the commonality of DNA damage in this miRNA:mRNA
relationship is apparent. Furthermore, researchers have suggested that DNA damage in brain
cells can produce locomotor disturbances and learning and memory delays460. My results are
consistent with these findings, and point to a relationship between specific behaviours
(locomotor activity, learning and memory), genes (Ccdc6), and miRNAs (miR-302c) that may
play a role in maintaining disrupted cellular processes (DNA damage). A model of the
interaction between miR-302c and Ccdc6, and their potential influence of neurodevelopment and
behaviour is shown in Figure 31.
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Figure 31. The molecular interaction between miR-302c and Ccdc6, and their potential
implication for FASD-relevant cellular processes and behaviours. Alignment equences of
microRNA 302c (miR-302c) and Coiled-coil domain containing 6 (Ccdc6) were idenitifed using
TargetScanMouse 5.2 (http://www.targetscan.org/mmu_50/). Binding of miR-302c to Ccdc6 was
predicted using TargetScanMouse. Red arrows indicate expression. A red “X” indicates
blocking. Dashed arrows indicate correlation. Dark red line represents miR-302c. UTR =
untranslated region.
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4.5 Conclusions and implications
4.5.1 Prenatal ethanol exposure leads to behavioural and transcriptomic alterations in
the mouse brain
From the behavioural experiments gathered in this report, prenatal alcohol exposure,
independent on timing of exposure, leads to FASD-relevant behavioural abnormalities in B6
mice. These mice are delayed in the achievement of developmental milestones, particularly those
related to motor coordination, and show increased activity levels in response to their placement
in a novel environment. Although all ethanol mice exhibit deficits in spatial learning and
memory, their extent depends on timing of gestational alcohol exposure. It appears that, when
exposed at late-gestation, ethanol young adults can “catch up” following repeated learning trials.
Anxiety-related traits are not consistent between treatments, with second trimester exposed mice
showing lowered anxiety-like behaviour compared to control mice; meanwhile, first trimester
ethanol and control mice are not significantly different. Such a marked difference in timing of
exposure is consistent with the spectrum of disabilities observed in individuals with FASD.
The second set of experiments provided evidence that prenatal ethanol exposure leads to
general alterations in the brain transcriptome, independent of timing of exposure. However, the
specific genes that are altered are dependent upon timing of exposure. Furthermore, the
characterized functions, pathways, and networks associated with the DEGs are consistent with
disruptions of cellular and neurodevelopmental processes that occur at comparable stages of
brain development. When comparing transcript levels between immediate exposure (fetal brain)
and long-term (adult brain) effects of exposure, common processes related to DNA/chromatin
stability, apoptosis, and inflammation are affected. Functioning of the immune system is a
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disrupted process in all three treatments, indicating that it is compromised no matter of the
timing or term of ethanol exposure. The confirmation of specific long-term genes involved in
neurodevelopment and FASD-related behavioural phenotypes lends evidence to the functions
that are maintained into adulthood. The results from gene expression analysis in this report
provide further evidence that no time during gestation is safe from the teratogenic effects of
alcohol on gene expression, and subsequent behavioural dysfunction.
The final sets of experiments in this thesis included the analysis of global miRNA levels
in the long-term brains of ethanol mice and resulted in relatively low numbers of affected
miRNAs. However, given that miRNAs can target multiple genes, it is not unlikely that only a
few key miRNAs would be affected, particularly long after ethanol had been introduced to the
fetus. The relationship between miRNAs and their target mRNAs revealed the importance of
processes involved in cellular development, proliferation, differentiation, and repair in the
pathogenesis of FASD. Although these processes peak in middle to late gestation, the results
show that they are extremely important developmental mechanisms that can be disrupted at any
time following prenatal alcohol exposure and may lead to FASD-related abnormalities. The
experiments completed in this thesis could be adapted to studying other complex disorders.
4.5.2 Implications for FASD: from mouse models to humans
The comprehensive nature of these results, which include behavioural testing and
transcriptome ― including miRNA ― analysis of multiple treatment groups, allow for some
conclusions to be made regarding the implications to FASD. The results generated from this
study have helped to elucidate the molecular mechanisms that may take place immediately
following gestational ethanol exposure, and transform into changes in adulthood. Genes and
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processes affected in the short-term exposure may represent direct effects of ethanol. Meanwhile,
genes and processes disrupted in the long-term may result from the indirect effect of ethanol on
gene expression via microRNAs. These long-term alterations may lead to a molecular “footprint”
in the adult. These results help to provide evidence that no time is safe from the consumption of
alcohol during pregnancy. Furthermore, although there are differences in timing of ethanol
exposure, the results still point to deficits in cognitive functions and brain-related transcriptome
alterations that have the potential to last a lifetime. The developing brain undergoes an
immediate response to an environmental teratogen (ethanol), and will never be the same, thereby
leading to life-long impairments in motor skills, activity, and spatial learning in mice. Some of
these abnormalities are reminiscent to those characterizing children with FASD. Also, certain
brain-related processes, including inflammation and DNA damage, are disrupted in the fetal
brains of mice exposed to ethanol in the womb. The results may further help to elucidate the
molecular mechanisms underlying FASD-related abnormalities. Given that these experiments
were successful in determining functions, networks, and miRNAs that are disrupted following
ethanol exposure, they could be developed as biomarkers for identifying individuals with FASD.
4.5.3 Future directions
The results included in this thesis implicate gene expression alterations and miRNA
disruptions in FASD-related abnormalities in mice. Such results offer novel approaches toward
unraveling the biological mechanisms underlying FASD. The identified miRNAs and mRNAs
related to the behavioural abnormalities may present novel targets for understanding of the
mechanism involved in FASD. The disrupted miRNAs and mRNA may lead to the development
of biological diagnosis, via biological markers, and subsequent therapies for individuals affected
with this disorder. Biological markers such as hub genes or disrupted cellular processes, coupled
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with maternal education and early, multidisciplinary intervention, may provide avenues to better
prognosis of families and children with FASD. Early intervention, including environmental
enrichment and improved maternal care have been reported to ameliorate some of the deficits
associated with prenatal alcohol exposure35,71,187. Multidisciplinary therapy refers to the
participation of multiple individuals in helping a child with FASD. Such individuals may include
parents, teachers, psychologists, and other health care professionals. Children with FASD who
have a strong, multidisciplinary support-system have improved performance in the classroom30.
The coupling of maternal education, and early and multidisciplinary intervention, with a
molecular seach for biological markers in FASD will lead to better diagnosis and prognosis for
individuals suffering from this disorder. This approach can be applied to other complex disorders
with fetal origin.
I hypothesize that the observed changes in behaviours such as spatial learning are likely
specific to particular brain regions. One of the candidate regions involves the hippocampus,
which has been implicated in learning and memory290,461. Performing histological analysis of
specific brain regions, staining for apoptotic neurons, and measuring transcriptomic and
behavioural changes between control and ethanol-treated mice in a specific brain region may
help to identify regional cell processes involved in specific behaviours. Once specific genes (eg.
disrupted

hubs)

and

microRNAs

are

identified,

luciferase

reporter

assays

or

immunohistochemistry techniques, along with qRT-PCR confirmation, would provide evidence
for specific miRNA:mRNA relationships altered as a result of prenatal ethanol exposure.
Subsequent knockdown and transient overexpression experiments would further our
understanding of specific molecular consequences on the developing fetal brain. Another brain
region disrupted following prenatal ethanol exposure includes the cerebellum53.The cerebellum
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is involved in motor control and cognitive functions including attention and language259.
Performing a similar protocol on cerebellum samples from control and ethanol-exposed adult
mice may help to explain the prolonged molecular effects of ethanol on life-long motor skill
disabilities related to FASD.
As mentioned, my findings may open avenues of correction by molecular manipulation
of specific cellular pathways or network hubs (eg. MAPK signaling, PI3K/AKT signaling) in
specific brain regions. Such manipulations may involve epigenetic regulation, as already
suggested by other researchers42,95,462,463. Along with the disrupted miRNAs identified during the
course of this research, additional results of DNA methylation and histone modifications could
be insightful. Indeed, the involvement of miRNAs, DNA methylation, and histone modifications
in prenatal ethanol exposure has been reported95,464,465. Epigenetic modifications may help to
explain the underlying cause(s) of FASD, given their regulation of gene expression. In my study,
I was able to identify and correlate specific neurodevelopmental genes and microRNAs with
potential contributions to disruption in cellular processes and FASD-relevant behaviours. This
brought-together a unifying theory that involved gene expression changes and gene regulation at
the transcriptional level by microRNAs. It is well-known that the central dogma of molecular
biology includes multiple gene regulatory levels. DNA methylation and histone modifications
exert their effects on gene regulation at the post-transcriptional level. Post-translational
modifications may also impact the stability of a protein once it is translated from a mRNA. An
altered set of proteins may have consequences on neurodevelopment. It would be relevant to
assess specific protein functioning following prenatal ethanol exposure using a Western blot.
Additionally, a yeast-2-hybrid screen may provide relevant information regarding protein-protein
dynamics, and how such interactions may lead to altered behaviours.
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For inclusion in this thesis, I have examined the behavioural and gene expression changes
associated with prenatal ethanol exposure. Furthermore, I have assessed gene regulation at the
transcriptional level (miRNAs). As outlined, an important next step would be to investigate
other epigenetic mechanisms at differing levels of gene regulation. Epigenetic manipulation of
genetic pathways that are disrupted following prenatal ethanol exposure may be useful in the
development of novel corrective measures for individuals with FASD.
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Appendix A. Animal use protocol approvals from Animal Care and Veterinary Services at
the University of Western Ontario.

November 1, 2009
*This is the 2nd Renewal of this protocol
*A Full Protocol submission will be required in 2011

Dear Dr. Singh:
Your Animal Use Protocol form entitled:

Genetic Regulatory Mechanisms
has had its yearly renewal approved by the Animal Use Subcommittee.
This approval is valid from November 1, 2009 to October 31, 2010
The protocol number for this project remains as 2007-059
1. This number must be indicated when ordering animals for this project.
2. Animals for other projects may not be ordered under this number.
3. If no number appears please contact this office when grant approval is received.
If the application for funding is not successful and you wish to proceed with the project, request that an internal
scientific peer review be performed by the Animal Use Subcommittee office.
4. Purchases of animals other than through this system must be cleared through the ACVS office. Health
certificates will be required.

REQUIREMENTS/COMMENTS
Please ensure that individual(s) performing procedures on live animals, as described in this protocol, are familiar
with the contents of this document.

The holder of this Animal Use Protocol is responsible to ensure that all associated safety
components (biosafety, radiation safety, general laboratory safety) comply with institutional safety
standards and have received all necessary approvals. Please consult directly with your
institutional safety officers.
c.c. Approved Protocol
Approval Letter

- S. Singh, W. Lagerwerf, S. Waring
- S. Singh, W. Lagerwerf, S. Waring

The University of Western Ontario
Animal Use Subcommittee / University Council on Animal Care
Health Sciences Centre, ● London, Ontario ● CANADA – N6A 5C1
PH: 519-661-2111 ext. 86770 ● FL 519-661-2028 ● www.uwo.ca / animal
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Nov.1, 2010
*This is the 3rd Renewal of this protocol
*A Full Protocol submission will be required in 2011
Dear Dr. Singh

Your Animal Use Protocol form entitled:

Genetic Regulatory Mechanisms: Genes Determining Ethanol Preference in Mice
has had its yearly renewal approved by the Animal Use Subcommittee.
This approval is valid from Nov.1, 2010 to Oct.31, 2011
The protocol number for this project remains as 2007-059
1. This number must be indicated when ordering animals for this project.
2. Animals for other projects may not be ordered under this number.
3. If no number appears please contact this office when grant approval is received.
If the application for funding is not successful and you wish to proceed with the project, request that an internal
scientific peer review be performed by the Animal Use Subcommittee office.
4. Purchases of animals other than through this system must be cleared through the ACVS office. Health
certificates will be required.
REQUIREMENTS/COMMENTS
Please ensure that individual(s) performing procedures on live animals, as described in this protocol, are familiar
with the contents of this document.

The holder of this Animal Use Protocol is responsible to ensure that all associated safety
components (biosafety, radiation safety, general laboratory safety) comply with institutional safety
standards and have received all necessary approvals. Please consult directly with your
institutional safety officers.

c.c. M. Kleiber, W. Lagerwerf

The University of Western Ontario
Animal Use Subcommittee / University Council on Animal Care
Health Sciences Centre, ● London, Ontario ● CANADA – N6A 5C1
PH: 519-661-2111 ext. 86770 ● FL 519-661-2028 ● www.uwo.ca / animal

AUSPC
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Subject:

eSirius Notification - Annual Protocol Renewal APPROVED by the AUS 2007-059-10::5

2007-059-10::5:
AUP Number: 2007-059-10
AUP Title: Genetic Regulatory Mechanisms: Genes Determining Ethanol Preference in Mice
Approval Date: 10/27/2011
The YEARLY RENEWAL to Animal Use Protocol (AUP) 2007-059-10 has been approved.

1. This AUP number must be indicated when ordering animals for this project.
2. Animals for other projects may not be ordered under this AUP number.
3. Purchases of animals other than through this system must be cleared through the ACVS office.
Health certificates will be required.
REQUIREMENTS/COMMENTS
Please ensure that individual(s) performing procedures on live animals, as described in this protocol, are
familiar with the contents of this document.
The holder of this Animal Use Protocol is responsible to ensure that all associated safety components
(biosafety, radiation safety, general laboratory safety) comply with institutional safety standards and have
received all necessary approvals. Please consult directly with your institutional safety officers.
Submitted by: Kinchlea, Will D
on behalf of the Animal Use Subcommittee
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Appendix B. Differentially expressed genes (DEGs) in the fetal brain following prenatal
ethanol exposure during the second trimester equivalent (T2-S).
Transcript
ID
10599884

Gene Symbola

mrna_assignment

p-value

Slitrk2

0.046

10592186

Gm9896

0.004

1.392

10510191

Zfp600

0.049

1.355

10546706

Rybp

0.030

1.351

10600024

Gpr50

0.020

1.336

10473224

Dusp19

0.045

1.302

10387816

Rnasek

0.010

1.301

10460582

AI837181

0.036

1.296

10445107

Gm4831

0.022

1.279

10519219

Gltpd1

0.034

1.276

10548565

Magohb

0.047

1.249

10559486

Lair1

0.019

1.247

10493860

Sprr2b

0.030

1.242

10516544

Hpca

0.033

1.234

10455112

Pcdhb17

NM_001161431 // RefSeq // Mus
musculus SLIT and NTRK-like family,
member 2
ENSMUST00000065197 // Gm9896 //
predicted gene 9896
NM_001177545 // RefSeq // Mus
musculus zinc finger protein 600
NM_019743 // RefSeq // Mus musculus
RING1 and YY1 binding protein
NM_010340 // RefSeq // Mus musculus
G-protein-coupled receptor 50
ENSMUST00000028384 // ENSEMBL //
cdna:known
chromosome:NCBIM37:2:80457202:804
71818:1gene
NM_173742 // RefSeq // Mus musculus
ribonuclease, RNase K (Rnasek)
ENSMUST00000159759 // ENSEMBL //
cdna:known
chromosome:NCBIM37:19:5425157:542
7313:1 gene
ENSMUST00000174626 // ENSEMBL //
cdna:pseudogene
chromosome:NCBIM37:17:37250800:37
25139
NM_024472 // RefSeq // Mus musculus
glycolipid transfer protein domain
containing 1
NM_025564 // RefSeq // Mus musculus
mago-nashi homolog B (Drosophila)
NM_001113474 // RefSeq // Mus
musculus leukocyte-associated Ig-like
receptor 1
NM_011469 // RefSeq // Mus musculus
small proline-rich protein 2B
ENSMUST00000095807 // ENSEMBL //
cdna:known
chromosome:NCBIM37:4:128788814:12
8796211:-1
NM_053142 // RefSeq // Mus musculus
protocadherin beta 17

FoldChangeb
1.429

0.008

1.234
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10473464
10378855
10389231
10361818

10605507

10432180
10498500
10373944
10598169
10584252
10352119
10350188
10606554
10360664

10430871
10362426
10457778

10398388
10398336
10436600
10411126

Olfr1015

NM_146571 // RefSeq // Mus musculus
olfactory receptor 1015
Ssh2
NM_177710 // RefSeq // Mus musculus
slingshot homolog 2 (Drosophila)
Ccl3
NM_011337 // RefSeq // Mus musculus
chemokine (C-C motif) ligand 3
Nmbr
ENSMUST00000020015 // ENSEMBL //
cdna:known
chromosome:NCBIM37:10:14480027:14
490389:1 gene
Zc3h18
NM_001029993 // RefSeq // Mus
musculus zinc finger CCCH-type
containing 18
Ccnt1
NM_009833 // RefSeq // Mus musculus
cyclin T1
Vmn2r1
NM_019918 // RefSeq // Mus musculus
vomeronasal 2, receptor 1
Zmat5
NM_026015 // RefSeq // Mus musculus
zinc finger, matrin type 5
4930449I24Rik NM_001243109 // RefSeq // Mus
musculus predicted gene 3404
Gm9513
NM_001128510 // RefSeq // Mus
musculus predicted gene 9513
Pppde1
NM_024282 // RefSeq // Mus musculus
PPPDE peptidase domain containing 1
Tmem9
NM_025439 // RefSeq // Mus musculus
transmembrane protein 9
Nap1l3
NM_138742 // RefSeq // Mus musculus
nucleosome assembly protein 1-like 3
Gm10001
NM_001081227 // RefSeq // Mus
musculus RIKEN cDNA 6330403A02
gene
Tdg
NM_011561 // RefSeq // Mus musculus
thymine DNA glycosylase
Trdn
NM_029726 // Trdn // triadin // 10 A4 //
76757
Gm10551
AK162814 // GenBank HTC // Mus
musculus 16 days neonate thymus cDNA,
RIKEN full-length
Mir380
NR_029881 // RefSeq // Mus musculus
microRNA 380, microRNA
Mir540
NR_030260 // RefSeq // Mus musculus
microRNA 540, microRNA
Mir99a
NR_029535 // RefSeq // Mus musculus
microRNA 99a, microRNA
Jmy
NM_021310 // RefSeq // Mus musculus

0.032

1.229

0.049

1.228

0.034

1.225

0.040

1.223

0.042

1.223

0.014

1.223

0.036

1.222

0.022

1.218

0.023

1.218

0.026

1.214

0.004

1.212

0.003

1.208

0.028

1.207

0.037

1.206

0.042

1.203

0.032

-1.907

0.007

-1.333

0.006

-1.331

0.042

-1.323

0.003

-1.309

0.023

-1.302
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10423505

Cmbl

10398334

Mir337

10398338

Mir665

10605081

Bcap31

10457834

Nol4

10466779

Pip5k1b

10513082

D730040F13R
ik

10577152

E330037G11R
ik

10449111

Wdr90

10457205

Crem

10598381

Gpkow

10579508

Ano8

a

junction-mediating and regulatory protein
NM_181588 // RefSeq // Mus musculus
carboxymethylenebutenolidase-like
(Pseudomonas)
NR_029765 // RefSeq // Mus musculus
microRNA 337, microRNA
NR_030425 // RefSeq // Mus musculus
microRNA 665, microRNA
NM_012060 // RefSeq // Mus musculus
B cell receptor associated protein 31
NM_199024 // RefSeq // Mus musculus
nucleolar protein 4
NM_008846 // RefSeq // Mus musculus
phosphatidylinositol-4-phosphate
5kinase, type 1 b
NM_175518 // D730040F13Rik //
RIKEN cDNA D730040F13 gene // 4 B3
// 242474 /// E
AK087889 // E330037G11Rik // RIKEN
cDNA E330037G11 gene // 8 A1.1 //
102220
NM_001163766 // RefSeq // Mus
musculus WD repeat domain 90
NM_001110856 // RefSeq // Mus
musculus cAMP responsive element
modulator
NM_173747 // RefSeq // Mus musculus
G patch domain and KOW motifs
NM_001164679 // RefSeq // Mus
musculus anoctamin 8

0.039

-1.298

0.008

-1.296

0.021

-1.271

0.026

-1.229

0.015

-1.222

0.014

-1.222

0.033

-1.214

0.027

-1.214

0.012

-1.211

0.047

-1.211

0.002

-1.205

0.032

-1.203

List of DEGs generated using Partek Genomics Suite Software with a ± 1.2-fold change cut off and p < 0.05.
DEGs are listed from highest to lowest fold change.
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Appendix C. Differentially expressed genes (DEGs) in the adult brain following prenatal
ethanol exposure during the first trimester equivalent (T1-L).
Transcript
ID

Gene Symbola

mrna_assignment

p-value

FoldChangeb

10417371

Gm3696

0.035

1.438

10367497

Olfr787

0.044

1.325

10362428

Trdn

0.015

1.308

10433902

Gm12191

0.027

1.302

10406452

Gm10759

0.024

1.301

10604342

Gm4987

0.006

1.291

10546238

Vmn1r48

0.008

1.266

10344805

Cspp1

0.036

1.217

10513514

Mup5

7.5E-4

1.213

10369890

Cisd1

0.038

1.204

10461391

Pcna

0.049

-1.391

10403658

Gng4

0.032

-1.344

10438064

Vpreb1

0.023

-1.329

10494643

Hmgcs2

0.007

-1.323

10426875

Atf1

0.012

-1.319

10472994

Mtx2

0.026

-1.316

10595805

Rasa2

0.045

-1.285

10421972

Rpl36a

0.003

-1.280

10577444

Defb11

NM_001024712 // RefSeq // Mus
musculus predicted gene 3696
NM_001011822 // RefSeq // Mus
musculus olfactory receptor 787
NM_029726 // RefSeq // Mus musculus
triadin
NR_028101 // RefSeq // Mus musculus
predicted gene 12191, non-coding
AY344585 // GenBank // Mus musculus
hypothetical protein (Arzc)
NM_001085510 // RefSeq // Mus
musculus predicted gene 4987
NM_053218 // RefSeq // Mus musculus
vomeronasal 1 receptor 48
NM_026493 // RefSeq // Mus musculus
centrosome and spindle pole associated
protein 1
NM_008649 // RefSeq // Mus musculus
major urinary protein 5
XR_032286 // RefSeq // PREDICTED:
Mus
musculus
similar
to
phosphoribosylaminoimine
NM_011045 // RefSeq // Mus musculus
proliferating cell nuclear antigen
NM_010317 // RefSeq // Mus musculus
guanine nucleotide binding protein
NM_016982 // RefSeq // Mus musculus
pre-B lymphocyte gene 1
NM_008256 // RefSeq // Mus musculus 3hydroxy-3-methylglutaryl-Coenzyme
A
synthase
NM_007497 // RefSeq // Mus musculus
activating transcription factor 1
NM_016804 // RefSeq // Mus musculus
metaxin 2, nuclear gene encoding
NM_053268 // RefSeq // Mus musculus
RAS p21 protein activator 2
NM_019865 // RefSeq // Mus musculus
ribosomal protein L36A
NM_139221 // RefSeq // Mus musculus
defensin beta 11

0.026

-1.277
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10360460

Chml

10361651

Nup43

10587633

Mrap2

10406777

Gcnt4

10570029

Myo16

10469571

Otud1

10412719

Synpr

10410115
10412100

1110018J18Ri
k
Map3k1

10449971

Zfp763

10466423

Cep78

10572085

Nat1

10588582

6430571L13Ri
k

10520355

Htr5a

10566237

Olfr624

10351277

Nme7

10475946

Zc3h6

10400143

Stxbp6

10594044

Islr

10368495

Rspo3

10450682

H2-T23

NM_021350 // RefSeq // Mus musculus
choroideremia-like
NM_145706 // RefSeq // Mus musculus
nucleoporin 43
NM_001177731 // RefSeq // Mus
musculus
melanocortin
2
receptor
accessory protein
NM_001166065 // RefSeq // Mus
musculus
glucosaminyl
(N-acetyl)
transferase 4
NM_001081397 // RefSeq // Mus
musculus myosin XVI
NM_027715 // RefSeq // Mus musculus
OTU domain containing 1
NM_028052 // RefSeq // Mus musculus
synaptoporin
NM_025370 // RefSeq // Mus musculus
RIKEN cDNA 1110018J18 gene
NM_011945 // RefSeq // Mus musculus
mitogen-activated protein kinase kinase
kinase 1
NM_028543 // RefSeq // Mus musculus
zinc finger protein 763
NM_198019 // RefSeq // Mus musculus
centrosomal protein 78
NM_008673 // RefSeq // Mus musculus Nacetyl transferase 1
BC116708 // GenBank // Mus musculus
RIKEN cDNA 6430571L13 gene, mRNA
(cDNA clone)
NM_008314 // RefSeq // Mus musculus 5hydroxytryptamine (serotonin) receptor 5A
NM_001011865 // RefSeq // Mus
musculus olfactory receptor 624
NM_138314 // RefSeq // Mus musculus
non-metastatic cells 7
NM_178404 // RefSeq // Mus musculus
zinc finger CCCH type containing 6
NM_144552 // RefSeq // Mus musculus
syntaxin binding protein 6 (amisyn)
NM_012043 // RefSeq // Mus musculus
immunoglobulin superfamily containing
leucine-rich repeat
NM_028351 // RefSeq // Mus musculus Rspondin 3 homolog (Xenopus laevis)
NM_010398 // RefSeq // Mus musculus

0.002

-1.268

0.049

-1.264

0.035

-1.263

0.0383

-1.263

0.039

-1.257

0.049

-1.251

0.039

-1.250

0.005

-1.249

0.043

-1.247

0.026

-1.244

0.010

-1.244

0.024

-1.240

0.023

-1.240

0.022

-1.238

0.003

-1.237

0.014

-1.236

0.004

-1.232

0.028

-1.225

0.030

-1.224

0.047

-1.219

0.003

-1.217
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10588083

Faim

10379028

Mir451

10547088

Mbd4

10567299

Itpripl2

10561008

Ceacam1

10546430

Adamts9

10469108

Gm10857

10347106

Rpe

10462346

Rcl1

10589994

Eomes

10420596

Tnfrsf19

10589587

Setd2

10484457

Clp1

10380210

Sfrs1

10492757

Plrg1

a

histocompatibility 2, T region locus 23
NM_001122851 // RefSeq // Mus
musculus
Fas
apoptotic
inhibitory
molecule
NR_029971 // RefSeq // Mus musculus
microRNA 451, microRNA
NM_010774 // RefSeq // Mus musculus
methyl-CpG binding domain protein 4
NM_001033380 // RefSeq // Mus
musculus
inositol
1,4,5-triphosphate
receptor
NM_001039185 // RefSeq // Mus
musculus
carcinoembryonic
antigenrelated cell adhesion
NM_175314 // RefSeq // Mus musculus a
disintegrin-like and metallopeptidase
NR_033470 // RefSeq // Mus musculus
predicted gene 10857
NM_025683 // RefSeq // Mus musculus
ribulose-5-phosphate-3-epimerase
NM_021525 // RefSeq // Mus musculus
RNA terminal phosphate cyclase-like 1
NM_010136 // RefSeq // Mus musculus
eomesodermin homolog (Xenopus laevis)
NM_013869 // RefSeq // Mus musculus
tumor necrosis factor receptor superfamily
NM_001081340 // RefSeq // Mus
musculus SET domain containing 2
ENSMUST00000028475 // ENSEMBL //
Polyribonucleotide 5'-hydroxyl-kinase
NM_173374 // RefSeq // Mus musculus
splicing factor, arginine/serine-rich 1
NM_016784 // RefSeq // Mus musculus
pleiotropic regulator 1, PRL1 homolog
(Arabidopsis)

0.007

-1.217

0.024

-1.215

0.013

-1.213

0.036

-1.211

0.038

-1.209

0.006

-1.208

0.002

-1.206

0.047

-1.206

0.017

-1.206

0.039

-1.204

0.024

-1.203

0.005

-1.202

0.023

-1.202

0.028

-1.202

0.029

-1.200

List of DEGs generated using Partek Genomics Suite Software with a ± 1.2-fold change cut off and p < 0.05.
DEGs are listed from highest to lowest fold change.
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Appendix D. Differentially expressed genes (DEGs) in the adult brain following prenatal
ethanol exposure during the second trimester equivalent (T2-L).
Transcript
ID
10469320

Gene Symbola

mrna_assignment

p-value

Gm9875

0.044

10557229

LOC100134980

0.033

1.304

10461152

Snhg1

0.010

1.265

10436200

Gm8824

0.049

1.260

10491060

Spin3

0.012

1.254

10552570

Klk1b11

0.049

1.254

10579915

Smarca5

0.047

1.243

10418604

Phf7

0.038

1.242

10473125

Itga4

0.029

1.235

10593095

Cep164

0.009

1.235

10398286

Mir342

0.041

1.232

10544106

Zc3hav1

0.049

1.231

10567450

Dnahc3

0.029

1.229

10474335

Immp1l

0.023

1.229

10358621

Hmcn1

0.036

1.225

10513920

Gm11488

0.045

1.225

10603005

Gm15204

ENSMUST00000064229 // ENSEMBL
// Putative uncharacterized protein gene
BC016578 // GenBank // Mus musculus
hypothetical LOC100134980, mRNA
AK051045 // GenBank HTC // Mus
musculus 9 days embryo whole body
cDNA, RIKEN
XR_034572 // RefSeq // PREDICTED:
Mus musculus hypothetical protein
LOC100048225
XR_031023 // RefSeq // PREDICTED:
Mus musculus similar to spindlin
(LOC675593)
NM_010640 // RefSeq // Mus musculus
kallikrein 1-related peptidase b11
NM_053124 // RefSeq // Mus musculus
SWI/SNF related, matrix associated,
actin
NM_027949 // RefSeq // Mus musculus
PHD finger protein 7
NM_010576 // RefSeq // Mus musculus
integrin alpha 4
NM_001081373 // RefSeq // Mus
musculus centrosomal protein 164
NR_029771 // RefSeq // Mus musculus
microRNA 342, microRNA
ENSMUST00000121946 // ENSEMBL
//
cdna:pseudogene
chromosome:NCBIM37:6:38492303:3
BC051401 // GenBank // Mus musculus
dynein, axonemal, heavy chain 3
NM_028260 // RefSeq // Mus musculus
IMP1 inner mitochondrial membrane
peptidase-like (S. cerevisiae)
NM_001024720 // RefSeq // Mus
musculus hemicentin 1
ENSMUST00000117277 // ENSEMBL
//
cdna:pseudogene
chromosome:NCBIM37:4:73158649:7
ENSMUST00000119454 // ENSEMBL
//
cdna:pseudogene

FoldChangeb
1.337

0.008

1.224

235

10584582

Gm10694

10491877

D3Ertd751e

10399314

Mfsd2b

10365098

Tbxa2r

10371842

Uhrf1bp1l

10362937

Gm6983

10474915

Gchfr

10545079

A530053G22Rik

10413596

Sfmbt1

10423733

Vps13b

10438098

Sdf2l1

10403943

Hist1h2bm

10394735

Pdia6

10443463

Cdkn1a

10544525

Pdia4

10374035

Xbp1

10471586

Hspa5

10596575

Manf

chromosome:NCBIM37:X:158789528
ENSMUST00000098870 // ENSEMBL
// Putative uncharacterized protein gene
NM_028667 // RefSeq // Mus musculus
DNA segment, Chr 3, ERATO Doi 751,
expressed
NM_001033488 // RefSeq // Mus
musculus major facilitator superfamily
domain containing 2B
NM_009325 // RefSeq // Mus musculus
thromboxane A2 receptor
NM_029166 // RefSeq // Mus musculus
UHRF1 (ICBP90) binding protein 1like
XR_033422 // RefSeq // PREDICTED:
Mus musculus similar to ribosomal
protein S8
NM_177157 // RefSeq // Mus musculus
GTP cyclohydrolase I feedback
regulator
NR_015565 // RefSeq // Mus musculus
RIKEN cDNA A530053G22 gene
NM_001166532 // RefSeq // Mus
musculus Scm-like with four mbt
domains 1
GENSCAN00000007934 // ENSEMBL
//
cdna:Genscan
chromosome:NCBIM37:15:35501834:3
56
NM_022324 // RefSeq // Mus musculus
stromal cell-derived factor 2-like 1
NM_178200 // RefSeq // Mus musculus
histone cluster 1, H2bm
NM_027959 // RefSeq // Mus musculus
protein disulfide isomerase associated 6
NM_007669 // RefSeq // Mus musculus
cyclin-dependent kinase inhibitor 1A
(P21)
NM_009787 // RefSeq // Mus musculus
protein disulfide isomerase associated 4
NM_013842 // RefSeq // Mus musculus
X-box binding protein 1
NM_022310 // RefSeq // Mus musculus
heat shock protein 5
NM_029103 // RefSeq // Mus musculus
mesencephalic
astrocyte-derived

0.006

1.223

0.038

1.22

0.045

1.216

0.033

1.209

0.041

1.205

0.019

1.204

0.012

1.203

0.049

1.202

0.015

1.201

0.044

1.201

0.009

-1.783

0.023

-1.467

0.014

-1.465

0.021

-1.425

0.012

-1.414

0.028

-1.367

0.005

-1.365

0.009

-1.349

236

10374464

Spred2

10397966

Otub2

10408202

Hist1h3f

10408083

Hist1h3g

10404049

Hist1h3d

10404065

Hist2h3b

10520862

Fosl2

10403073

Ighg

10361250

Camk1g

10434675

Dnajb11

10363845

Ccdc6

10408246

Hist1h3a

10468980

Fam107b

10413726

Tnnc1

10507328

Prdx1

10535369

Gm15770

10578984

Tufm

10447594

Dynlt1a

neurotrophic
BC040462 // GenBank // Mus musculus
sprouty-related,
EVH1
domain
containing 2
NM_001177841 // RefSeq // Mus
musculus OTU domain, ubiquitin
aldehyde binding 2
NM_013548 // RefSeq // Mus musculus
histone cluster 1, H3f
NM_145073 // RefSeq // Mus musculus
histone cluster 1, H3g
NM_178204 // RefSeq // Mus musculus
histone cluster 1, H3d
NM_178215 // RefSeq // Mus musculus
histone cluster 2, H3b
NM_008037 // RefSeq // Mus musculus
fos-like antigen 2
X70423 // GenBank // M.musculus
mRNA for monoclonal antibody heavy
chain gamma 2
NM_144817 // RefSeq // Mus musculus
calcium/calmodulin-dependent protein
kinase 1G
NM_026400 // RefSeq // Mus musculus
DnaJ (Hsp40) homolog, subfamily B,
member 11
NM_001111121 // RefSeq // Mus
musculus coiled-coil domain containing
6
NM_013550 // RefSeq // Mus musculus
histone cluster 1, H3a
BC021353 // GenBank // Mus musculus
family with sequence similarity 107,
member b
NM_009393 // RefSeq // Mus musculus
troponin C, cardiac/slow skeletal
NM_011034 // RefSeq // Mus musculus
peroxiredoxin 1
ENSMUST00000117498 // ENSEMBL
//
cdna:pseudogene
chromosome:NCBIM37:5:143614295:
NM_172745 // RefSeq // Mus musculus
Tu translation elongation factor,
mitochondrial
NM_001166629 // RefSeq // Mus
musculus dynein light chain Tctex-type

0.031

-1.336

0.047

-1.314

0.023

-1.307

0.030

-1.303

0.041

-1.292

0.029

-1.283

0.040

-1.281

0.022

-1.280

0.023

-1.266

0.003

-1.254

0.019

-1.254

0.026

-1.245

0.040

-1.245

0.021

-1.245

0.049

-1.230

0.017

-1.230

0.048

-1.225

0.005

-1.223
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10424213
10516765
10419525

10524234

10494978

10490946
10465553
10578771

10448676

10548785

10396237

10416251
10363350

1A
Zhx2
NM_199449 // RefSeq // Mus musculus
zinc fingers and homeoboxes 2
Serinc2
NM_172702 // RefSeq // Mus musculus
serine incorporator 2
A930018M24Rik BC144873 // GenBank // Mus musculus
cDNA
clone
MGC:178429
IMAGE:9053421
Galnt9
NM_198306 // RefSeq // Mus musculus
UDP-N-acetyl-alpha-Dgalactosamine:polypeptidase
Ptpn22
NM_008979 // RefSeq // Mus musculus
protein tyrosine phosphatase, nonreceptor type 22 (lymphoid)
Hsp90aa1
NM_010480 // RefSeq // Mus musculus
heat shock protein 90, alpha (cytosolic)
Fkbp2
NM_008020 // RefSeq // Mus musculus
FK506 binding protein 2
Galnt7
NM_144731 // RefSeq // Mus musculus
UDP-N-acetyl-alpha-D-galactosamine:
polypeptidase
Slc9a3r2
NM_023055 // RefSeq // Mus musculus
solute
carrier
family
9
(sodium/hydrogen exchange), isoform 3
regulator 2
Dynlt1c
NM_001166630 // RefSeq // Mus
musculus dynein light chain Tctex-type
1C
2700049A03Rik NM_001163378 // RefSeq // Mus
musculus RIKEN cDNA 2700049A03
gene
Egr3
NM_018781 // RefSeq // Mus musculus
early growth response 3
P4ha1
NM_011030 // RefSeq // Mus musculus
procollagen-proline, 2-oxoglutarate 4dioxygenase subunit alpha-1

10406626

Homer1

10582429

Cbfa2t3

a

0.012

-1.221

0.016

-1.221

0.042

-1.217

0.015

-1.217

0.033

-1.216

0.041

-1.215

0.042

-1.214

0.019

-1.212

0.006

-1.211

0.039

-1.208

0.007

-1.205

0.040

-1.205

0.003

-1.205

NM_147176 // RefSeq // Mus musculus 0.021
homer homolog 1 (Drosophila)
NM_009824 // RefSeq // Mus musculus 0.043
core-binding factor, runt domain, alpha
subunit

-1.203
-1.203

List of DEGs generated using Partek Genomics Suite Software with a ± 1.2-fold change cut off and p < 0.05.
DEGs are listed from highest to lowest fold change.
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Appendix E. Journal copyright approval form.
To whom it may concern:
Regarding the following paper published in the Journal of Behavioral and Brain Sciences:
Neurodevelopmenntal Timin
ng of Ethanol Exposure May Contribute to Observed
Heterogeneity of Behavioral Deficits in a Mouse Model of Fetal Alcohol Spectrum Disorder
(FASD)
Katarzyna Mantha, Morgan Kleiber, Shiva Singh
PP. 85-999, Pub. Date: February 27, 2013
DOI: 100.4236/jbbs..2013.31009
The coauthor Katarzyna Mantha from University of Western Ontario is thereby allowed to
include the above paper into her doctoral thesis “Neurodevelopmmental consequences of prenatal
alcohol exposure: Behavioural and transcriptomic altterations in a mouse model”, all the contents
cited from the mentioned paper should be footnoted as references. Use of this paper for other
purpose should be submitted to the JBBS editorial board office for permission.

Best Wishes
Karen Zhang
Editoriaal Assistant of JBBS
http://wwww.scirp.orrg/journal/jbbbs/
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Appendix F. Ingenuity Pathway Analysis network legend for relationship types, molecular
shapes, and relationships.
Relationship types

Molecular shapes
Cytokine/Growth
factor

A

Activation

B

Binding

Enzyme

C

Causes/Leads to

G-protein coupled
receptor

EC

Chemical-chemical
interaction
Chemical-protein
interaction
Expression (includes
metabolism/synthesis
for chemicals)
Enzyme Catalysis

I

Inhibition

Phosphatase

L

Proteolysis (includes
degradation for
Chemicals)

Transcription
regulator

LO

Localization

CC
CP
E

PD

Biochemical
Modification
Group/complex
Membership
Phosphorylation/Depho
sphorylation
Protein-DNA binding

PP
PR
RB
RE
RR
T
TR

Protein-Protein binding
Protein-RNA binding
Regulation of binding
Reaction
RNA-RNA Binding
Transcription
Translocation

M
MB
P

Ion channel
Kinase
Ligand-dependent
nuclear receptor
Peptidase

Translation
regulator
Transmembrane
receptor
Transporter
microRNA
Complex/Group
Other

Relationships
Binding
Inhibition
Acts on
Inhibits and
acts on
Leads to
Translocates
to
Reaction
Direct
interaction
Indirect
interaction
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